0001641172-25-004916.txt : 20250415 0001641172-25-004916.hdr.sgml : 20250415 20250415172917 ACCESSION NUMBER: 0001641172-25-004916 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250415 DATE AS OF CHANGE: 20250415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bowen Acquisition Corp CENTRAL INDEX KEY: 0001973056 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41741 FILM NUMBER: 25840706 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVE, SUITE 2446 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 203-998-5540 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVE, SUITE 2446 CITY: NEW YORK STATE: NY ZIP: 10170 10-K 1 form10-k.htm
false FY 0001973056 00-0000000 0001973056 2024-01-01 2024-12-31 0001973056 BOWN:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2024-01-01 2024-12-31 0001973056 BOWN:OrdinarySharesParValue0.0001PerShareMember 2024-01-01 2024-12-31 0001973056 BOWN:RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember 2024-01-01 2024-12-31 0001973056 2024-06-28 0001973056 2025-04-15 0001973056 2024-10-01 2024-12-31 0001973056 2024-12-31 0001973056 2023-12-31 0001973056 us-gaap:NonrelatedPartyMember 2024-12-31 0001973056 us-gaap:NonrelatedPartyMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember 2023-12-31 0001973056 2023-02-17 2023-12-31 0001973056 BOWN:RedeemableOrdinarySharesMember 2024-01-01 2024-12-31 0001973056 BOWN:RedeemableOrdinarySharesMember 2023-02-17 2023-12-31 0001973056 BOWN:NonRedeemableOrdinarySharesMember 2024-01-01 2024-12-31 0001973056 BOWN:NonRedeemableOrdinarySharesMember 2023-02-17 2023-12-31 0001973056 us-gaap:CommonStockMember 2023-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001973056 us-gaap:RetainedEarningsMember 2023-12-31 0001973056 us-gaap:CommonStockMember 2023-02-16 0001973056 us-gaap:AdditionalPaidInCapitalMember 2023-02-16 0001973056 us-gaap:RetainedEarningsMember 2023-02-16 0001973056 2023-02-16 0001973056 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001973056 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001973056 us-gaap:CommonStockMember 2023-02-17 2023-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2023-02-17 2023-12-31 0001973056 us-gaap:RetainedEarningsMember 2023-02-17 2023-12-31 0001973056 us-gaap:CommonStockMember 2024-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001973056 us-gaap:RetainedEarningsMember 2024-12-31 0001973056 us-gaap:NonrelatedPartyMember 2024-01-01 2024-12-31 0001973056 us-gaap:NonrelatedPartyMember 2023-02-17 2023-12-31 0001973056 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0001973056 us-gaap:RelatedPartyMember 2023-02-17 2023-12-31 0001973056 us-gaap:IPOMember 2023-07-14 2023-07-14 0001973056 us-gaap:IPOMember 2023-07-14 0001973056 us-gaap:PrivatePlacementMember 2023-07-14 2023-07-14 0001973056 us-gaap:PrivatePlacementMember 2023-07-14 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-17 2023-07-17 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-18 2023-07-18 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-18 0001973056 us-gaap:PrivatePlacementMember 2023-07-18 2023-07-18 0001973056 us-gaap:IPOMember 2023-07-18 2023-07-18 0001973056 us-gaap:IPOMember 2023-07-18 0001973056 2024-10-07 0001973056 BOWN:EarlyBirdCapitalMember 2024-10-07 0001973056 us-gaap:SubsequentEventMember 2025-01-10 2025-01-10 0001973056 us-gaap:SubsequentEventMember 2025-01-10 0001973056 us-gaap:SubsequentEventMember 2025-01-14 2025-01-14 0001973056 us-gaap:SubsequentEventMember 2025-04-14 2025-04-14 0001973056 us-gaap:SubsequentEventMember 2025-04-14 0001973056 BOWN:MergerSharesMember BOWN:AgreementMember 2024-01-18 2024-01-18 0001973056 BOWN:EarnoutSharesMember BOWN:AgreementMember srt:MaximumMember 2024-01-18 2024-01-18 0001973056 BOWN:RedeemableSharesMember 2024-01-01 2024-12-31 0001973056 BOWN:NonRedeemableSharesMember 2024-01-01 2024-12-31 0001973056 BOWN:RedeemableSharesMember 2023-02-17 2023-12-31 0001973056 BOWN:NonRedeemableSharesMember 2023-02-17 2023-12-31 0001973056 us-gaap:IPOMember 2024-01-01 2024-12-31 0001973056 us-gaap:IPOMember 2024-12-31 0001973056 us-gaap:IPOMember 2023-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2024-01-01 2024-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2024-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2023-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-14 2023-07-14 0001973056 BOWN:QianzhiMember 2024-01-01 2024-12-31 0001973056 us-gaap:PrivatePlacementMember BOWN:SponsorsMember 2023-07-14 2023-07-14 0001973056 us-gaap:PrivatePlacementMember BOWN:EBCMember 2023-07-14 2023-07-14 0001973056 us-gaap:PrivatePlacementMember BOWN:UnderwritersMember 2023-07-14 2023-07-14 0001973056 BOWN:SponsorsMember 2023-02-27 2023-02-27 0001973056 BOWN:SponsorsMember us-gaap:OverAllotmentOptionMember 2023-02-27 2023-02-27 0001973056 BOWN:EBCMember 2023-03-15 2023-03-15 0001973056 BOWN:EBCMember 2023-03-15 0001973056 BOWN:SponsorsMember 2024-10-14 2024-10-14 0001973056 BOWN:EBCFounderSharesMember 2024-10-14 0001973056 BOWN:PromissoryNoteMember BOWN:SponsorsMember 2023-02-27 0001973056 BOWN:PromissoryNoteMember BOWN:SponsorsMember 2023-02-27 2023-02-27 0001973056 BOWN:EBCFounderSharesMember 2024-12-31 0001973056 us-gaap:OverAllotmentOptionMember srt:MaximumMember 2024-01-01 2024-12-31 0001973056 us-gaap:RelatedPartyMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AccountingServicesExpenseMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AccountingServicesExpenseMember 2023-12-31 0001973056 BOWN:AccountingServiceAgreementAndOtherMember 2023-02-17 2023-12-31 0001973056 BOWN:SponsorsMember srt:MaximumMember 2023-07-11 2023-07-11 0001973056 BOWN:EBCFounderSharesMember 2024-01-01 2024-12-31 0001973056 BOWN:FounderSharesMember 2024-01-01 2024-12-31 0001973056 2023-03-15 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member BOWN:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember 2023-03-15 0001973056 BOWN:FounderSharesMember 2024-10-14 0001973056 2024-10-14 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member BOWN:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember 2024-10-14 0001973056 us-gaap:RelatedPartyMember BOWN:InitialAccountingServiceFeeMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:InitialAccountingServiceFeeMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AccountingServiceFeeAndOthersMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AccountingServiceFeeAndOthersMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AdministrationFeeMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AdministrationFeeMember 2023-12-31 0001973056 BOWN:BusinessCombinationMarketingAgreementMember 2024-01-01 2024-12-31 0001973056 BOWN:BusinessCombinationMarketingAgreementMember 2024-12-31 0001973056 BOWN:QianzhiMember 2024-01-01 2024-12-31 0001973056 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001973056 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001973056 us-gaap:SubsequentEventMember 2025-01-13 2025-01-13 0001973056 us-gaap:SubsequentEventMember 2025-03-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the fiscal year ended December 31, 2024

 

☐. Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from ___________ to ____________

 

Commission File Number 001-41741

 

BOWEN ACQUISITION CORP

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A

(State or Other Jurisdiction

of Incorporation or Organization)

  

(I.R.S. Employer

Identification No.)

 

420 Lexington Ave, Suite 2446

New York, NY 10170

(Address of Principal Executive Offices) (Zip Code)

 

(203) 998-5540

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one ordinary share and one right   BOWNU   The Nasdaq Stock Market LLC
         
Ordinary Shares, par value $0.0001 per share   BOWN   The Nasdaq Stock Market LLC
         
Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination   BOWNR   The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of June 28, 2024 (the last business day of the registrant’s most recently completed second fiscal quarter), the aggregate market value of the ordinary shares held by non-affiliates of the registrant was approximately $74.9 million based on its last reported sales price of $10.55 on Nasdaq.

 

As of April 15, 2025, 3,010,973 Ordinary Shares, par value $0.0001 per share, were issued and outstanding.

 

Documents Incorporated by Reference: The information contained in the registrant’s definitive proxy statement/prospectus dated December 18, 2024, as filed with the Securities and Exchange Commission on such date, pursuant to Rule 424(b)(3) (SEC File No. 333-282021) is incorporated into certain portions of Parts I, II, and III, as disclosed herein.

 

 

 

 

 

 

BOWEN ACQUISITION CORP

FORM 10-K

 

TABLE OF CONTENTS

 

PART I    
Item 1. Business 1
Item 1A. Risk Factors 3
Item 1B. Unresolved Staff Comments 5
Item 1C. Cybersecurity 5
Item 2. Properties 6
Item 3. Legal Proceedings 6
Item 4. Mine Safety Disclosures 6
     
PART II    
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 6
Item 6. [Reserved] 7
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 7
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 10
Item 8. Financial Statements and Supplementary Data 10
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures 10
Item 9A. Controls and Procedures 10
Item 9B. Other Information 11
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 12
     
PART III    
Item 10. Directors, Executive Officers and Corporate Governance 12
Item 11. Executive Compensation 16
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 17
Item 13. Certain Relationships and Related Transactions, and Director Independence 19
Item 14. Principal Accountant Fees and Services 21
     
PART IV    
Item 15. Exhibits, Financial Statement Schedules 22
Item 16. Form 10-K Summary 23

 

i 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; SUMMARY OF RISK FACTORS

 

Certain statements in this Annual Report on Form 10-K (the “Annual Report”) of Bowen Acquisition Corp (the “Company,” “we,” “us,” “our” or “Bowen”) may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Annual Report may include, for example, statements about:

 

  ● our ability to complete our initial business combination;
     
   ● our expectations around the performance of prospective target business or businesses;
     
   ● our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
     
   ● our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;
     
   ● our potential ability to obtain additional financing to complete our initial business combination;
     
   ● our pool of prospective target businesses;
     
   ● our public securities’ potential liquidity and trading;
     
   ● the lack of a market for our securities;
     
   ● the use of proceeds not held in the Trust Account (as defined below) or available to us from interest income on the Trust Account balance;
     
   ● the Trust Account not being subject to claims of third parties; or
     
   ● our financial performance.

 

The forward-looking statements contained in this Annual Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the section of this Annual Report entitled “Risk Factors”. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

ii 

 

 

PART I

 

ITEM 1. BUSINESS

 

We are a blank check company incorporated on February 17, 2023, in the Cayman Islands as an exempted company, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”).

 

Our sponsors are Createcharm Holdings Ltd and Bowen Holding LP (each a “Sponsor” and collectively the “Sponsors”), each of which is affiliated with members of our management team. On February 27, 2023, Bowen Holdings LP acquired an aggregate of 1,725,000 of our ordinary shares, par value $0.0001 per share (such ordinary shares generally, the “Ordinary Shares”, such 1,725,000 Ordinary Shares, the “Founder Shares”), for an aggregate purchase price of $25,000. Thereafter, it transferred an aggregate of 1,155,750 Founder Shares to Createcharm Holdings Ltd.

 

On March 15, 2023, the Company issued to EarlyBirdCapital, Inc. (“EBC” or “EarlyBirdCapital”), the representative of the underwriters in our initial public offering (“IPO” or “Initial Public Offering”) 180,000 Ordinary Shares (the “EBC Founder Shares”) for an aggregate purchase price of $2,520. On July 14, 2023, the Company consummated the IPO of 6,000,000 units (generally the “Units” and such Units as sold in the IPO, the “Public Units”). Each Unit consists of one Ordinary Share (Ordinary Shares included in the Public Units, the “Public Shares”), and one right (generally, the “Rights”, such Rights as included in the Public Units, the “Public Rights”), each Right entitling the holder thereof to receive one-tenth of one Ordinary Share upon the completion of a Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $60,000,000.

 

Simultaneously with the consummation of the Initial Public Offering, the Company consummated a private placement (the “Private Placement”) of 330,000 Units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating total proceeds of $3,300,000. The Private Placement Units were purchased by Createcharm Holdings Ltd and EarlyBirdCapital. The Private Placement Units are identical to the Units sold in the Initial Public Offering. The Ordinary Shares contained in the Private Placement Units are referred to herein as the “Private Placement Shares” and the Rights contained in the Private Placement Units are referred to herein as the “Private Placement Rights”).

 

On July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000 Units. As a result, on July 18, 2023, the Company sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. In connection with the underwriters’ exercise of their over-allotment option, Createcharm Holdings Ltd and EarlyBirdCapital also purchased an aggregate of an additional 31,500 Private Placement Units from the Company, generating gross proceeds of $315,000.

 

Recent Developments

 

On January 18, 2024, Bowen, Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of Bowen (“Merger Sub”), Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People’s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (“Qianzhi”), and Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (“NewCo”, and collectively with Bowen, Merger Sub and Qianzhi, the “Parties”), entered into an Agreement and Plan of Reorganization (the “Business Combination Agreement”), which provides for a Business Combination between Bowen and Qianzhi.

 

The Business Combination Agreement contemplates that, at the closing of the Business Combination (the “Closing”), upon the terms and subject to the conditions of the Business Combination Agreement and in accordance with the Companies Act (Revised) of the Cayman Islands, as amended (the “Cayman Companies Act”), Merger Sub will merge with and into NewCo (the “Merger”), with NewCo being the surviving company of the Merger (“Surviving Company”) and becoming a wholly owned subsidiary of Bowen. In the Merger, the holders (the “NewCo Shareholders”) of the ordinary shares of NewCo (“NewCo Ordinary Shares”) will receive Ordinary Shares of the Company. The Merger and the other transactions contemplated by the Business Combination Agreement are referred to herein collectively as the “Transactions.” Consistent with the Business Combination Agreement and in preparation for the Transactions, Qianzhi and NewCo completed a restructuring (the “Restructuring”) in which Qianzhi became a wholly owned subsidiary of NewCo by the issuance of NewCo Ordinary Shares to the former holders of ordinary shares of Qianzhi in exchange for such ordinary shares of Qianzhi.

 

 1

 

 

Pursuant to the Business Combination Agreement, at the effective time of the Merger (the “Effective Time”), all NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time other than (i) NewCo Ordinary Shares held by the parties to the Business Combination Agreement or their respective wholly-owned subsidiaries and (ii) those NewCo Ordinary Shares owned by the holders of NewCo Ordinary Shares who have validly exercised and not effectively withdrawn or lost their rights to dissent from the Merger pursuant to the Cayman Companies Act, will be automatically converted into the right to receive an aggregate of (a) 7,246,377 Ordinary Shares of the Company, a portion of which shall be deposited into escrow to provide for indemnification in accordance with the Business Combination Agreement (the “Merger Shares”), and (b) the right to receive earnout consideration of up to an aggregate of 1,400,000 Ordinary Shares of the Company (the “Earnout Shares”), if and to the extent certain net income milestones are achieved by the combined company and its subsidiaries during the fiscal years ended March 31, 2025 and 2026 or if there occurs any transaction resulting in a change of control during the period of time that the Earnout Shares are earnable.

 

For additional information regarding Qianzhi and NewCo, the Business Combination Agreement and the Transactions, see the Company’s definitive proxy statement/prospectus, as filed with the Securities and Exchange Commission on December 18, 2024 (the “Definitive Proxy Statement/Prospectus”).

 

On October 14, 2024, Qianzhi and EarlyBirdCapital loaned the Company an aggregate of $690,000 (or $0.10 per Public Share), which funds were deposited into the Trust Account. The funds were deposited into the Trust Account pursuant to the Articles and the trust agreement governing the Trust Account in order to extend the time that the Company has to consummate an initial business combination from October 14, 2024 to April 14, 2025. The loans are evidenced by promissory notes issued by the Company to the lenders. The notes bear no interest and are repayable in full upon consummation of a Business Combination.

 

On January 10, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to April 14, 2025. In connection with the meeting, an aggregate of 6,052,095 Public Shares were redeemed at a price of approximately $10.99 per share.

 

On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of 103,432 Public Shares were redeemed at a price of approximately $11.03 per share.

 

The Company is now in the process of seeking to satisfy the remaining conditions to the Closing and to consummate the Transactions. If the Company consummates the Transactions, the business of the Company will be that of Qianzhi. For further details regarding Qianzhi and its business, see the section titled “Information about NewCo and Qianzhi” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein. If the Company is unable to consummate the Transactions for whatever reason, it will either dissolve and liquidate in accordance with the terms of its amended and restated memorandum and articles of association or seek additional time to consummate an alternative Business Combination and attempt to locate and consummate such an alternative transaction. For further details regarding the Company and its business, see the section titled “Information about Bowen” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

If we are unable to consummate the Transactions and seek an alternative transaction, we anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment bankers and investment professionals. Target businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us by calls or mailings. These sources may also introduce us to target businesses in which they think we may be interested on an unsolicited basis, since many of these sources will know what types of businesses we are targeting. Our officers and directors, as well as our Sponsors, and their affiliates, may also bring to our attention target business candidates that they become aware of through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows, conferences or conventions. In addition, we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result of the business relationships of our officers and directors and our Sponsors and their respective industry and business contacts as well as their affiliates. We may engage the services of professional firms or other individuals that specialize in business acquisitions, in which event we may pay a finder’s fee, consulting fee, advisory fee or other compensation to be determined in an arm’s length negotiation based on the terms of the transaction.

 

 2

 

 

ITEM 1A. RISK FACTORS

 

The Business Combination and each of Qianzhi and Bowen are subject to numerous risks and uncertainties. Accordingly, an investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together with the other information contained in this Annual Report on Form 10-K and the Definitive Proxy Statement/Prospectus before making a decision to invest in our securities. If any of the following events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your investment. The risk factors described below are not necessarily exhaustive and you are encouraged to perform your own investigation with respect to us and our business.

 

Risks Relating to Qianzhi’s Business and Industry

 

  ● If Qianzhi’s products fail to meet the demands of its customers or to reflect the latest developments in the personal hygiene and disinfection products market, it may be unable to retain existing customers or attract new customers, and its business, financial condition and results of operations may be materially and adversely affected.
     
  ● A significant portion of Qianzhi’s revenue is concentrated with a small number of customers and it could be seriously harmed if these customers significantly reduced the volume of business they conduct, or cease doing business, with Qianzhi.
     
  ● Qianzhi may be unable to maintain its relationships with its customers and Qianzhi may fail to engage new customers.
     
  ● Qianzhi may be compelled to undertake product recalls or other actions, which could adversely affect its brand image, financial condition, results of operations, and growth prospects.
     
  ● Qianzhi’s revenues and financial results may be adversely affected by an economic slowdown on a global scale or in any jurisdictions in which it operates.
     
  ● Heightened tensions in international relations may adversely impact Qianzhi’s business, financial condition, and results of operations.
     
  ● Qianzhi faces intense competition in the personal hygiene and disinfection products industry from numerous competitors.
     
  ● Qianzhi is subject to cost overruns and delays, regulatory requirements, and miscalculations in capacity needs with respect to its expansion projects and its manufacturing facilities, as well as disruptions to its manufacturing facilities and those of its contract manufacturers and other suppliers.
     
  ● Qianzhi’s facilities and operations may require continuous and substantial investment and upgrading.
     
  ● Qianzhi has a limited operating history and its ability to successfully commercialize products of high quality and appeal to customers at scale is unproven and still evolving.
     
  ● Qianzhi may experience net losses and may not sustain profitability in the future.
     
  ● Qianzhi relies on third-party suppliers and distributors for many of the materials utilized in its products and they may not continue to produce products or provide services that are consistent with its standards or applicable regulatory requirements, which could harm Qianzhi’s brand, cause consumer dissatisfaction, and require it to find alternative suppliers of its products.
     
  ● Qianzhi’s success depends on the continuing efforts of its senior management team and other key employees.
     
  ● If Qianzhi fails to maintain an effective system of internal control over financial reporting, it may be unable to accurately report financial results or prevent fraud, and investor confidence in Qianzhi and the market price of its securities may be adversely affected.
     
  ● Failure or security breach of Qianzhi’s information technology systems may disrupt its operations.

 

 3

 

 

  ● Certain regulatory actions call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the Public Company Accounting Oversight Board. These developments could add uncertainties to Qianzhi’s operations.
     
  ● Forecasts and projections of Qianzhi’s operating and financial results relies in large part upon assumptions and analyses developed by its management. If these assumptions or analyses prove to be incorrect, Qianzhi’s actual operating results may be materially different from those forecasted or projected.
     
  ● Qianzhi’s business plans require a significant amount of capital. In addition, Qianzhi’s future capital needs may require it to obtain additional equity or debt financing that may dilute shareholders or introduce covenants that may restrict its operations or its ability to pay dividends.
     
  ● Qianzhi’s future growth is dependent on the demand for, and upon consumers’ willingness to adopt personal hygiene products and disinfectants, which is associated with consumers’ demand for personal hygiene products and disinfectants, and adoption of new personal hygiene products and disinfectants.

 

Risks Relating to Doing Business in the People’s Republic of China (“PRC”)

 

  ● Failure to meet the PRC government’s complex regulatory requirements on and significant oversight over Qianzhi’s business operation could result in a material adverse change in its operations and the value of securities.
     
  ● The approval of and filing with the China Securities Regulatory Commission (“CSRC”) or other PRC government authorities is required in connection with the business combination. However, Qianzhi cannot predict whether or when it will be able to obtain such approval or complete such filing, and even if it obtains such approval, it could be rescinded. Any failure to or delay in obtaining such approval or complying with such filing requirements in relation to offering, or a rescission of such approval, could subject Qianzhi to sanctions imposed by the CSRC or other PRC government authorities.
     
  ● Additional regulations under the PRC Law Relating to Data Security and Confidentiality and Archives Management may subject Qianzhi to additional compliance requirements in the future.
     
  ● PRC regulations of loans and direct investment by offshore holding companies to PRC entities may delay or prevent Qianzhi from using the proceeds of its offshore financing to make loans or additional capital contributions to its PRC subsidiary, which could materially and adversely affect Qianzhi’s liquidity and its ability to fund and expand its business.
     
  ● Chinese regulatory authorities could disallow Qianzhi’s holding company structure, which may result in a material change in its operations and/or a material change in the value of the combined company’s securities, including that it could cause the value of such securities to significantly decline.
     
  ● Qianzhi may be materially adversely affected if its shareholders and beneficial owners who are PRC entities fail to comply with the PRC overseas investment regulations.
     
  ● Qianzhi relies on dividends and other distributions on equity paid by its PRC subsidiaries to fund any cash and financing requirements it may have, and any limitation on the ability of Qianzhi’s PRC subsidiaries to make payments to Qianzhi could have a material and adverse effect on its ability to conduct business.

 

Risks Relating to Intellectual Property, Information Technology and Legal Proceedings

 

  ● Qianzhi may be subject to intellectual property infringement claims, which may be expensive to defend and may disrupt its business and operations.
     
  ● As Qianzhi’s patents may expire and may not be extended, its patent applications may not be granted, and its patent rights may be contested, circumvented, invalidated, or limited in scope, its patent rights may not protect it effectively. In particular, Qianzhi may not be able to prevent others from developing or exploiting competing technologies, which could materially and adversely affect its business, financial condition, and results of operations.
     
  ● If Qianzhi’s trademarks and trade names are not adequately protected, then it may not be able to build name recognition in its markets of interest and its business may be adversely affected.

 

 4

 

 

  ● Qianzhi depends on information technology to conduct its business. Any significant disruptions to information technology systems or facilities, or those of third parties with which Qianzhi does business, such as disruptions caused by cyber-attacks, could adversely impact its business.
     
  ● You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against Qianzhi or its management based on foreign laws. It may also be difficult for you or overseas regulators to conduct investigations or collect evidence within China.

 

Risks Relating to Being a Public Company Following the Business Combination

 

  ● A market for the combined company’s shares may not develop, which would adversely affect the liquidity and price of the combined company’s shares.
     
  ●

The issuance of additional shares in connection with financings, acquisitions, investments, equity incentive plans

or otherwise will dilute all other shareholders.

     
  ● The combined company may be unable to maintain the listing of its securities on the Nasdaq Global Market in the future.
     
  ●

You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be

limited, because the Company is incorporated under the laws of the Cayman Islands, and will conduct its operations, and

its directors and executive officers reside, outside of the United States.

 

Risks Related to Bowen Before the Business Combination

 

  ● Bowen’s officers and directors have interests in the business combination that are different from those of Public Shareholders.
     
  ● Bowen may become involved in litigation, including securities class action litigation relating to the proposed business combination that may materially adversely affect it.

 

For additional detail on these and other risks, see the section entitled “Risk Factors” in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 1C. CYBERSECURITY

 

We are a blank check company with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable target businesses for a business combination. Therefore, we do not consider that we face significant cybersecurity risk. Nevertheless, we employ various procedures designed to identify, protect, detect and respond to and manage reasonably foreseeable cybersecurity risks and threats given our limited operations. These include, but are not limited to, internal reporting, monitoring and detection tools and anti-virus software. We also periodically assess risks from cybersecurity and technology threats and monitor our information systems for potential vulnerabilities, including those that could arise from internal sources and external sources such as third-party service providers we do business with.

 

To date, we have not experienced any cybersecurity attacks. However, any such attack could adversely affect our business. Further, a penetration of our systems or a third-party’s systems or other misappropriation or misuse of personal information could subject us to business, regulatory, litigation and reputation risk, which could have a negative effect on our business, financial condition and results of operations.

 

 5

 

 

The Audit Committee of the Board oversees our cybersecurity risk and receives regular reports from our management team on various potential cybersecurity matters, including areas of emerging risks, incidents and industry trends, and other areas of importance. We may in the future engage an assessor(s), consultant(s), auditor(s) or other third party(s) to supplement our existing cybersecurity processes.

 

ITEM 2. PROPERTY

 

Our current executive offices are located at 420 Lexington Avenue, Suite 2446, New York, New York 10170, and our telephone number is (203) 998-5540. Pursuant to an Administrative Services Agreement, until the completion of our initial Business Combination or liquidation, we will pay a monthly fee of $10,000 to Bowen Holding LP for office space, secretarial and administrative services. We consider our current office space, combined with the other office space otherwise available to our executive officers, adequate for our current operations.

 

If the Business Combination with Qianzhi is consummated, the Company will likely utilize the principal administrative office of Qianzhi which is located at 17 Floor, Tower B, Jingji 100, Luohu District, Shenzhen City, covering an area of approximately 700m2 with a lease term from May 2023 to September 2026. For additional information on Qianzhi’s facilities, see the section entitled “Information about NewCo and Qianzhi – Facilities” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

ITEM 3. LEGAL PROCEEDINGS

 

There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

PART II

 

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

Our Ordinary Shares, Rights and units are listed on the Nasdaq Stock Market LLC under the symbols “BOWN”, “BOWNR and” “BOWNU,” respectively.

 

Holders

 

As of December 31, 2024, there were 3 holders of record of our units, 6 holders of record of our Ordinary Shares and 1 holder of record of our Rights.

 

Dividends

 

We have not paid any cash dividends on our Ordinary Shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will be within the discretion of our board of directors at such time and we will only pay such dividend out of our profits or share premium (subject to solvency requirements) as permitted under Cayman Islands law. Further, if we incur any indebtedness in connection with our initial Business Combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

 

 6

 

 

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

 

On February 27, 2023, Bowen Holding LP acquired an aggregate of 1,725,000 Founder Shares for an aggregate purchase price of $25,000. Bowen Holding LP thereafter transferred an aggregate of 1,155,750 Founder Shares to Createcharm Holdings Ltd, our other Sponsor. The Company also issued to EarlyBirdCapital 180,000 EBC Founder Shares for an aggregate purchase price of $2,520 on March 15, 2023. The issuance of the foregoing securities was exempt pursuant to Section 4(a)(2) of the Securities Act.

 

On July 14, 2023, the Company consummated the Initial Public Offering of 6,000,000 Units. Each Unit consists of one Ordinary Share of the Company and one Right, each Right entitling the holder thereof to receive one-tenth of one Ordinary Share upon the completion of the Company’s initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $60,000,000. EarlyBirdCapital acted as sole book-running manager of the Initial Public Offering and Revere Securities acted as co-manager of the Initial Public Offering. The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-272076). The Securities and Exchange Commission declared the registration statement effective on July 11, 2023.

 

Simultaneously with the consummation of the Initial Public Offering, the Company consummated the Private Placement of 330,000 Private Placement Units at a price of $10.00 per Private Placement Unit, generating total proceeds of $3,300,000. The Private Placement Units were purchased by Createcharm Holdings Ltd and EarlyBirdCapital. The Private Placement Units are identical to the Public Units sold in the Initial Public Offering. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement Units or underlying securities (except to certain transferees) until after the completion of the Company’s initial business combination. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

On July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000 Units. As a result, on July 18, 2023, the Company sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. In connection with this sale, Createcharm Holdings Ltd and EarlyBirdCapital also purchased an additional 31,500 Private Placement Units from the Company, generating gross proceeds of $315,000. The issuance of the additional Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

As of July 18, 2023, an aggregate of $69,690,000 was deposited in the Trust Account established with Continental Stock Transfer & Trust Company acting as trustee in connection with the Initial Public Offering.

 

We paid a total of $1,725,000 in underwriting discounts and commissions related to the Initial Public Offering.

 

On January 10, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial business combination to up to April 14, 2025. In connection with the meeting, an aggregate of 6,052,095 Public Shares were redeemed at a price of approximately $10.99 per share. On April 14, 2025, the Company held another extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial business combination to up to July 14, 2025. In connection with the meeting, an aggregate of 103,432 Public Shares were redeemed at a price of approximately $11.03 per share. As a result, approximately $8,211,537 remained in the Trust Account (without taking into account any Public Shares submitted for redemption in connection with the vote taken to approve the Business Combination with Qianzhi).

 

ITEM 6. [RESERVED]

 

Not applicable.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Cautionary Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Annual Report.

 

 7

 

 

Overview

 

We are a blank check company incorporated on February 17, 2023 as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While we intend to focus our search on businesses in Asia, we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination. We intend to effectuate our initial business combination using cash from the proceeds of this offering and the private placement of the private units, promissory loans with target or related parties, the proceeds of the sale of our securities in connection with our initial business combination, our shares, debt or a combination of cash, stock and debt.

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception through December 31, 2024 were organizational activities, those necessary to prepare for the IPO described below, and since the closing of the IPO, identifying a target company for our initial Business Combination, and professional costs related with the initial Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We generated non-operating income in the form of interest income on marketable securities held after the IPO. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

 

For the year ended December 31, 2024, we had a net income of $2,963,852, which consists of a loss of $633,764 derived from operating costs, and interest expense of $87,267, offset by income earned on the Trust Account of $3,684,883.

 

For the period from February 17, 2023 (inception) through the year ended December 31, 2023, we had a net income of $1,484,790, which consists of a loss of $244,568 derived from formation and operating costs offset by income earned on the Trust Account of $1,729,358.

 

Liquidity, Capital Resources and Going Concern

 

On July 14, 2023, we consummated our IPO of 6,000,000 Units, at $10.00 per Unit, generating gross proceeds of $60,000,000. Simultaneously with the closing of our IPO, we consummated the sale of 330,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsors, generating total gross proceeds of $3,300,000.

 

On July 17, 2023, the underwriters exercised the over-allotment option in full to purchase 900,000 Units. As a result, on July 18, 2023, we sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. Simultaneously with the closing of the full exercise of the over-allotment option, we completed the private sale of an aggregate of 31,500 Private Placement Units, at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds of $315,000. Transaction costs amounted to $3,318,898 consisting of $1,725,000 of cash underwriting fees and $1,593,898 of other offering costs.

 

Following the closing of the IPO and the sale of over-allotment units, an amount of $69,690,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement was placed in a trust account. The funds held in the Trust Account may be invested in U.S. government securities with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account, to complete our initial business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

 8

 

 

As of December 31, 2024, we had cash and cash equivalent of $103,774. We will use these funds primarily to complete the business combination. This includes conducting ongoing due diligence, obtaining necessary regulatory and shareholder approvals, preparing required filings and disclosures, structuring and negotiating transaction terms, and covering costs related to legal, financial, and other advisory services. Additionally, funds may be used to pay taxes to the extent the interest earned on the trust account is not sufficient to pay our taxes.

 

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination.

 

As of December 31, 2024, we had cash and cash equivalent of $103,774 and a working capital deficit of $799,056. We have incurred and expect to continue to incur significant professional costs to remain as a public traded company and to incur transaction costs in pursuit of a Business Combination. In connection with our assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” we believe that these conditions raise substantial doubt about our ability to continue as a going concern. In addition, if we are unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, we have determined that such additional condition also raises substantial doubt about our ability to continue as a going concern. Management expects to obtain additional funds from related parties to provide the additional working capital necessary to carry out its objective to consummate a business combination.  The consolidated financial statements do not include any adjustments that might result from the outcome of the uncertainty.

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2024. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Related Party Transactions

 

Please refer to Financial Statement Note 5 - Related Parties.

 

Other Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities reflected on our balance sheet.

 

Registration Rights

 

The holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration rights agreement dated July 11, 2023 requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 9

 

 

Business Combination Marketing Agreement

 

We have engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation of its initial Business Combination in an amount equal to 3.5% of the gross proceeds of the IPO. In addition, the Company will pay EBC a service fee in an amount equal to 1.0% of the total consideration payable in the initial Business Combination if it introduces the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and is due at the closing date of the initial Business Combination.

 

Critical Accounting Policies and Estimates

 

The preparation of consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed as of the date of the financial statements, and that management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results may differ from these estimates. Management does not believe that we have any critical accounting estimates; however, we have identified the following critical accounting policy:

 

Net Income (Loss) per Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less interest income and unrealized gain or loss on investments in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders.

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our consolidated financial statements.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not required for smaller reporting companies.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

This information appears following Item 15 of this Report and is included herein by reference.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2024. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective, due solely to the material weakness in our internal control over financial reporting related to the Company’s lack of qualified SEC reporting professional. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the consolidated financial statements included in this Form 10-K present fairly in all material respects our financial position, results of operations and cash flows for the period presented. Management intends to continue implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we intend to expand and improve our review process for complex securities and related accounting standards. We have improved this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

 

 10

 

 

Management’s Report on Internal Controls Over Financial Reporting

 

Our management is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as such term is defined in Exchange Act Rules 13(a)-15(f). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the U.S.

 

Our internal control over financial reporting includes those policies and procedures that:

 

  ● pertain to the maintenance of records, in reasonable detail, accurately and fairly reflect our transactions and dispositions of our assets;
  ● provide reasonable assurance our transactions are recorded as necessary to permit preparation of our financial statements in accordance with accounting principles generally accepted in the U.S., and our receipts and expenditures are being made only in accordance with authorizations of our management and our directors; and
  ● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets could have a material effect on the financial statements

 

Due to its inherent limitations, a system of internal control over financial reporting can provide only reasonable assurance and may not prevent or detect all misstatements. Further, because of changes in conditions, effectiveness of internal controls over financial reporting may vary over time. Our system contains self-monitoring mechanisms, so actions will be taken to correct deficiencies as they are identified.

 

Our management conducted an evaluation of the effectiveness of the system of internal control over financial reporting based on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management concluded that our disclosure controls and procedures were not effective, due solely to the material weakness in our internal control over financial reporting related to the Company’s lack of qualified SEC reporting professional. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the consolidated financial statements included in this Form 10-K present fairly in all material respects our financial position, results of operations and cash flows for the period presented. Management intends to continue implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we intend to expand and improve our review process for complex securities and related accounting standards. We have improved this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

 

This Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the SEC to permit us to provide only management’s report in this Form 10-K.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

During the quarter ended December 31, 2024, no director or officer adopted or terminated any (i) “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K intending to satisfy the affirmative defense conditions of Rule 10b5–1(c) or (ii) “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K; and (ii) there was no information that was required to be disclosed on a Current Report on Form 8-K during such quarter that was not so disclosed.

 

 11

 

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

PART III

 

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

 

If the Company consummates the Transactions, the officers and directors of the Company will be as follows:

 

Name   Age   Position
Executive Officers          
Dajun Wang     59   Chief Executive Officer and Director
Liangwen Wang     37   Chief Financial Officer
           
Directors          
Dajun Wang     59   Director
Wei Liang     46   Director
Wen He     57   Independent Director
Zhenning He     28   Independent Director
Jun Zhang     61   Independent Director

 

The biographies of the above-identified individuals and other information relating to the officers and directors of the combined company (including the committees of the board) are set forth in the section titled “Directors and Executive Officers of New Bowen after the Business Combination” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

If the Company is unable to consummate the Transactions for whatever reason, the Company’s officers and directors will not change. Our current directors and executive officers are as follows:

 

Name   Age   Position
Na Gai   38   Chairwoman of the Board of Directors
Jiangang Luo   56   Chief Executive Officer
Jing Lu   60   Chief Financial Officer
Lawrence Leighton   90   Independent Director
Wei Li   46   Independent Director
June Zhang   61   Independent Director

 

Na Gai, our Chairwoman, has served as the executive president for Shenzhen Guoxing Capital Co., Ltd., an asset management and investment company based in China, since September 2015. Ms. Gai also served as a partner of Hunan Zhongsheng Hongcheng Investment Management Partnership (LP), a private equity investment company based in China, from February to May 2017. Since October 2021, she has also served as an independent director for Flag Ship Acquisition Corp., a blank check company like our company that is seeking to consummate its Initial Public Offering. Ms. Gai received a bachelor degree of Business Administration from The Open University of China and an accounting diploma from Changsha University of Science & Technology. Ms. Gai was also certified as AFP Financial planner in August 2017. Ms. Gai is a Chinese citizen. We believe Ms. Gai is well-qualified to serve as a member of our board of directors due to her experience, contacts and relationships.

 

 12

 

 

Jiangang Luo, our Chief Executive Officer, has been the manager of Cleantech Global Limited, an investment consulting firm, since 2014, and the president of Prime Science & Technology, Inc., a computer/software consulting and IT outsourcing company, since 2006. Since 2021, he has also been the president of PNE Limited Partner LLC and Luo & Long General Partner LLC, which are special purpose vehicles that were established for the sole purpose of investing in Princeton NuEnergy, a US based cleantech company. From 2011 to 2016, he served as managing partner of Faith Asset Management LLC, a global investment firm focused on the clean energy sector. From 2000 to 2006, he worked for Oracle as a Principal Consultant. Before 2000, he worked as a senior information system professional in various Fortune 500 companies including China Resources Group and Liz Claiborne. Mr. Luo also served as an executive for many non-profit organizations such as Chairman of the Tsinghua Alumni Association in New York and President of New Jersey Chinese Computer Professionals Society. Mr. Luo is a member of Tsinghua Entrepreneur & Elite Club. He has invested in many cleantech/fintech companies over the last 10 years. Mr. Luo received degrees in Applied Mathematics and Computer Science from Tsinghua University, a Computer Science Masters degree from New Jersey Institute of Technology and a masters degree in Computational Mathematics from Tsinghua University. Mr. Luo is a US citizen.

 

Dr. Jing Lu, our Chief Financial Officer, has more than 20 years of experience in the financial service industry. Dr. Lu has served as a Managing Director and then Chief Operating Officer of China Bridge Capital International Inc., a PE/VC investment advisory company specialized in innovative technologies from 2017 to 2019 and from March 2021 to January 2022. She has also served as Chief Financial Officer of Keyarch Acquisition Corporation, a blank check company similar to our company, since March 2021. She also served as Chief Investment Officer for the New Hope Fertility Center (NHFC) from 2019 to 2021, sourcing and managing PE investments, bank loans and government PPP loans. Prior to China Bridge Capital, Dr. Lu was President of ACE AV Consulting Inc. from 2005 to 2017. Dr. Lu was an Executive Director at CIBC World Markets in 2001 working on corporate securities. Between 1998 and 2001, Dr. Lu worked at the Federal Reserve Bank of New York as a bank regulator and supervisor, working on Basel Capital Accords as well as examining banks’ implementation of the Basel Accords. Before moving to New York, Dr. Lu was a professor of economics at York University in Canada for four years, specializing her teaching and research in Macroeconomics, Institutional Economics, and Econometrics. Dr. Lu received a Ph.D. and M.A. in Economics from Western University in Canada, a Graduate Certificate in Economics from the People’s University in China, and a B.A in World Economy from Fudan University in China. Dr. Lu is a U.S. citizen and resident of the State of New York.

 

Lawrence Leighton, one of our director nominees, is a seasoned international investment banker with approximately 50 years of experience. He has worked with many major international companies throughout his career, including Pernod Ricard SA (ENXTPA: RI) and Verizon Communications Inc. (NYSE: VZ). Mr. Leighton has served as a Managing Director of Bentley Associates, a boutique investment bank, since 1997. In 1989, he became President and Chief Executive Officer of UI USA, the US subsidiary of Union d’Ètudes et d’Investissements, the merchant banking arm of Credit Agricôle, the largest bank in France. From 1982 to 1989, Mr. Leighton served as a Managing Director of Chase Bank. Previously, he was a Limited Partner at Bear, Stearns & Co., focusing on international mergers and acquisitions. Starting in 1974, he was with Norton Simon as the Director of Strategic Planning/Mergers & Acquisitions. Before Norton Simon, Mr. Leighton was with Clark, Dodge & Co. where he became Co-Head of the Corporate Finance Department. He has been a member of the board of directors of Bon Natural Life Limited, a natural products and ingredients business, since June 2021. Mr. Leighton received a B.S.E. degree from Princeton University and an M.B.A. from Harvard Business School. Mr. Leighton is a U.S. Citizen. We believe Mr. Leighton is well-qualified to serve as a member of our board of directors due to his experience, contacts and relationships.

 

Wei Li, one of our director nominees, has five years of Wall Street experience at 1st-tier financial institutions including Barclays Capital and HSBC. Ms. Li is the co-founder and has served as CEO of Hyatt Capital Management, a private investment fund and financial service company dedicated in impact investing in the Asian pacific area, since 2018. Previously, Ms. Li served as Managing Director and Head of Structured Finance at China Renaissance (HK.1911), a leading boutique investment bank in Hong Kong, Shanghai and Beijing (where she was based during her time there), from 2016 to 2018. She was Executive Director & Head of Private Credit Investment at CITIC Securities (SH.600030), an investment bank, from 2011 to 2016. Ms. Li received a M. Phil degree in Land Economy from University of Cambridge and is a Ph.D candidate from University of Rochester. Ms. Li is a CFA charter-holder. We believe Ms. Li is well-qualified to serve as a member of our board of directors due to her experience, contacts and relationships

 

 13

 

 

Jun Zhang, one of our director nominees, has served as Senior Partner and Associate Director at Mazars (Shenzhen Branch) since 2000. Mr. Zhang also founded Shenzhen Zhonghuan Certified Public Accountants Co., Ltd, an accounting firm, in 2009 and has served as Chairman since its founding. From 1994 to 2000, he served as Partner and Associate Director at Shenzhen Wenwu Accounting Firm. From 1989 to 1994, he was the Senior Manager at Shenzhen Shekou Zhonghua Accounting Firm. He served as Project Manager at Wuhan Accounting Firm of Wuhan Finance Bureau from 1986 to 1989. Mr. Zhang received a Master’s degree in Management from Zhongnan University of Economics and Law and Bachelor’s degree in Financial Accounting from Jianghan University. He is a CPA in China. Mr. Zhang is a Chinese citizen. We believe Mr. Zhang is well-qualified to serve as a member of our board of directors due to his experience, contacts and relationships.

 

Number and terms of office of officers and directors

 

Our board of directors is divided into three classes with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of shareholders) serving a three-year term. The term of office of the first class of directors, consisting of Wei Li, will expire at our first annual meeting of shareholders. The term of office of the second class of directors, consisting of Lawrence Leighton, will expire at the second annual meeting of shareholders. The term of office of the third class of directors, consisting of Na Gai and Jun Zhang, will expire at the third annual meeting of shareholders.

 

Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint such officers as it deems appropriate pursuant to our amended and restated memorandum and articles of association.

 

Director Independence

 

Nasdaq listing standards require that a majority of our board of directors be independent, subject to certain phase-in provisions. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that each of Lawrence Leighton, Wei Li and Jun Zhang are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent directors are present.

 

Audit Committee

 

Effective July 11, 2023, we formed an audit committee. Lawrence Leighton, Wei Li and Jun Zhang serve as members of our audit committee, with Jun Zhang serving as the Chairman of the audit committee. Under Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent, subject to certain phase-in provisions. Each such person meets the independent director standard under Nasdaq listing standards and under Rule 10-A-3(b)(1) of the Exchange Act.

 

Each member of the audit committee is financially literate and our board of directors has determined that Jun Zhang qualifies as an “audit committee financial expert” as defined in applicable SEC rules.

 

We have adopted an audit committee charter, which details the principal functions of the audit committee, including:

 

  ● the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us;
     
  ● pre-approving all audit and permitted non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
     
  ● reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;

 

 14

 

 

  ● setting clear hiring policies for employees or former employees of the independent auditors;
     
  ● setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
     
  ● obtaining and reviewing a report, at least annually, from the independent auditors describing (i) the independent auditor’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;
     
  ● reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
     
  ● reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our consolidated financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.

 

Compensation Committee

 

Effective July 11, 2023, we established a compensation committee of the board of directors. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members of the compensation committee, all of whom must be independent, subject to certain phase-in provisions. Lawrence Leighton, Wei Li and Jun Zhang serve as members of our compensation committee, with Lawrence Leighton serving as the chairman of the compensation committee. Each such person meets the independent director standard under Nasdaq listing standards applicable to members of the compensation committee.

 

We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:

 

  ● reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;
     
  ● reviewing and approving on an annual basis the compensation of all of our other officers;
     
  ● reviewing on an annual basis our executive compensation policies and plans;

 

  ● implementing and administering our incentive compensation equity-based remuneration plans;
     
  ● assisting management in complying with our proxy statement and annual report disclosure requirements;
     
  ● approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;
     
  ● if required, producing a report on executive compensation to be included in our annual proxy statement; and
     
  ● reviewing, evaluating, and recommending changes, if appropriate, to the remuneration for directors.

 

Notwithstanding the foregoing, other than reimbursement of expenses, no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing shareholders, officers, directors or any of their respective affiliates, prior to, or for any services they render in order to complete the consummation of a business combination although we may consider cash or other compensation to officers or advisors we may hire to be paid either prior to or in connection with our initial business combination. Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation committee will only be responsible for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business combination.

 

 15

 

 

The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.

 

Director Nominations

 

We do not have a standing nominating committee. In accordance with Rule 5605(e)(2) of the Nasdaq Rules, a majority of the independent directors may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. As there is no standing nominating committee, we do not have a nominating committee charter in place.

 

The board of directors will also consider director candidates recommended for nomination by our shareholders during such times as they are seeking proposed nominees to stand for election at the next annual meeting of shareholders (or, if applicable, a special meeting of shareholders). Our shareholders that wish to nominate a director for election to our board of directors should follow the procedures set forth in our amended and restated memorandum and articles of association.

 

We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, our board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.

 

Code of Ethics

 

Effective July 11, 2023, we adopted a code of ethics that applies to all of our executive officers, directors, and employees. The code of ethics codifies the business and ethical principles that govern all aspects of our business.

 

Insider Trading Policy

 

We have an insider trading policy governing the purchase, sale, and other dispositions of our securities that applies to our directors, officers, employees, and consultants. The policy generally prohibits the purchase, sale or trade of our securities with the knowledge of material nonpublic information. We believe our insider trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, and listing standards applicable to our company.

 

ITEM 11. EXECUTIVE COMPENSATION

 

Executive Compensation

 

No executive officer has received any cash compensation for services rendered to us. Commencing July 11, 2023, through the acquisition of a target business, we pay Bowen Holding LP an aggregate fee of $10,000 per month for providing us with office space and certain office and secretarial services. Additionally, on February 20, 2023, we engaged TenX Global Capital, a member of Bowen Holding LP, to provide us with consulting and advisory services in connection with, among other things, assisting us with the preparation of, and the accounting relating to, our quarterly and annual reports to be filed with the Securities and Exchange Commission at a price of $5,250 per quarter. However, these arrangements are solely for our benefit and are not intended to provide our officers or directors compensation in lieu of a salary.

 

 16

 

 

Other than the foregoing fees and the repayment of loans that may be made by our Sponsors, officers, directors or their affiliates to us, no compensation or fees of any kind, including finder’s fees, consulting fees or other similar fees, will be paid to our initial stockholders, special advisors, members of our management team or their respective affiliates, for services rendered prior to or in connection with the consummation of our initial business combination (regardless of the type of transaction that it is). However, they will receive reimbursement for any out-of-pocket expenses incurred by them in connection with activities on our behalf, such as identifying potential target businesses, performing business due diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants or similar locations of prospective target businesses to examine their operations. There is no limit on the amount of out-of-pocket expenses reimbursable by us.

 

For information relating to executive compensation assuming we consummate the Transactions, see the section titled “Executive Officer and Director Compensation” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

Since our formation, we have not granted any stock options or stock appreciation rights or any other awards under long-term incentive plans to any of our executive officers or directors. In connection with the Transactions, in January 2025, the Company’s shareholders approved an incentive equity plan. For information relating to grants that may be made after consummation of the Transactions, see the section titled “Proposal 7: The Incentive Plan Proposal” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

 

The following table sets forth information regarding the beneficial ownership of our Ordinary Shares as of the date of this Annual Report by:

 

  ● each person known by us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;
     
  ● each of our officers and directors; and
     
  ● all of our officers and directors as a group.

 

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares beneficially owned by them. The following table does not reflect record of beneficial ownership of the Rights included in the units offered in the Initial Public Offering or the Private Placement Units as these Rights may not be convertible within 60 days of the date hereof. The following also does not take into account the redemption of public shares held by any holder not affiliated with our Sponsors, officers and directors that owned more than 5% of our outstanding ordinary shares.

 

 

Name and address of beneficial owner(1)  Amount and
nature of
beneficial
ownership		  Approximate
percentage of
outstanding
ordinary shares
Createcharm Holdings Ltd (2) (7)   1,497,532    49.7%
Bowen Holding LP (3) (7)   569,250    18.9%
Na Gai(4)   *    * 
Jiangang Luo(4)   *    * 
Jing Lu (4)   *     * 
Lawrence Leighton (4)   *    * 
Wei Li(4)   *    * 
Jun Zhang (4)   *    * 
EarlyBirdCapital, Inc. (7)   199,718    6.6%
All officers and directors as a group (six individuals)(4)   0    0%
First Trust Merger Arbitrage Fund(5)   656,000    21.8%
AQR Capital Management, LLC(6)   483,000    16.0%

 

 17

 

 

* Less than one percent.

 

(1) Unless otherwise noted, the business address of each of the following entities or individuals is c/o Bowen Acquisition Corp, 420 Lexington Avenue, Room 2446, New York NY 10170.
   
(2) Createcharm Holdings Ltd is the record holder of the Founder Shares reported herein. Na Gai is the sole director and shareholder of Createcharm Holdings Ltd. Accordingly, she may be deemed to be the beneficial owner of such shares. Ms. Gai disclaims beneficial ownership of the shares owned by Createcharm Holdings Ltd. except to the extent of her ultimate pecuniary interest therein.
   
(3) Bowen Holding LP is the record holder of the Founder Shares reported herein. Bowen Management LLC is the managing member of Bowen Holding LP and Dahe Zhang is the manager of Bowen Management LLC. Accordingly, Dahe Zhang is deemed to be the beneficial owner of such shares. Mr. Zhang disclaims beneficial ownership of the shares owned by Bowen Holding LP except to the extent of his ultimate pecuniary interest therein.
   
(4) Does not include any shares that may be indirectly owned by (i) Jiangang Luo, Jing Lu, Lawrence Leighton, Wei Li and Jun Zhang, as a result of each such person holding a partnership interest in Bowen Holding LP, and (ii) Na Gai as a result of her being the sole director and shareholder of Createcharm Holdings Ltd.
   
(5) The address for First Trust Merger Arbitrage Fund is 235 West Galena Street, Milwaukee, WI 53212 (“VARBX”). Based on a Schedule 13G filed jointly by VARBX, First Trust Capital Management L.P., First Trust Capital Solutions L.P. and FTCS Sub GP LLC on November 14, 2024.
   
(6) The address for AQR Capital Management, LLC is One Greenwich Plaza, Greenwich, CT 06830, based on a Schedule 13G filed jointly by AQR Capital Management, LLC, AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC on November 14, 2024.
   
(7) On October 14, 2024, one of the Sponsors transferred 30,000 of its Founder Shares to EarlyBirdCapital in connection with the loans. The transfer is yet to be finalized as of the date of this Annual Report.

 

Our Sponsors and their controlling individuals and our executive officers are deemed to be our “promoters” as such term is defined under the federal securities laws.

 

Restrictions on Transfers of Founder Shares, EBC Founder Shares, and Private Units

 

Following the consummation of our Initial Public Offering, the Founder Shares were placed into an escrow account maintained by Continental Stock Transfer & Trust Company acting as escrow agent. The Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of our initial business combination, or earlier, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities or other property, except (a) to our Sponsors, officers, directors, any affiliates or family members of any of our Sponsors, officers or directors or any members of our initial shareholders, or any affiliate of our initial shareholders; (b) in the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of a business combination at prices no greater than the price at which the securities were originally purchased; (f) by virtue of the laws of the Cayman Islands or the organizational documents of our Sponsors upon their dissolution; or (g) to us for no value for cancellation in connection with the consummation of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreements unless we otherwise consent to a transfer without a continuation of such restrictions.

 

 18

 

 

Our Sponsors and EBC have purchased from us an aggregate of 361,500 Private Placement Units in a private placement that closed simultaneously with the closing of our Initial Public Offering and related over-allotment option. The Private Placement Units are identical to the units sold in our Initial Public Offering, subject to limited exceptions. Our Sponsors and EBC have agreed not to transfer, assign or sell any of the Private Placement Units or underlying securities (except to the same permitted transferees as the Founder Shares and provided the transferees agree to the same terms and restrictions as the permitted transferees of the Founder Shares must agree to, each as described herein) until the completion of our initial Business Combination.

 

The Company also issued 180,000 EBC Founder Shares to EarlyBirdCapital for an aggregate purchase price of $2,520 on March 15, 2023. The EBC Founder Shares may not be transferred, assigned or sold (except to the same permitted transferees as the Founder Shares and provided the transferees agree to the same terms and restrictions as the permitted transferees of the Founder Shares must agree to, each as described herein) until the consummation of an initial Business Combination.

 

Registration Rights

 

The holders of the Founder Shares, EBC Founder Shares, Private Placement Units, Working Capital Units (if any) and their underlying securities will be entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

In compliance with FINRA Rule 5110(f)(2)(G), the registration rights granted to EBC are limited to demand and “piggy back” rights for periods of five and seven years, respectively, from the effective date of our prospectus filed in connection with our Initial Public Offering and EBC may only exercise its demand rights on one occasion.

 

Equity Compensation Plans

 

As of December 31, 2024, we had no compensation plans (including individual compensation arrangements) under which equity securities of the registrant were authorized for issuance. In connection with the Transactions, in January 2025, the Company’s shareholders approved an incentive equity plan. For information relating to such plan, see the section titled “Proposal 7: The Incentive Plan Proposal” contained in the Definitive Proxy Statement/Prospectus, incorporated by reference herein.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

On February 27, 2023, Bowen Holdings LP acquired an aggregate of 1,725,000 Founder Shares for an aggregate purchase price of $25,000. Thereafter, it transferred an aggregate of 1,155,750 Founder Shares to Createcharm Holdings Ltd. On October 14, 2024, one of the Sponsors transferred 30,000 of its Founder Shares to EarlyBirdCapital in connection with the loans.

 

Our Sponsors purchased an aggregate of 361,500 Private Placement Units in the Private Placement that was consummated concurrently with the IPO, including those Private Placement Units purchased following the full exercise of the underwriters’ over-allotment option, for a purchase price of $10.00 per Private Placement Unit, for an aggregate purchase price of $3,615,000. Each Private Placement Unit consists of one Private Placement Share and one Private Placement Right. The Private Placement Units (including the Private Placement Shares, Private Placement Rights, and the Ordinary Shares issuable upon conversion of the Private Placement Rights included in such Private Placement Units) and the Working Capital Units that may be issued upon conversion of working capital loans (including the Ordinary Shares, Rights, and Ordinary Shares issuable upon conversion of the Rights included in such Working Capital Units) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder.

 

 19

 

 

Except as set forth herein, no compensation of any kind, including finder’s and consulting fees, will be paid to our initial shareholders, existing officers, directors and advisors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our initial shareholders or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 

Our Sponsors agreed to loan us up to $300,000 to be used for a portion of the expenses of our Initial Public Offering. These loans are non-interest bearing, unsecured and were due at the closing of our Initial Public Offering. The Promissory Note expired on July 14, 2023.

 

On July 11, 2023, Bowen Holding LP agreed that through the earlier of our consummation of our initial business combination or the liquidation of the Trust Account, it will make available to us certain general and administrative services, including office space, utilities and administrative support, as we may require from time to time. We have agreed to pay $10,000 per month for these services. We believe, based on rents and fees for similar services, that these fees are at least as favorable as we could have obtained from an unaffiliated person.

 

On February 20, 2023, we engaged TenX Global Capital, a member of Bowen Holding LP, to provide us with consulting and advisory services in connection with, among other things, (i) preparing certain of our consolidated financial statements and other financial-related disclosures at a fixed price of $20,000 and (ii) assisting us with the preparation of, and the accounting relating to, our quarterly and annual reports to be filed with the Securities and Exchange Commission at a price of $5,250 per quarter commencing on the month following the consummation of our Initial Public Offering.

 

In addition, in order to finance transaction costs in connection with an intended initial business combination, our initial shareholders, officers, directors or their affiliates may, but are not obligated to, loan us funds on a non-interest bearing basis as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into Working Capital Units at $10.00 per Working Capital Unit at the option of the lender. The Working Capital Units would be identical to the Private Placement Units. Except as set forth above, the terms of such loans have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our initial shareholders, officers, directors or their affiliates as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account, but if we do, we will request such lender to provide a waiver against any and all rights to seek access to funds in our Trust Account.

 

After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to stockholders, to the extent then known, in the proxy solicitation materials furnished to our stockholders. However, the amount of such compensation may not be known at the time of the stockholder meeting held to consider an initial business combination, as it will be up to the directors of the post-combination business to determine executive and director compensation. In this event, such compensation will be publicly disclosed at the time of its determination in a Current Report on Form 8-K or a periodic report, as required by the SEC.

 

Related Party Policy

 

Our Code of Ethics, which we adopted upon consummation of our Initial Public Offering, requires us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts of interests, except under guidelines approved by the board of directors (or the audit committee). Related-party transactions are defined as transactions in which (1) the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2) we or any of our subsidiaries is a participant, and (3) any (a) executive officer, director or nominee for election as a director, (b) greater than 5% beneficial owner of our Ordinary Shares, or (c) immediate family member, of the persons referred to in clauses (a) and (b), has or will have a direct or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial owner of another entity). A conflict-of-interest situation can arise when a person takes actions or has interests that may make it difficult to perform his or her work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family, receives improper personal benefits as a result of his or her position.

 

 20

 

 

We also require each of our directors and executive officers to annually complete a directors’ and officers’ questionnaire that elicits information about related party transactions.

 

Our audit committee, pursuant to its written charter, is responsible for reviewing and approving related-party transactions to the extent we enter into such transactions. All ongoing and future transactions between us and any of our officers and directors or their respective affiliates will be on terms believed by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions will require prior approval by our audit committee and a majority of our uninterested “independent” directors, or the members of our board who do not have an interest in the transaction, in either case who had access, at our expense, to our attorneys or independent legal counsel. We will not enter into any such transaction unless our audit committee and a majority of our disinterested “independent” directors determine that the terms of such transaction are no less favorable to us than those that would be available to us with respect to such a transaction from unaffiliated third parties. Additionally, we require each of our directors and executive officers to complete a directors’ and officers’ questionnaire that elicits information about related party transactions.

 

These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer.

 

Director Independence

 

Currently, Lawrence Leighton, Wei Li and Jun Zhang would each be considered an “independent director” under the Nasdaq listing rules, which is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship, which, in the opinion of the company’s board of directors would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our independent directors will have regularly scheduled meetings at which only independent directors are present.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 

The following is a summary of fees paid or to be paid to UHY LLP, or UHY, for services rendered.

 

The firm of UHY LLP, or UHY, acts as our independent registered public accounting firm. The following is a summary of fees paid to UHY for services rendered.

 

Audit Fees. Audit fees consist of fees billed for professional services rendered for the audit of our year-end consolidated financial statements and interim review of the financial information included in our registration statement or Form 10-Q for the respective periods. The aggregate fees billed by UHY for professional services rendered for the audit of our annual financial statements, review of the financial information included in our Forms 10-Q for the respective periods and other required filings with the SEC for the year ended December 31, 2024 totaled $257,906. The fees rendered for the initial audit, post-IPO balance sheet audit, and for the review of our registration statements and other regulatory documents filed with SEC for the period from February 17, 2023 (inception) through December 31, 2023 totaled $156,351.

 

Audit-Related Fees. Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our consolidated financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay UHY for consultations concerning financial accounting and reporting standards for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) through December 31, 2023.

 

All Other Fees. There were no fees billed for products and services provided by our independent registered public accounting firm other than those set forth above for the year ended December 31, 2024 and the period from February 17, 2023 (inception) through December 31, 2023.

 

Pre-Approval Policy

 

Our audit committee was formed in connection with the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).

 

 21

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENTS, AND SCHEDULES

 

  (a) The following documents are filed as part of this report:

 

  (1) Financial Statements:

 

  Page
   
Report of Independent Registered Public Accounting Firm F-2
Consolidated Balance Sheets F-3
Consolidated Statements of Operations F-4
Consolidated Statements of Changes in Stockholders’ (Deficit) Equity F-5
Consolidated Statements of Cash Flows F-6
Notes to Consolidated Financial Statements F-7 to F-18

 

  (2) Financial Statement Schedules:

 

None.

 

  (b) The following Exhibits are filed as part of this report:

 

Exhibit No.   Description
   
2.1   Agreement and Plan of Merger, dated as of January 18, 2024, by and among Bowen Acquisition Corp, Bowen Merger Sub, Shenzhen Qianzhi BioTech Company Limited and Qianzhi Group Holding (Cayman) Limited.**
     
3.1   Amended and Restated Memorandum and Articles of Association.*
   
4.1   Specimen Unit Certificate.***
   
4.2   Specimen Ordinary Share Certificate.***
   
4.3   Specimen Rights Certificate.***
   
4.4   Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant.*
   
4.5   Description of the Registrant’s Securities.*****
     
10.1   Letter Agreement from each of the Registrant’s initial shareholders, officers and directors.***
   
10.2   Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.*
     
10.3   Registration Rights Agreement.*
     
10.4   Private Placement Units Purchase Agreement between the Registrant and the Sponsors.***

 

 22

 

 

10.5   Private Placement Units Purchase Agreement between the Registrant and EarlyBirdCapital, Inc..***
     
10.6   Form of Indemnification Agreement.*
     
10.7   Administrative Services Agreement.*
     
10.8   Form of Share Escrow Agreement among the Registrant, Continental Stock Transfer & Trust Company and the Initial Shareholders.***
     
10.9   Form of Business Combination Marketing Agreement between the Registrant and EarlyBirdCapital, Inc.***
     
10.10   Form of Voting Agreement.**
     
10.11   Subscription Agreement.***
     
14   Code of Ethics.****
     
19.1   Insider Trading Policy******
     
31.1   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
97   Clawback Policy*****
     
101.INS   Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Labels Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on July 11, 2023.
** Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 24, 2024.
*** Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on December 5, 2024
**** Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (SEC File Nos. 333-272076).
***** Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed on March 29, 2024.
****** Filed herewith.

 

ITEM 16. FORM 10-K SUMMARY

 

None.

 

 23

 

 

SIGNATURES

 

Pursuant to the requirements of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 15th day of April, 2025.

 

  BOWEN ACQUISITION CORP
     
  By: /s/ Jiangang Luo
    Jiangang Luo
    Chief Executive Officer

 

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Name   Position   Date
         
/s/ Na Gai   Chairwoman   April 15, 2025
Na Gai    
     
/s/ Jiangang Luo   Chief Executive Officer   April 15, 2025
Jiangang Luo   (Principal Executive Officer)    
     
/s/ Jing Lu   Chief Financial Officer   April 15, 2025
Jing Lu   (Principal Financial and Accounting Officer)    
     
/s/Lawrence Leighton   Director   April 15, 2025
Lawrence Leighton        
     
/s/Wei Li   Director   April 15, 2025
Wei Li        
         
/s/Jun Zhang   Director   April 15, 2025
Jun Zhang    

 

 24

 

 

BOWEN ACQUISITION CORP

INDEX TO THE FINANCIAL STATEMENTS

 

  Page
   
Report of Independent Registered Public Accounting Firm (PCAOB #1195) F-2
Financial Statements:  
Consolidated Balance Sheets F-3
Consolidated Statements of Operations F-4
Consolidated Statements of Changes in Stockholders’ (Deficit) Equity F-5
Consolidated Statements of Cash Flows F-6
Notes to Consolidated Financial Statements F-7 to F-18

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Shareholders of Bowen Acquisition Corp and its subsidiary

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Bowen Acquisition Corp and its wholly owned subsidiary (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of operations, changes in shareholders’ equity (deficit), and cash flows for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) to December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements presents fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) to December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared to assume the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has no revenue, and incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in the pursuit of the consummation of a business combination. The Company’s cash and working capital as of December 31, 2024, are not sufficient to complete its planned activities for the upcoming year. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans regarding these matters are also described in Note 1 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to that matter.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ UHY LLP
 
We have served as the Company’s auditor since 2023.
 
New York, New York
April 15, 2025

 

F-2

 

 

BOWEN ACQUISITION CORP

CONSOLIDATED BALANCE SHEETS

 

   2024   2023 
   December 31, 
   2024   2023 
ASSETS        
Current Assets:          
Cash and cash equivalents  $103,774   $426,913 
Other receivable   138,046    -  
Prepaid expenses   12,239    79,481 
Total Current Assets   254,059    506,394 
Investment held in Trust Account   75,794,241    71,419,358 
Total Assets  $76,048,300   $71,925,752 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current Liabilities:          
Accrued offering costs and expenses  $309,004   $78,610 
Accrued expenses - related party   101,285    25,250 
Promissory note - related party (net of unamortized debt discount of $122,174 and $0, respectively) (Note 5)   377,826    - 
Promissory Note   190,000    - 
Payable to target company   75,000    - 
Total Current Liabilities   1,053,115    103,860 
           
Total Liabilities   1,053,115    103,860 
           
Commitments and contingencies (Note 6)   -    - 
Ordinary shares subject to possible redemption, 6,900,000 shares at redemption value of $10.98 and $10.35 per share as of December 31, 2024 and 2023, respectively   75,794,241    71,419,358 
           
Shareholders’ Equity:          
Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding   -     -  
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding (excluding 6,900,000 shares subject to redemption on December 31, 2024 and 2023, respectively)   227    227 
Additional paid-in capital   -    - 
Retained earnings (Accumulated deficit)   (799,283)   402,307 
           
Total Shareholders’ Equity (Deficit)   (799,056)   402,534 
Total Liabilities and Shareholders’ Equity  $76,048,300   $71,925,752 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-3

 

 

BOWEN ACQUISITION CORP

CONSOLIDATED STATEMENTS OF OPERATIONS

 

         
   For the Year
Ended
December 31, 2024		   For the Period from February 17, 2023 (Inception) Through December 31, 2023 
Formation and operating costs  $633,764   $244,568 
Loss from operations   (633,764)   (244,568)
           
Other income:          
Interest earned on investments held in trust account   3,684,883    1,729,358 
Total other income   3,684,883    1,729,358 
           
Other expense:          
Interest expense   (87,267)   - 
Total other expense   (87,267)   - 
           
Net income  $2,963,852   $1,484,790 
           
Basic and diluted weighted average ordinary shares outstanding, redeemable ordinary shares   6,900,000    3,819,156 
Basic and diluted net income per share, redeemable ordinary shares  $0.48   $1.12 
Basic and diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares   2,266,500    2,095,943 
Basic and diluted net loss per share, non-redeemable ordinary shares  $(0.15)  $(1.32)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-4

 

 

BOWEN ACQUISITION CORP

STATEMENTS OF CHANGES IN SHAREHOLDERS’ (DEFICIT) EQUITY

 

FOR THE YEAR ENDED DECEMBER 31, 2024

 

   Shares   Amount   Capital   Deficit)  

(Deficit)

 
   Ordinary Shares  

Additional

Paid-in

  

Retained

Earnings (Accumulated

  

Total

Shareholders’ Equity

 
   Shares   Amount   Capital   Deficit)  

(Deficit)

 
Balance as of January 1, 2024   2,266,500   $227   $-   $402,307   $402,534 
                          
Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)   -    -    (209,442)   (3,475,442)   (3,684,884)
Subsequent measurement of Common stock subject to possible redemption (extension deposit)   -    -    -    (690,000)   (690,000)
Debt discount allocation to APIC   -    -    209,442    -    209,442 
Net income   -    -    -    2,963,852    2,963,852 
                          
Balance as of December 31, 2024   2,266,500   $227   $-   $(799,283)  $(799,056)

 

FOR THE PERIOD FROM FEBURARY 17, 2023 (INCEPTION) THROUGH DECEMBER 31, 2023

 

   Ordinary Shares  

Additional

Paid-in

   Retained Earnings (Accumulated  

Total

Shareholders’

 
   Shares   Amount   Capital   Deficit)   Equity 
Balance on February 17, 2023 (inception)   -   $-   $-   $-   $- 
Issuance of ordinary shares to Sponsors   1,725,000    173    24,827    -    25,000 
Issuance of ordinary shares to Underwriter   180,000    18    1,015,982    -    1,016,000 
Proceeds from sale of public units   6,000,000    600    59,999,400    -    60,000,000 
Proceeds from over-allotment   900,000    90    8,999,910    -    9,000,000 
Sale of Private Units   330,000    33    3,299,967    -    3,300,000 
Over-allotment of Private Units   31,500    3    314,997    -    315,000 
Underwriter’s commission on sale of Public Units   -    -    (1,500,000)   -    (1,500,000)
Underwriter’s commission on Over-allotment   -    -    (225,000)   -    (225,000)
Other offering costs   -    -    (1,593,898)   -    (1,593,898)
Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital   (6,900,000)   (690)   (65,235,677)   -    (65,236,367)
Allocation of offering costs to ordinary shares subject to redemption   -    -    3,137,867    -    3,137,867 
Deduction for increase of carrying value of redeemable shares   -    -    (7,591,500)   -    (7,591,500)
Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)   -    -    (646,875)   (1,082,483)   (1,729,358)
Net income   -    -    -    1,484,790    1,484,790 
Balance as of December 31, 2023   2,266,500   $227   $-   $402,307   $402,534 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-5

 

 

BOWEN ACQUISITION CORP

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the Year Ended
December 31, 2024		  

For the Period from
February 17, 2023
(Inception) Through

December 31, 2023

 
Cash flows from operating activities:          
Net income  $2,963,852   $1,484,790 
Adjustments to reconcile net income to net cash used in operating activities:          
Income earned on investment held in Trust Account   (3,684,883)   (1,729,358)
Amortized interest expense from debt discount   87,267    - 
Changes in current assets and liabilities:          
Accrued offering costs and expenses   161,565    6,714 
Accrued expenses - related party   75,780    25,250 
Prepaid expenses   73,280    (79,481)
Net cash used in operating activities   (323,139)   (292,085)
           
Cash flows from investing activities:          
Investments of cash into Trust Account   -    (69,690,000)
Extension deposit to Trust Account   (690,000)   - 
Net cash used in investing activities   (690,000)   (69,690,000)
           
Cash flows from financing activities:          
Proceeds from promissory note – related party   500,000    - 
Proceeds from promissory note   190,000    - 
Proceeds from issuance of founder shares   -    2,520 
Proceeds from sale of ordinary shares   -    69,000,000 
Proceeds from Private Placement   -    3,615,000 
Payments of underwriter’s discount   -    (1,725,000)
Payments to related party   -    (151,318)
Payment of offering costs   -    (332,204)
Net cash provided by financing activities   690,000    70,408,998 
           
Net change in cash   (323,139)   426,913 
Cash at beginning of period   426,913    - 
Cash at the end of period  $103,774   $426,913 
           
Supplemental disclosure of noncash financing activities          
           
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)  $3,684,883   $1,729,358 
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)  $690,000   $- 
Offering costs paid by related party  $75,000   $- 
Offering costs adjusted from prepaid expenses  $-    894 
Debt discount in connection with promissory note  $209,442   $- 
Offering costs paid by Sponsor in exchange for issuance of ordinary shares  $-   $25,000 
Offering costs charged to APIC  $-   $1,593,898 
Reclassification of ordinary shares subject to redemption  $-   $65,236,367 
Allocation of offering costs to ordinary shares subject to redemption  $-   $3,137,868 
Remeasurement adjustment on ordinary shares subject to possible redemption  $-   $7,591,500 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-6

 

 

BOWEN ACQUISITION CORP

Notes to the CONSOLIDATED financial statements

 

NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS

 

Organizational and General

 

Bowen Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”).The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.

 

The Company’s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership (the “Sponsors”). As of December 31, 2024, the Company had not commenced any operations. All activities for the period from February 17, 2023 (inception) through December 31, 2024 relate to the Company’s formation, the initial public offering (“IPO”) and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company is generating non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

 

The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on July 11, 2023. On July 14, 2023, the Company consummated the IPO of 6,000,000 of its units (“Public Units”). Each Public Unit consists of one ordinary share, $0.0001 par value (“Ordinary Shares”), of the Company and one right (“Rights”), each Right entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company’s initial business combination. The Public Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $60,000,000.

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement (“Private Placement”) of 330,000 units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating total proceeds of $3,300,000. The Private Placement Units were purchased by Createcharm Holdings Ltd, one of the Company’s sponsors, and EarlyBirdCapital, Inc. (“EBC”), the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion of the Company’s initial Business Combination.

 

On July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000 Units. As a result, on July 18, 2023, the Company sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. In connection with this sale, Createcharm Holdings Ltd. and EBC also purchased an additional 31,500 Private Placement Units from the Company.

 

As of July 18, 2023, transaction costs amounted to $3,318,898 consisting of $1,725,000 of cash underwriting fees and $1,593,898 of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon completion of the IPO.

 

F-7 

 

 

The Company will have until 18 months from the closing of the IPO to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period and shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay the Company’s taxes, if any (less certain amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

On November 20, 2023, a wholly-owned subsidiary of the Company, Bowen Merger Sub (“Merger Sub”) was formed for the purpose of entering into a business combination agreement. See “Proposed Business Combination” below.

 

Effective as of October 7, 2024, the Company notified the trustee of the Trust Account that it was extending the time to consummate an initial Business Combination from October 14, 2024 to January 14, 2025. Effective as of October 14, 2024, Shenzhen Qianzhi (as defined below) and EBC, two designees of the Sponsors, loaned the Company an aggregate of $690,000, which funds were deposited into the Trust Account for such extension. The loans are evidenced by promissory notes (the “Notes”) issued by the Company to the designees. The Notes bear no interest and are repayable in full upon consummation of a Business Combination. In connection with the loans, one of the Sponsors transferred 30,000 of its Founder Shares to EBC.

 

The Company had called an extraordinary general meeting (the “Extension Meeting”) for January 10, 2025 to approve, by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”), by up to three one-month increments, from January 14, 2025 to as late as April 14, 2025, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. In connection with the meeting, an aggregate of 6,052,095 Public Shares were redeemed at a price of approximately $10.99 per share. Following the redemptions, the Company has 847,905 Public Shares, and approximately $9,319,446 remaining in Trust Account.

 

On January 14, 2025, the Company held another extraordinary general meeting to approve the business combination with Qianzhi (as defined below). At the meeting, all proposals were approved by shareholders. An aggregate of 137,936 Public Shares requested redemption in connection with such vote. However, as the business combination has not been consummated, none of such shares has been redeemed. As of the filing date, since the business combination has not been consummated, none of such shares have been redeemed.

 

On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of 103,432 Public Shares were redeemed at a price of approximately $11.03 per share. Following the redemptions, the Company has 744,473 Public Shares, and approximately $8,211,537 remaining in Trust Account.

 

Proposed Business Combination

 

On January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the “Agreement”) with (i) Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (“Merger Sub”), (ii) Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People’s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (“Shenzhen Qianzhi”or “Qianzhi”), and (iii) Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (“NewCo,” and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the “Parties”, each a “Party”).

 

Pursuant to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the “Merger”), with NewCo being the surviving company of the Merger (“Surviving Company”) and becoming a wholly owned subsidiary of the Company. In the Merger, the holders (the “NewCo Shareholders”) of the ordinary shares of NewCo (“NewCo Ordinary Shares”) will receive ordinary shares of the Company (“Parent Ordinary Shares”).

 

Pursuant to the Agreement, at the effective time of the Merger (the “Effective Time”), all of NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) 7,246,377 Parent Ordinary Shares (the “Merger Shares”), and (b) the right to receive earnout consideration of up to an aggregate of 1,400,000 Parent Ordinary Shares (the “Earnout Shares”).

 

The Company’s Registration Statement on Form S-4 (“S-4”) was declared effective on December 18, 2024. As of the filing date, the business combination remained pending, awaiting required regulatory approvals.

 

F-8 

 

 

Going Concern Consideration

 

As of December 31, 2024, the Company had cash and cash equivalent of $103,774 and a working capital deficit of $799,056. The Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. Management expects to obtain additional funds from related parties to provide the additional working capital necessary to carry out its objective to consummate a business combination. The consolidated financial statement does not include any adjustments that might result from the outcome of the uncertainty.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

F-9 

 

 

Use of Estimates

 

The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $103,774 and $426,913 as of December 31, 2024 and 2023, respectively.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of December 31, 2024 and 2023, the Trust Account had balance of $75,794,241 and $71,419,358, respectively. The interest and dividend income earned from the Trust Account totaled $3,684,883 and $1,729,358 for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) through December 31, 2023, respectively, which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.

 

Offering Costs

 

Offering costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on July 14, 2023.

 

Interest Expenses

 

Interest expense in 2024 is primarily from the amortization of the debt discount in connection with the promissory note issued by the Company to related party. See Note 5 - Related Parties for more information.

 

Amortization of Debt Discount

 

The Company’s promissory note issued with related party is recorded net of debt discount which comprised issuance costs, and the discount initially recognized for the fair value of the shares transferred. The portion of the debt issuance costs allocated to the promissory note, is being amortized over the terms, which is upon consummation of the Business Combination. The amortization of debt issuance costs and discount is included in interest expense within the accompanying consolidated statements of operations.

 

F-10 

 

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statements.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

The net income (loss) per share presented in the statements of operations is based on the following:

  

For the Year

Ended
December 31, 2024

  

For the Period

from
February 17, 2023
(Inception)

Through

December 31, 2023

 
Net income  $2,963,852   $1,484,790 
Interest earned on investment held in Trust Account   (3,684,883)   (1,729,358)
Accretion of temporary equity into redemption value   (690,000)   (7,591,500)
Net loss including accretion of equity into redemption value  $(1,411,031)  $(7,836,068)

 

F-11 

 

   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
   

For the Year ended

December 31, 2024

  

For the Period from
February 17, 2023
(Inception) Through

December 31, 2023

 
   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
Particulars  Shares   Shares   Shares   Shares 
Basic and diluted net income (loss) per share:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Ownership percentage   75%   25%   65%   35%
Numerators:                    
Allocation of net loss including accretion of temporary equity  $(1,062,141)  $(348,890)  $(5,059,453)  $(2,776,615)
Accretion of temporary equity into redemption value   690,000    -    7,591,500    - 
Interest earned on Trust Account   3,684,883    -    1,729,358    - 
Allocation of net income (loss)  $3,312,742    (348,890)  $4,261,405   $(2,776,615)
                     
Denominators:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Basic and diluted net income/(loss) per share  $0.48   $(0.15)  $1.12   $(1.32)

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

 

F-12 

 

 

At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET

Public offering proceeds   $ 60,000,000  
Less:        
Proceeds allocated to Public Rights     (3,272,724 )
Allocation of offering costs related to redeemable shares     (2,925,140 )
Plus:        
Accretion of carrying value to redemption value     6,797,864  
Ordinary shares subject to possible redemption     60,600,000  
         
Over-allotment        
Plus:        
Over-allotment proceeds     9,000,000  
Less:        
Proceeds allocated to Public Rights     (490,909 )
Allocation of offering costs related to redeemable shares     (212,727 )
Plus:        
Accretion of carrying value to redemption value     793,636  
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     1,729,358  
Ordinary shares subject to possible redemption, December 31, 2023   $ 71,419,358  
Plus:        
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     3,684,883  
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)     690,000  
Ordinary shares subject to possible redemption, December 31, 2024   $ 75,794,241  

 

Recent Accounting Standards

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance in ASU 2023-07 on January 1, 2024, and there is no significant impact on the disclosure of the consolidated financial statements. The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

 

NOTE 3 — INITIAL PUBLIC OFFERING

 

On July 14, 2023, the Company sold 6,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights. The Company also granted the underwriters a 45-day option to purchase up to an additional 900,000 units to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.

 

The Company incurred $75,000 Nasdaq delayed entry fee during the IPO in 2023 and this balance was subsequently paid by Qianzhi which is the target company. As of December 31, 2024, this balance is recorded as “Payable to target” on the consolidated balance sheet.

 

NOTE 4 — PRIVATE PLACEMENTS

 

The Sponsors and EBC had agreed to purchase an aggregate of 330,000 Private Placement Units (312,000 Private Placement Units to be purchased by the Sponsors and 18,000 Private Placement Units to be purchased by EBC or its designees), or 361,500 Private Placement Units if the underwriters’ over-allotment is exercised in full, at a price of $10.00 per Private Placement Unit ($3,300,000, or an aggregate of $3,615,000 if the underwriters’ over-allotment is exercised in full) from the Company in a private placement that will occur simultaneously with the closing of the Initial Public Offering.

 

F-13 

 

 

Simultaneously with the closing of the IPO on July 14, 2023, the Company consummated the private sale of 330,000 Private Placement Units. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. The proceeds from the sale of the Private Placement Units were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to certain exceptions.

 

On July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.

 

NOTE 5 — RELATED PARTIES

 

Founder Shares and EBC Founder Shares

 

On February 27, 2023, the Sponsors received 1,725,000 of the Company’s ordinary shares (“Founder Shares”) in exchange for $25,000 paid for offering costs borne by the Sponsors. Up to 225,000 of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full. On July 17, 2023, the underwriters exercised their over-allotment option in full.

 

On March 15, 2023, the Company issued to EBC 180,000 ordinary shares (“EBC founder shares”) for a purchase price of $0.014 per share and an aggregate purchase price of $2,520. The EBC founder shares are deemed to be underwriters’ compensation by FINRA pursuant to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $1,016,000 or $5.65 per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value of the shares as offering cost.

 

The fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:

 

Time to expiration     1.84  
Risk-free rate     4.0 %
Volatility     5.0 %
Dividend yield     0.0 %
Probability of completion of business combination     60.0 %

 

The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an initial business combination.

 

On October 14, 2024, one of the Sponsors transferred 30,000 of its Founder Shares to EBC in connection with $500,000 loan for the extension. See below for more details.

 

Promissory Note — Related Party

 

On February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on July 14, 2023.

 

On October 14, 2024, EBC loaned the Company $500,000 which funds were deposited into the Trust Account for the extension. The loan is evidenced by promissory note issued by the Company (“Extension Note”). The Extension Note bears no interest and is repayable in full upon consummation of a Business Combination. In connection with the loan, one of the Sponsors transferred 30,000 of its Founder Shares to EBC. The value of the shares transferred is reflected as debt discount and fully amortized as interest expense over the life of the loan per ASC 835. As of December 31, 2024, $500,000 was outstanding.

 

F-14 

 

 

The Company estimated the fair value of the Founder Shares to be approximately $209,442 or $6.98 per share using the Black-Scholes option pricing model. The fair value of the Founder Shares was estimated at October 14, 2024. The Company used the following assumptions to estimate the fair value of Founder Shares using Level 3 fair value measurements inputs at the measurement date:

 

Time to expiration     1.0  
Risk-free rate     4.2 %
Volatility     5.0 %
Dividend yield     0.0 %
Probability of completion of business combination     65.0 %

 

Based on the fair value of the Founder Shares, the Company recorded a debt discount of $209,442, which is amortized as interest expense over the loan period. The loan period extends until the consummation of the Business Combination, estimated to occur on April 15, 2025. As of December 31, 2024, the Company recorded an interest expense of $87,267.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of IPO to purchase up to 900,000 additional Units to cover over-allotments, at the IPO price less the underwriting discounts and commissions.

 

The underwriters were entitled to a cash underwriting discount of $0.25 per Unit, or $1,500,000 in the aggregate (or $1,725,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable upon the closing of the IPO.

 

On July 17, 2023, the underwriters exercised the over-allotment option in full to purchase 900,000 Units. As a result, on July 18, 2023, the Company sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds to the Company of $9,000,000.

 

Due to Related Party

 

The Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest bearing. Before the IPO, the Sponsors had paid $151,318 on behalf of the Company for expenses related to IPO, which was fully repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.

 

As of December 31, 2024, the total accrued expenses due to related parties was $101,285, which includes $90,000 payable for administration fee and $11,285 payable for accounting related and other service fee. As of December 31, 2023, the total accrued expenses due to related parties was $25,250, which include $20,000 payable for administration fee and $5,250 payable for accounting service fee. See following paragraphs for details.

 

Accounting Service Agreement and Others

 

The Company has engaged TenX Global Capital, a related party of the Company, to assist in initial accounting preparation, preparing quarterly and annual financial statements commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $5,250 each quarter. TenX Global Capital also provides other services following the consummation of the IPO.

 

F-15 

 

 

Administration Fee

 

Commencing on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the Company an allocable share of its overhead, up to $10,000 per month, until to the close of the Business Combination, to compensate it for the Company’s use of its office, utilities and personnel.

 

The following table presents details about the expenses incurred and payable for the year ended December 31, 2024 and during the period from February 17, 2023 (inception) through December 31, 2023:

 

                
Nature  Operating Costs   Payable Balance as of December 31, 
   For the year ended December 31, 2024   During the period from February 17, 2023 (inception) through December 31, 2023   2024   2023 
Initial accounting service fee  $-   $20,000   $-   $- 
Accounting service fee and others   21,785    10,500    11,285    5,250 
Administration fee   120,000    56,667    90,000    20,000 
Total  $141,785   $87,167   $101,285   $25,250 

 

NOTE 6 — COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Business Combination Marketing Agreement

 

The Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation of its initial Business Combination in an amount of $2,415,000, equal to 3.5% of the gross proceeds of the IPO. In addition, the Company will pay EBC a service fee in an amount equal to 1.0% of the total consideration payable in the initial Business Combination if it introduces the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and is due at the closing date of the initial Business Combination. No such service has been provided by EBC.

 

Business Combination Transaction Cost

 

The Company has engaged several service providers including legal and valuation services, specifically for business combination between the Company and Shenzhen Qianzhi BioTechnology Co. Ltd. (“Qianzhi”). Per the agreed terms, Qianzhi agreed to be responsible for all expenses incurred by the Company in connection with business combination. For the year ended December 31, 2024, $527,145 of business combination related cost has been incurred which $389,099 was reimbursed by Qianzhi. During the period from February 17, 2023 (inception) through December 31, 2023, $181,022 of business combination related cost has been incurred and reimbursed by Qianzhi. This activity has been recorded on the net basis and no impact to financial statements.

 

NOTE 7 — SHAREHOLDERS’ EQUITY

 

Preferred Shares — The Company is authorized to issue 2,000,000 preferred shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2024 and 2023, there were no preferred shares issued or outstanding.

 

F-16 

 

 

Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. On February 27, 2023, the Sponsors received 1,725,000 of the Founder Shares in exchange for $25,000 paid for offering costs borne by the Sponsors, of which an aggregate of up to 225,000 of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares will equal 20% of the Company’s issued and outstanding ordinary shares after the IPO (excluding shares underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on July 17, 2023. As of December 31, 2024 and 2023, there were 2,266,500 ordinary shares issued and outstanding (excluding 6,900,000 shares subject to possible redemption).

 

Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.

 

NOTE 8 — Fair Value Measurements

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2024 and 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

Date   Nature   Level     Fair Value  
December 31, 2024   Marketable securities held in the trust account     1     $ 75,794,241  
                     

December 31, 2024

   Cash equivalents     1     $

103,774

  
                     
December 31, 2023   Marketable securities held in the trust account     1     $ 71,419,358  
                     
December 31, 2023   Cash equivalents     1     $ -  

 

F-17 

 

 

NOTE 9 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required adjustment or disclosure in the financial statements.

 

On January 10, 2025, the Company held an extraordinary general meeting (the “Meeting”) by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date (the “Extension”) by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”), by up to three one-month increments, from January 14, 2025 to as late as April 14, 2025, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. In connection with the meeting, an aggregate of 6,052,095 Public Shares were redeemed at a price of approximately $10.99 per share.

 

On January 13, 2025, the Company entered into Prepaid Forward Purchase Agreement (the “FPA”) by and among the Company, NewCo, and the funds, accounts and/other investment vehicles managed by Harraden Circle Investments, LLC signatory thereto (collectively, the “Purchaser”). In accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser shall purchase from holders of ordinary shares, par value $0.0001 per share, of the Company (“Company Ordinary Share”) that have elected to redeem their Company Ordinary Shares in connection with the contemplated business combination (“Business Combination”) between the Company, NewCo and Qianzhi, up to the lesser of (a) 550,000 Company Ordinary Shares and (b) such number of Company Ordinary Shares as shall, following the Business Combination between the Company, NewCo and Qianzhi, not to exceed 9.9% of the total number of Company Ordinary Shares to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price (the “Redemption Price”) per share to be paid to redeeming public shareholders of the Company. The current Redemption Price payable to redeeming public shareholders is approximately $10.991 per share. Any Company Ordinary Shares purchased pursuant to the FPA will not be voted in favor of approving the Business Combination. Upon the Business Combination closing, 50,000 Purchased Shares shall be deemed to be “Commitment Shares” and the remaining Forward Purchased Shares shall be deemed to be “Prepaid Forward Purchase Shares”. No later than the earlier of (a) one business day after the Business Combination closing and (b) the date any assets from the Company’s trust account are disbursed in connection with the Business Combination, the Company and NewCo shall cause Purchaser to be paid directly, out of the funds held in the Company’s trust account, a cash amount (the “Prepayment Amount”) equal to the number of Forward Purchased Shares multiplied by the Redemption Price. Upon the subsequent sale of the Prepaid Forward Purchase Shares by the Purchaser, the Purchaser will remit the Reference Price (as defined below) per share to the Company. On the date that is twelve months after the closing of the Business Combination (the “Maturity Date”), any Prepaid Forward Purchase Shares not sold by the Purchaser will be returned by the Purchaser to the Company and any remaining amounts in respect of the Prepaid Forward Purchase Shares will be retained by Purchaser. Prior to the Maturity Date, the Purchaser may sell Commitment Shares at any price in Purchaser’s sole discretion. The Purchaser has agreed that until the Maturity Date, the Prepaid Forward Purchase Shares may not be sold for a price less than the Reference Price. The “Reference Price” will initially equal the Redemption Price and may, at the Company’s option, be reduced (but never increased) at any time to the lowest daily volume weighted average price of the Company Ordinary Shares for the preceding 10 trading days.

 

On January 14, 2025, the Company held an extraordinary general meeting (the “Business Combination Meeting”) to approve, among other matters, its proposed business combination (the “Business Combination”) with NewCo and Qianzhi. The Company’s shareholders voted on the proposals at the Business Combination Meeting, all of which were described in the Company’s Registration Statement on Form S-4 (“S-4”) which was filed with the Securities and Exchange Commission (“SEC”) and included a prospectus of the Company as well as the Company’s proxy statement (the “Proxy Statement/Prospectus”). All of the proposals were approved. An aggregate of 137,936 Public Shares requested redemption in connection with such vote. However, as the business combination has not been consummated, none of such shares has been redeemed.

 

On March 19, 2025, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, for the prior 30 consecutive business days (through March 18, 2025), the closing market value of listed securities (MVLS) of the Company’s ordinary shares, $0.00001 par value per share, had been below the minimum of $50 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Rule”). The notice stated that the Company would be afforded 180 calendar days (until September 15, 2025) to regain compliance. In order to regain compliance, the closing MVLS of the Company’s securities must be at least $50 million for a minimum of ten consecutive business days. If the Company does not regain compliance within the 180-day period, the securities will be subject to delisting. On April 10, 2025, the Company received a notice from Nasdaq stating that it has regained compliance with the Rule, and this matter is now closed.

 

On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of 103,432 Public Shares were redeemed at a price of approximately $11.03 per share.

 

F-18 

 

 EX-19.1 2 ex19-1.htm

 

Exhibit 19.1

 

BOWEN ACQUISITION CORP

 

INSIDER TRADING POLICY

 

The Board of Directors of Bowen Acquisition Corp (“Company”) has adopted this Insider Trading Policy for directors, officers, employees and consultants of the Company and its subsidiaries with respect to the trading of the Company’s securities, as well as the securities of publicly-traded companies with whom the Company and/or its subsidiaries have a business relationship.

 

United States federal and state securities laws prohibit the purchase or sale of a company’s securities by persons who are aware of material information about that company that is not generally known or available to the public. These laws also prohibit persons who are aware of such material nonpublic information from disclosing this information to others who may trade. Companies and their controlling persons are also subject to liability if they fail to take reasonable steps to prevent insider trading by company personnel. It is important that you understand the breadth of activities that constitute illegal insider trading and the consequences, which can be severe.

 

This Policy is designed to prevent insider trading or allegations of insider trading, and to protect the Company’s reputation for integrity and ethical conduct. It is your obligation to understand and comply with this Policy.

 

Scope of Policy

 

Persons Covered. As a director, officer, employee or consultant of the Company or its subsidiaries, this Policy applies to you. The same restrictions that apply to you also apply to your family members who reside with you, anyone else who lives in your household and any family members who do not live in your household but whose transactions in the Company’s securities are directed by you or are subject to your influence or control (such as parents or children who consult with you before they trade in the Company’s securities). This Policy also applies to any entities that you influence or control, including any corporations, partnerships or trusts. This group of people and entities is sometimes referred to in this Policy as “Insiders.”

 

Companies Covered. The prohibition on insider trading in this Policy is not limited to trading in the Company’s securities. It includes trading in the securities of other firms, such as customers or suppliers of the Company and those with which the Company may be negotiating major transactions, such as an acquisition, investment or sale. Information that is not material to the Company may nevertheless be material to one of those other firms.

 

Transactions Covered. This Policy applies to all transactions in the Company’s securities, except as otherwise set forth herein, including purchases and sales of shares, derivative securities such as put and call options or swaps relating to the Company’s securities, and convertible debentures or preference shares.

 

1

 

 

Transactions Not Covered. This Policy’s trading restrictions generally do not apply to the following transactions, except as specifically noted. However, you still may not engage in such transactions while in possession of material information about the Company which is not publicly available.

 

Option Exercises. This Policy does not apply to the exercise of stock options for cash or to the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements. This Policy does apply, however, to any sale of the underlying shares or to a cashless exercise of the stock option, as this entails selling a portion of the underlying shares to cover the costs of exercise.

 

Restricted Stock Awards. This Policy does not apply to the vesting of restricted stock, or the exercise of a tax withholding right pursuant to which you elect to have the Company withhold shares to satisfy withholding requirements upon the vesting of any restricted stock. The Policy does apply, however, to any market sale of restricted stock.

 

Transactions Not Involving a Purchase or Sale of Company Securities. Bona fide gifts of securities are not transactions subject to this Policy.

 

Additional Restrictions and Guidance on Certain Transactions. The Company has determined that there is a heightened legal risk and/or the appearance of improper or inappropriate conduct if the persons subject to this Policy engage in certain types of transactions. It therefore is the Company’s policy that any persons covered by this Policy may not engage in any of the following transactions:

 

Short-Term Trading. Short-term trading of the Company’s securities may be distracting to the person and may unduly focus the person on the Company’s short-term market performance instead of the Company’s long-term business objectives. For these reasons, you are strongly discouraged from trading in the Company’s securities for short-term trading profits.

 

Short Sales. Short sales of the Company’s securities (i.e., the sale of a security that the seller does not own) may evidence an expectation on the part of the seller that the securities will decline in value, and therefore have the potential to signal to the market that the seller lacks confidence in the Company’s prospects. In addition, short sales may reduce a seller’s incentive to seek to improve the Company’s performance. For these reasons, short sales of the Company’s securities by Insiders are prohibited. In addition, Section 16(c) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), prohibits officers and directors from engaging in short sales.

 

Publicly-Traded Options. Given the relatively short term of publicly-traded options, transactions in options may create the appearance that a director, officer or employee is trading based on material nonpublic information and focus such a person’s attention on short-term performance at the expense of the Company’s long-term objectives. Accordingly, transactions of Company securities by Insiders in put options, call options or other derivative securities (not including the Company’s publicly traded rights or warrants), on an exchange or in any other organized market, are prohibited by this Policy.

 

2

 

 

Hedging Transactions. Hedging or monetization transactions can be accomplished through a number of possible mechanisms, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds. Such hedging transactions may permit a director, officer or employee to continue to own the Company’s securities obtained through employee benefit plans or otherwise but without the full risks and rewards of ownership. When that occurs, the director, officer or employee may no longer have the same objectives as the Company’s other stockholders. Therefore, Insiders are prohibited from engaging in any such transactions.

 

Margin Accounts and Pledged Securities. Securities held in a margin account as collateral for a margin loan may be sold by the broker without the customer’s consent if the customer fails to meet a margin call. Similarly, securities pledged (or hypothecated) as collateral for a loan may be sold in foreclosure if the borrower defaults on the loan. Because a margin sale or foreclosure sale may occur at a time when the pledgor is aware of material nonpublic information or otherwise is not permitted to trade in the Company’s securities, Insiders are prohibited from holding the Company’s securities in a margin account or otherwise pledging the Company’s securities as collateral for a loan.

 

Policy Statement

 

No Trading on Material Nonpublic Information. You may not trade in the Company’s securities, directly or through family members or other persons or entities, while in possession of material information about the Company which is not publicly available. This restriction on trading does not apply to transactions made under a trading plan (described below) that has been adopted pursuant to Rule 10b5-1(c) promulgated under the Exchange Act, and that has been approved in writing by the Chief Executive Officer and General Counsel of the Company (an “approved Rule 10b5-1 trading plan”).

 

You have ethical and legal obligations to maintain the confidentiality of information about the Company and to not engage in transactions in the Company’s securities while in possession of material nonpublic information. You are responsible for making sure that you comply with this Policy, and that any family member, household member or entity whose transactions are subject to this Policy also comply with this Policy. In all cases, the responsibility for determining whether you are in possession of material nonpublic information rests with you, and any action on the part of the Company, the Chief Executive Officer or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate you from liability under applicable securities laws.

 

No Tipping. You may not pass on material nonpublic information to others or recommend to anyone the purchase or sale of any securities when you are aware of such information. This practice, known as “tipping,” also violates the securities laws and can result in the same civil and criminal penalties that apply to insider trading, even though you personally did not trade or gain any benefit from another’s trading.

 

3

 

 

Trading Restricted to “Window” Periods. To help prevent inadvertent violations of the federal securities laws and to avoid even the appearance of trading while in possession of material nonpublic information, unless you have entered into an approved Rule 10b5-1 trading plan, as described below, you will be prohibited from buying and selling Company securities at all times, except during specified “window” periods. A window period begins on the third (3rd) trading day after the public release by the Company of any financial or other material information and ends fifteen (15) calendar days prior to the end of the then current quarter. You will be notified of the commencement and duration of window periods.1 Even within the designated window periods, trading will be permitted only if no development of major importance remains unannounced.

 

Pre-clearance Procedures for Covered Persons. Directors, executive officers subject to Section 16 of the Exchange Act and certain designated employees and consultants of the Company and its subsidiaries who generally have access to material nonpublic information about the Company and its subsidiaries, together with family members that reside with them and other members of their household (“Covered Persons”), may not engage in any transaction involving the Company’s securities, including entry into an approved Rule 10b5-1 trading plan, without first obtaining pre-clearance of the transaction in writing from the Company’s Chief Executive Officer and General Counsel. Unless you have been notified by the Company that you are not a Covered Person, you should assume that you are. A request for pre-clearance should be submitted at least two (2) business days in advance of the proposed transaction(s).

 

No Violation of Securities Laws. No Insider may offer or sell the Company’s securities in violation of the registration requirements of the United States federal or any applicable state securities laws. The Company’s General Counsel must be consulted prior to any contemplated sale of the Company’s securities under an exemption from registration, such as SEC Rule 144, which may involve complex legal issues and impose reporting requirements on certain senior corporate officers and directors.

 

Future Evaluation of Transactions. If securities transactions ever become the subject of scrutiny, they are likely to be viewed with the benefit of hindsight. As a result, before determining to engage in any transaction, an Insider should carefully consider how his, her or its transaction might be viewed in the future. Any questions or uncertainties regarding this Policy should be directed to the Company’s Chief Executive Officer or General Counsel.

 

Exception for Approved 10b5-1 Trading Plans

 

Trades in the Company’s securities that are executed pursuant to an approved Rule 10b5-1 trading plan are not subject to the prohibition on trading on the basis of material nonpublic information contained in this Policy or to the restrictions set forth above relating to window periods and pre-clearance procedures.

 

 

1 A window period may also exist after the Company files proxy or tender offer materials or other filings in connection with its initial business combination. The commencement and end of any such window period will be determined by the Company at such time and you will be notified accordingly.

 

4

 

 

SEC Rule 10b5-1 provides an affirmative defense to Covered Persons from insider trading liability under the federal securities laws for trading plans that meet certain requirements. In general, the Rule 10b5-1 affirmative defense applies when the Covered Person adopted a written plan when he is not aware of material nonpublic information (an “Approved 10b5-1 Plan”).

 

The Approved 10b5-1 Plan must provide that no trades may occur thereunder until expiration of the applicable cooling-off period specified in Rule 10b5-1(c)(ii)(B). The appropriate cooling-off period will vary based on the status of the Covered Person within the Company. For directors and officers, the cooling-off period ends on the later of (x) ninety days after adoption or certain modifications of the Approved 10b5-1 Plan and (y) two business days following disclosure of the Company’s financial results in a Form 10-Q or Form 10-K for the quarter in which the Approved 10b5-1 Plan was adopted. For all other Covered Persons, the cooling-off period ends 30 days after adoption or modification of the Approved 10b5-1 Plan. This required cooling-off period will apply to the entry into a new Approved 10b5-1 Plan and any revision or modification of an existing Approved 10b5-1 Plan.

 

The Approved 10b5-1 Plan must be entered into in good faith by the Covered Person, and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1, at a time when the Covered Person is not in possession of material nonpublic information about the Company; and, if the individual is a director or officer, the Approved 10b5-1 Plan must include representations by the individual certifying to that effect.

 

The Approved 10b5-1 Plan must either (i) give a third party the discretionary authority to execute purchases and sales, outside the control of the Covered Person, so long as such third party does not possess any material nonpublic information about the Company or (ii) explicitly specify the security or securities to be purchased or sold, the amount of securities to be purchased or sold, the prices and/or dates of transactions, or other formula(s) describing such transactions.

 

The Approved 10b5-1 Plan must be the only outstanding Approved 10b5-1 Plan entered into by the Covered Person (subject to certain exceptions). Furthermore, the affirmative defense will not be available to a Covered Person for more than one single-trade plan during any 12- month period.

 

The Company requires that all Rule 10b5-1 trading plans be reviewed and approved by counsel to the Company at least five days in advance of being entered into (or, if revised or amended, such proposed revisions or amendments have been reviewed and approved by counsel to the Company at least five days in advance of being entered into). Rule 10b5-1 trading plans generally may only be adopted during a window period and may only be adopted during a time that the person adopting the plan is not aware of any material nonpublic information.

 

5

 

 

Definition of Material Nonpublic Information

 

Material nonpublic information includes information that is not available to the public at large which could affect the market price of the security and to which a reasonable investor would attach importance in deciding whether to buy, sell or retain the security. You should assume that information is material if an investor might consider it important in deciding whether to buy or sell securities, even if the information by itself would not determine an investor’s decision.

 

Information is considered available to the public only after it has been released to the public through appropriate channels (e.g., by means of a press release or a public statement by a senior officer) and enough time has elapsed to permit the securities market to absorb and evaluate the information - you should assume a full two to three trading days after release.

 

Whether information is material is always a question of fact. Common examples of information that frequently will be regarded as material are:

 

  ● news of a significant pending transaction such as a proposed merger, acquisition, major sales or other commercial agreement, tender offer, sale of assets or disposition of a subsidiary;
     
  ● unannounced or unexpected results of operations or financial projections;
     
  ● changes to previously announced earnings guidance or the decision to suspend earnings guidance;
     
  ● major events regarding the Company’s securities, including changes in dividend policies, the declaration of a share split or the offering of additional securities or other major financing transactions;
     
  ● the establishment of a purchase program for the Company’s securities;
     
  ● changes in directors or senior management;
     
  ● changes in the Company’s auditors or a notification that the auditor’s report may no longer be replied upon;
     
  ● significant related party transactions;
     
  ● introductions of new products, processes or services;
     
  ● impending bankruptcy or financial liquidity problems;
     
  ● pending or threatened significant litigation or the resolution of such litigation; or
     
  ● the gain or loss of major contracts, orders, suppliers, customers or finance sources.

 

Of course, there are numerous other examples of material information and the determination will necessarily depend on the circumstances existing at the time.

 

6

 

 

Post-Termination Transactions

 

This Policy continues to apply to your transactions in the Company’s securities even after you have terminated employment or the rendering of other services to the Company or a subsidiary. If you are aware of material nonpublic information when your employment or service relationship terminates, you may not trade in Company securities until that information has become public or is no longer considered to be material.

 

Unauthorized Disclosure

 

Maintaining the confidentiality of information of the Company is essential for competitive, security and other business reasons, as well as to comply with securities laws. You should treat all information you hear about the Company or its business plans in connection with your employment as confidential and proprietary to the Company. Inadvertent disclosure of confidential or inside information may expose the Company and you to significant risk of investigation and litigation.

 

The timing and nature of the Company’s disclosure of material information to outsiders is subject to legal rules, the breach of which could result in substantial liability to you, the Company and its management. Accordingly, it is important that response to inquiries about the Company by the press, investment analysts or others in the financial community be made on the Company’s behalf only through authorized individuals.

 

Exceptions

 

The terms of the Company’s insider trading policy described above shall be strictly adhered to. Exceptions to this policy may be made only under certain limited circumstances, and only with the prior written approval of the Company’s Chief Executive Officer and General Counsel.

 

Section 16 Insiders

 

In addition to the general prohibition on insider trading, directors and “executive officers” of a public company, as well as persons owning 10% or more of the shares of the company, also are subject to the reporting and profit recapture provisions of Section 16 of the Exchange Act, which impose special filing requirements and potential sanctions (including loss of profits) on these persons for certain trades, regardless of whether they actually traded on inside information. In general, “executive officers” are the senior corporate officers of a public company. Directors are always subject to the provisions of Section 16.

 

7

 

 

Sales of Unregistered Securities

 

United States federal law provides that securities can be sold only if they have been registered with the SEC or an exemption from the registration requirements is available. Generally, any Company securities purchased in open-market transactions can be freely resold (subject, of course, to the restrictions on insider trading described in this policy and, for executive officers and directors, compliance with the reporting and other requirements of Rule 144 and Section 16, which are not eliminated by the adoption of a Plan). Shares received upon exercise of stock options may or may not be freely sold at the time of the exercise (they may be registered and freely sold but that is not always the case). If the shares underlying your options are not registered with the SEC, you may be permitted to sell them under SEC Rule 144; however, Rule 144 requires that a number of pre-conditions to sale be met, including that the shares be held for certain periods of time after they are purchased, certain volume restrictions, simultaneous reporting on Form 144 and limitations on the manner of sale. In addition, all resales of option shares by “affiliates” of the Company (as defined in Rule 144 to include any director, executive officer or 10% stockholder) – even shares that have been registered with the SEC on a Form S-8 – will be subject to certain of the Rule 144 conditions (but not the holding period). The rules on sales of unregistered shares under Rule 144 are rather complex and you are urged to contact the Company’s General Counsel if you have any question regarding your ability to sell Company shares.

 

Violations of Law and Policy

 

Violation of United States federal laws against insider trading and selling unregistered securities is a crime and may subject the violator to severe criminal and civil penalties, including imprisonment and substantial fines. In addition, violation of those laws and the Company’s policy described above is grounds for immediate termination of employment or service. The Company will cooperate with the appropriate government authorities in any investigation of insider trading by the Insiders or others.

 

Inquiries

 

Your compliance with this policy is of the utmost importance both for you and for the Company. If you have any questions about this policy or any particular trading activity which you would like to engage in, you should contact the Company’s General Counsel, Graubard Miller (either David Alan Miller at (212) 818-8661 or dmiller@graubard.com or Jeffrey M. Gallant at (212) 818-8638 or jgallant@graubard.com). Do not try to resolve uncertainties on your own, as the rules relating to insider trading are often complex, not always intuitive, and carry severe consequences.

 

8

 

 

ACKNOWLEDGMENT AND CERTIFICATION

 

The undersigned does hereby acknowledge receipt of the Company’s Insider Trading Policy. The undersigned has read and understands (or has had explained to him/her) such Policy and agrees to be governed by such Policy at all times in connection with the purchase and sale of securities and the confidentiality of non-public information.

 

   
  (Signature)
   
   
  (Please print name)
   
   
  (Date)

 

9

 

 EX-31.1 3 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY

ACT OF 2002

 

I, Jiangang, certify that:

 

  1. I have reviewed this Annual Report on Form 10-K of Bowen Acquisition Corp;
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d -15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: April 15, 2025 BOWEN ACQUISITION CORP
  (Registrant)
     
  By:  /s/ Jiangang Luo
    Jiangang Luo
    CHIEF EXECUTIVE OFFICER
    (PRINCIPAL EXECUTIVE OFFICER)

 

 

 

 EX-31.2 4 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY

ACT OF 2002

 

I, Jing Lu, certify that:

 

  1. I have reviewed this Annual Report on Form 10-K of Bowen Acquisition Corp;
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: April 15, 2025 BOWEN ACQUISITION CORP
  (Registrant)
     
  By:  /s/ Jing Lu
    Jing Lu
    CHIEF FINANCIAL OFFICER
    (PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER)

 

 

 

 EX-32.1 5 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Bowen Acquisition Corp (the “Company”) on Form 10-K for the year ended December 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Dated: April 15, 2025 BOWEN ACQUISITION CORP
  (Registrant)
     
  By:  /s/ Jiangang Luo
    Jiangang Luo
    CHIEF EXECUTIVE OFFICER
    (PRINCIPAL EXECUTIVE OFFICER)

 

Dated: April 15, 2025 BOWEN ACQUISITION CORP
  (Registrant)
     
  By:  /s/ Jing Lu
    Jing Lu
    CHIEF FINANCIAL OFFICER
    (PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER)

 

 

 

 EX-101.SCH 6 bown-20241231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Changes in Shareholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 999014 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:calculationLink link:definitionLink 999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 999016 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 999017 - Disclosure - PRIVATE PLACEMENTS link:presentationLink link:calculationLink link:definitionLink 999018 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 999019 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 999020 - Disclosure - SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 999021 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 999022 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 999023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 999024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999025 - Disclosure - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999026 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 999027 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999028 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 999029 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) link:presentationLink link:calculationLink link:definitionLink 999030 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) link:presentationLink link:calculationLink link:definitionLink 999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999032 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999033 - Disclosure - PRIVATE PLACEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999034 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink 999035 - Disclosure - SCHEDULE OF EXPENSES INCURRED AND PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 999036 - Disclosure - RELATED PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999038 - Disclosure - SHAREHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999039 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 999040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 bown-20241231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 bown-20241231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 bown-20241231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Units, each consisting of one ordinary share and one right Ordinary Shares, par value $0.0001 per share Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination Related and Nonrelated Parties [Axis] Nonrelated Party [Member] Related Party [Member] Redeemable Ordinary Shares [Member] Non Redeemable Ordinary Shares [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Sale of Stock [Axis] IPO [Member] Private Placement [Member] Over-Allotment Option [Member] EarlyBirdCapital [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Merger Shares [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Agreement [Member] Earnout Shares [Member] Statistical Measurement [Axis] Maximum [Member] Redeemable Shares [Member] Non Redeemable Shares [Member] Title and Position [Axis] Qianzhi [Member] Sponsors [Member] EBC [Member] Underwriters [Member] EBC Founder Shares [Member] Short-Term Debt, Type [Axis] Promissory Note [Member] Statement of Financial Position Location, Balance [Axis] General and Administrative Expense [Member] Accounting Services Expense [Member] Accounting Service Agreement And Other [Member] Founder Shares [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Measurement Input, Probability of Completion of Business Combination [Member] Initial Accounting Service Fee [Member] Accounting Service Fee and Others [Member] Administration Fee [Member] Business Combination Marketing Agreement [Member] Business Acquisition [Axis] Fair Value, Inputs, Level 1 [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Entity Listing, Par Value Per Share Auditor Firm ID Auditor Opinion [Text Block] Auditor Name Auditor Location Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current Assets: Cash and cash equivalents Other receivable Prepaid expenses Total Current Assets Investment held in Trust Account Total Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Accrued expenses Promissory Note Payable to target company Total Current Liabilities Total Liabilities Commitments and contingencies (Note 6) Ordinary shares subject to possible redemption, 6,900,000 shares at redemption value of $10.98 and $10.35 per share as of December 31, 2024 and 2023, respectively Shareholders’ Equity: Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding (excluding 6,900,000 shares subject to redemption on December 31, 2024 and 2023, respectively) Additional paid-in capital Retained earnings (Accumulated deficit) Total Shareholders’ Equity (Deficit) Total Liabilities and Shareholders’ Equity Unamortized debt discount Ordinary shares subject to redemption Ordinary shares redemption value per share Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Ordinary stock, par value Ordinary stock, shares authorized Ordinary stock, shares issued Ordinary stock, shares outstanding Formation and operating costs Loss from operations Other income: Interest earned on investments held in trust account Total other income Other expense: Interest expense Total other expense Net income Basic weighted average ordinary shares outstanding Diluted weighted average ordinary shares outstanding Basic net income (loss) per share Diluted net income (loss) per share Balance Balance, shares Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account) Subsequent measurement of Common stock subject to possible redemption (extension deposit) Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account) Net income Issuance of ordinary shares to Sponsors Issuance of ordinary shares to Sponsor, shares Issuance of ordinary shares to Underwriter Issuance of ordinary shares to Underwriter, shares Proceeds from sale of public units Proceeds from sale of public units, shares Proceeds from over-allotment Proceeds from over-allotment, shares Sale of Private Units Sale of Private Units, shares Over-allotment of Private Units Over-allotment of Private Units, shares Underwriter’s commission on sale of Public Units Underwriter’s commission on Over-allotment Other offering costs Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares Allocation of offering costs to ordinary shares subject to redemption Deduction for increase of carrying value of redeemable shares Balance Balance, shares Cash flows from operating activities: Adjustments to reconcile net income to net cash used in operating activities: Income earned on investment held in Trust Account Amortized interest expense from debt discount Changes in current assets and liabilities: Accrued expenses Prepaid expenses Net cash used in operating activities Cash flows from investing activities: Investments of cash into Trust Account Extension deposit to Trust Account Net cash used in investing activities Cash flows from financing activities: Proceeds from promissory note Proceeds from issuance of founder shares Proceeds from sale of ordinary shares Proceeds from Private Placement Payments of underwriter’s discount Payments to related party Payment of offering costs Net cash provided by financing activities Net change in cash Cash at beginning of period Cash at the end of period Supplemental disclosure of noncash financing activities Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) Subsequent measurement of ordinary shares subject to possible redemption (extension deposit) Offering costs paid by related party Offering costs adjusted from prepaid expenses Debt discount in connection with promissory note Offering costs paid by Sponsor in exchange for issuance of ordinary shares Offering costs charged to APIC Reclassification of ordinary shares subject to redemption Allocation of offering costs to ordinary shares subject to redemption Remeasurement adjustment on ordinary shares subject to possible redemption Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND BUSINESS OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Initial Public Offering INITIAL PUBLIC OFFERING Private Placements PRIVATE PLACEMENTS Related Party Transactions [Abstract] RELATED PARTIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHAREHOLDERS’ EQUITY Fair Value Disclosures [Abstract] Fair Value Measurements Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation and Principles of Consolidation Emerging Growth Company Use of Estimates Cash and cash equivalents Investments Held in Trust Account Offering Costs Interest Expenses Amortization of Debt Discount Income Taxes Net Income (Loss) per Ordinary Share Concentration of Credit Risk Fair Value of Financial Instruments Ordinary Shares Subject to Possible Redemption Recent Accounting Standards SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Related Party Transaction [Table] Related Party Transaction [Line Items] SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE SCHEDULE OF EXPENSES INCURRED AND PAYABLES SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Number of stock issued Ordinary shares, par value Price per share Proceeds from issuance of IPO Number of stock issued Gross proceeds Transaction cost Cash underwriting fees Other offering costs Deposit into trust account Number of shares transferred Share price Number of stock issued, shares Number of stock issued, value Cash and cash equivalent Working capital Interest earned on investment held in Trust Account Accretion of temporary equity into redemption value Net loss including accretion of equity into redemption value Weighted average shares outstanding - basic Weighted average shares outstanding - diluted Ownership percentage Allocation of net loss including accretion of temporary equity Accretion of temporary equity into redemption value Interest earned on Trust Account Allocation of net income (loss) Basic net income/(loss) per share Diluted net income/(loss) per share Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Public offering proceeds Proceeds allocated to public rights Allocation of offering costs related to redeemable shares Accretion of carrying value to redemption value Ordinary shares subject to possible redemption Over-allotment proceeds Proceeds allocated to Public Rights Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account Ordinary shares subject to possible redemption Ordinary shares subject to possible redemption Trust account balance Interest and dividend income earned from trust account Unrecognized tax benefits Interest and penalties accrued Cash, FDIC insured amount Stock issued during period shares Sale of stock, par share Stock holders equity related to initial public offering description Stock issued during the period, shares Nasdaq entry fee Unit exercise price per share Value of stock issued Units related to private placement description Time to expiration Founder shares measurement input Debt discount Initial accounting service fee Accounting service fee and others Administration fee Total Number of shares subject to forfeiture Ordinary share price Fair value of shares issued Fair value of ordinary per share price Loans payable Debt Instrument, Face Amount Debt Instrument, Maturity Date Debt short term amount Interest expense Cash underwriting discount per unit Aggregate cash underwriting discount Payments for underwriting expense Gross proceeds Related party debt Related Party Transaction, Amounts of Transaction Affiliate Costs Business combination related cost Percentage of gross proceeds of initial public offering Percentage of service fee of total consideration payable Preferred stock voting rights Common stock, shares authorized Common stock, par value Common stock voting rights Ordinary shares issued Ordinary shares outstanding Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Marketable securities held in the trust account Cash equivalents Subsequent Event [Table] Subsequent Event [Line Items] Subsequent descripition Ordinary shares subject to redemption. Interest earned on investments held in trust account. Redeemable Ordinary Shares [Member] Non Redeemable Ordinary Shares [Member] Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account). Subsequent measurement of common stock subject to possible redemption extension deposit. Stock issued during period value proceeds from sale of public units. Stock issued during period shares proceeds from sale of public units. Stock issued during period value proceeds from over-allotment. Stock issued during period shares proceeds from overallotment. Stock issued during period value sale of private units. Stock issued during period shares sale of private units. Adjustments to additional paid in capital underwriters commission on sale of public units. Adjustments to additional paid in capital underwriters commission on overallotment. Adjustments to additional paid in capital underwriter’s commission on sale of Public Units. Stock issued during period value initial measurement of ordinary shares. Stock issued during period shares initial measurement of ordinary shares. Adjustments to additional paid in capital allocation of offering costs to ordinary shares subject to redemption. Proceeds from issuance of founder shares. Payments of underwriter’s discount. Payment of offering costs. Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account). Offering costs paid by related party. Offering costs adjusted from prepaid expenses. Debt discount in connection with promissory note. Offering costs paid by Sponsor in exchange for issuance of ordinary shares. Offering costs charged to Additional Paid-in Capital. Reclassification of ordinary shares subject to redemption. Allocation of offering costs to ordinary shares subject to redemption. Remeasurement adjustment on ordinary shares subject to possible redemption. EarlyBirdCapital [Member] Merger Shares [Member] Agreement [Member] Earnout Shares [Member] Working capital deficit. Emerging Growth Company Policy [Text Block] Offering Costs Policy [Text Block] Interest Expenses Policy [Text Block] Net loss including accretion of equity into redemption value. Accretion of temporary equity into redemption value. Interest earned on investment held in trust account. Redeemable Shares [Member] Non Redeemable Shares [Member] Ownership percentage. Allocation of net loss including accretion of temporary equity. Schedule Of Ordinary Shares Subject To Possible Redemption Reflected In The Balance Sheet [Table Text Block] Accretion of carrying value to redemption value. Initial Public Offering [Text Block] Private Placements [Text Block] Sponsors [Member] EBC [Member] Underwriters [Member] Equity securities fvni term. Measurement Input, Probability of Completion of Business Combination [Member] Promissory Note [Member] Cash underwriting discount per unit. Cash underwriting discount. Accounting Services Expense [Member] Business Combination Marketing Agreement [Member] Percentage of gross proceeds of initial public offering. Percentage of service fee of total consideration payable. Qianzhi [Member] Founder Shares [Member] EBC Founder Shares [Member] Stock issued during period value over-allotment of Private Units. Stock issued during period shares overallotment of private units. Payable to target company Extension deposit to trust account Accounting Service Agreement And Other [Member] Initial Accounting Service Fee [Member] Accounting Service Fee and Others [Member] Schedule of Expenses Incurred and Payable [Table Text Block] Initial accounting service fee Accounting service fee and others Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Income (Loss) Other Nonoperating Income Other Nonoperating Expense Shares, Outstanding Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Prepaid Expense Net Cash Provided by (Used in) Operating Activities Payments to Acquire Other Investments ExtensionDepositToTrustAccount Net Cash Provided by (Used in) Investing Activities PaymentsOfUnderwritersDiscount PaymentOfOfferingCosts Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Cash and Cash Equivalents, Policy [Policy Text Block] Other Ownership Interests, Offering Costs InterestEarnedOnInvestmentHeldInTrustAccount NetLossIncludingAccretionOfEquityIntoRedemptionValue Offering Costs, Partnership Interests Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount EX-101.PRE 10 bown-20241231_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2024
Apr. 15, 2025
Jun. 28, 2024
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41741    
Entity Registrant Name BOWEN ACQUISITION CORP    
Entity Central Index Key 0001973056    
Entity Tax Identification Number 00-0000000    
Entity Incorporation, State or Country Code E9    
Entity Address, Address Line One 420 Lexington Ave    
Entity Address, Address Line Two Suite 2446    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10170    
City Area Code (203)    
Local Phone Number 998-5540    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company true    
Entity Public Float     $ 74.9
Entity Common Stock, Shares Outstanding   3,010,973  
Documents Incorporated by Reference [Text Block] The information contained in the registrant’s definitive proxy statement/prospectus dated December 18, 2024, as filed with the Securities and Exchange Commission on such date, pursuant to Rule 424(b)(3) (SEC File No. 333-282021) is incorporated into certain portions of Parts I, II, and III, as disclosed herein.    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Listing, Par Value Per Share $ 0.0001    
Auditor Firm ID 1195    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of Bowen Acquisition Corp and its wholly owned subsidiary (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of operations, changes in shareholders’ equity (deficit), and cash flows for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) to December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements presents fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) to December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.    
Auditor Name UHY LLP    
Auditor Location New York, New York    
Units, each consisting of one ordinary share and one right      
Title of 12(b) Security Units, each consisting of one ordinary share and one right    
Trading Symbol BOWNU    
Security Exchange Name NASDAQ    
Ordinary Shares, par value $0.0001 per share      
Title of 12(b) Security Ordinary Shares, par value $0.0001 per share    
Trading Symbol BOWN    
Security Exchange Name NASDAQ    
Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination      
Title of 12(b) Security Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination    
Trading Symbol BOWNR    
Security Exchange Name NASDAQ    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 103,774 $ 426,913
Other receivable 138,046
Prepaid expenses 12,239 79,481
Total Current Assets 254,059 506,394
Investment held in Trust Account 75,794,241 71,419,358
Total Assets 76,048,300 71,925,752
Current Liabilities:    
Payable to target company 75,000
Total Current Liabilities 1,053,115 103,860
Total Liabilities 1,053,115 103,860
Commitments and contingencies (Note 6)
Ordinary shares subject to possible redemption, 6,900,000 shares at redemption value of $10.98 and $10.35 per share as of December 31, 2024 and 2023, respectively 75,794,241 71,419,358
Shareholders’ Equity:    
Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding (excluding 6,900,000 shares subject to redemption on December 31, 2024 and 2023, respectively) 227 227
Additional paid-in capital
Retained earnings (Accumulated deficit) (799,283) 402,307
Total Shareholders’ Equity (Deficit) (799,056) 402,534
Total Liabilities and Shareholders’ Equity 76,048,300 71,925,752
Nonrelated Party [Member]    
Current Liabilities:    
Accrued expenses 309,004 78,610
Promissory Note 190,000
Related Party [Member]    
Current Liabilities:    
Accrued expenses 101,285 25,250
Promissory Note $ 377,826
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]    
Ordinary shares subject to redemption 6,900,000 6,900,000
Ordinary shares redemption value per share $ 10.98 $ 10.35
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Ordinary stock, par value $ 0.0001 $ 0.0001
Ordinary stock, shares authorized 200,000,000 200,000,000
Ordinary stock, shares issued 2,266,500 2,266,500
Ordinary stock, shares outstanding 2,266,500 2,266,500
Related Party [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Unamortized debt discount $ 122,174 $ 0
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Formation and operating costs $ 244,568 $ 633,764
Loss from operations (244,568) (633,764)
Other income:    
Interest earned on investments held in trust account 1,729,358 3,684,883
Total other income 1,729,358 3,684,883
Other expense:    
Interest expense (87,267)
Total other expense (87,267)
Net income $ 1,484,790 $ 2,963,852
Redeemable Ordinary Shares [Member]    
Other expense:    
Basic weighted average ordinary shares outstanding 3,819,156 6,900,000
Diluted weighted average ordinary shares outstanding 3,819,156 6,900,000
Basic net income (loss) per share $ 1.12 $ 0.48
Diluted net income (loss) per share $ 1.12 $ 0.48
Non Redeemable Ordinary Shares [Member]    
Other expense:    
Basic weighted average ordinary shares outstanding 2,095,943 2,266,500
Diluted weighted average ordinary shares outstanding 2,095,943 2,266,500
Basic net income (loss) per share $ (1.32) $ (0.15)
Diluted net income (loss) per share $ (1.32) $ (0.15)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Changes in Shareholders' (Deficit) Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Feb. 16, 2023
Balance, shares at Feb. 16, 2023      
Subsequent measurement of Common stock subject to possible redemption (extension deposit)      
Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account) (646,875) (1,082,483) (1,729,358)
Net income 1,484,790 1,484,790
Issuance of ordinary shares to Sponsors $ 173 24,827 25,000
Issuance of ordinary shares to Sponsor, shares 1,725,000      
Issuance of ordinary shares to Underwriter $ 18 1,015,982 1,016,000
Issuance of ordinary shares to Underwriter, shares 180,000      
Proceeds from sale of public units $ 600 59,999,400 60,000,000
Proceeds from sale of public units, shares 6,000,000      
Proceeds from over-allotment $ 90 8,999,910 9,000,000
Proceeds from over-allotment, shares 900,000      
Sale of Private Units $ 33 3,299,967 3,300,000
Sale of Private Units, shares 330,000      
Over-allotment of Private Units $ 3 314,997 315,000
Over-allotment of Private Units, shares 31,500      
Underwriter’s commission on sale of Public Units (1,500,000) (1,500,000)
Underwriter’s commission on Over-allotment (225,000) (225,000)
Other offering costs (1,593,898) (1,593,898)
Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital $ (690) (65,235,677) (65,236,367)
Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares (6,900,000)      
Allocation of offering costs to ordinary shares subject to redemption 3,137,867 3,137,867
Deduction for increase of carrying value of redeemable shares (7,591,500) (7,591,500)
Balance at Dec. 31, 2023 $ 227 402,307 402,534
Balance, shares at Dec. 31, 2023 2,266,500      
Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account) (209,442) (3,475,442) (3,684,884)
Subsequent measurement of Common stock subject to possible redemption (extension deposit) (690,000) (690,000)
Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account) 209,442 209,442
Net income 2,963,852 2,963,852
Balance at Dec. 31, 2024 $ 227 $ (799,283) $ (799,056)
Balance, shares at Dec. 31, 2024 2,266,500      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Cash flows from operating activities:    
Net income $ 1,484,790 $ 2,963,852
Adjustments to reconcile net income to net cash used in operating activities:    
Income earned on investment held in Trust Account (1,729,358) (3,684,883)
Amortized interest expense from debt discount 87,267
Changes in current assets and liabilities:    
Prepaid expenses (79,481) 73,280
Net cash used in operating activities (292,085) (323,139)
Cash flows from investing activities:    
Investments of cash into Trust Account (69,690,000)
Extension deposit to Trust Account (690,000)
Net cash used in investing activities (69,690,000) (690,000)
Cash flows from financing activities:    
Proceeds from issuance of founder shares 2,520
Proceeds from sale of ordinary shares 69,000,000
Proceeds from Private Placement 3,615,000
Payments of underwriter’s discount (1,725,000)
Payments to related party (151,318)
Payment of offering costs (332,204)
Net cash provided by financing activities 70,408,998 690,000
Net change in cash 426,913 (323,139)
Cash at beginning of period 426,913
Cash at the end of period 426,913 103,774
Supplemental disclosure of noncash financing activities    
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 1,729,358 3,684,883
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit) 690,000
Offering costs paid by related party 75,000
Offering costs adjusted from prepaid expenses 894
Debt discount in connection with promissory note 209,442
Offering costs paid by Sponsor in exchange for issuance of ordinary shares 25,000
Offering costs charged to APIC 1,593,898
Reclassification of ordinary shares subject to redemption 65,236,367
Allocation of offering costs to ordinary shares subject to redemption 3,137,868
Remeasurement adjustment on ordinary shares subject to possible redemption 7,591,500
Nonrelated Party [Member]    
Changes in current assets and liabilities:    
Accrued expenses 6,714 161,565
Cash flows from financing activities:    
Proceeds from promissory note 190,000
Related Party [Member]    
Changes in current assets and liabilities:    
Accrued expenses 25,250 75,780
Cash flows from financing activities:    
Proceeds from promissory note $ 500,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Pay vs Performance Disclosure [Table]    
Net Income (Loss) $ 1,484,790 $ 2,963,852
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2024
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Abstract]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] We are a blank check company with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable target businesses for a business combination. Therefore, we do not consider that we face significant cybersecurity risk. Nevertheless, we employ various procedures designed to identify, protect, detect and respond to and manage reasonably foreseeable cybersecurity risks and threats given our limited operations. These include, but are not limited to, internal reporting, monitoring and detection tools and anti-virus software. We also periodically assess risks from cybersecurity and technology threats and monitor our information systems for potential vulnerabilities, including those that could arise from internal sources and external sources such as third-party service providers we do business with.

 

To date, we have not experienced any cybersecurity attacks. However, any such attack could adversely affect our business. Further, a penetration of our systems or a third-party’s systems or other misappropriation or misuse of personal information could subject us to business, regulatory, litigation and reputation risk, which could have a negative effect on our business, financial condition and results of operations.

 

The Audit Committee of the Board oversees our cybersecurity risk and receives regular reports from our management team on various potential cybersecurity matters, including areas of emerging risks, incidents and industry trends, and other areas of importance. We may in the future engage an assessor(s), consultant(s), auditor(s) or other third party(s) to supplement our existing cybersecurity processes.

 
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable target businesses for a business combination. Therefore, we do not consider that we face significant cybersecurity risk. Nevertheless, we employ various procedures designed to identify, protect, detect and respond to and manage reasonably foreseeable cybersecurity risks and threats given our limited operations.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] The Audit Committee of the Board oversees our cybersecurity risk and receives regular reports from our management team on various potential cybersecurity matters, including areas of emerging risks, incidents and industry trends, and other areas of importance.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND BUSINESS OPERATIONS
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS

 

Organizational and General

 

Bowen Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”).The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.

 

The Company’s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership (the “Sponsors”). As of December 31, 2024, the Company had not commenced any operations. All activities for the period from February 17, 2023 (inception) through December 31, 2024 relate to the Company’s formation, the initial public offering (“IPO”) and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company is generating non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

 

The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on July 11, 2023. On July 14, 2023, the Company consummated the IPO of 6,000,000 of its units (“Public Units”). Each Public Unit consists of one ordinary share, $0.0001 par value (“Ordinary Shares”), of the Company and one right (“Rights”), each Right entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company’s initial business combination. The Public Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $60,000,000.

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement (“Private Placement”) of 330,000 units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating total proceeds of $3,300,000. The Private Placement Units were purchased by Createcharm Holdings Ltd, one of the Company’s sponsors, and EarlyBirdCapital, Inc. (“EBC”), the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion of the Company’s initial Business Combination.

 

On July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000 Units. As a result, on July 18, 2023, the Company sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. In connection with this sale, Createcharm Holdings Ltd. and EBC also purchased an additional 31,500 Private Placement Units from the Company.

 

As of July 18, 2023, transaction costs amounted to $3,318,898 consisting of $1,725,000 of cash underwriting fees and $1,593,898 of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon completion of the IPO.

 

 

The Company will have until 18 months from the closing of the IPO to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period and shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay the Company’s taxes, if any (less certain amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

On November 20, 2023, a wholly-owned subsidiary of the Company, Bowen Merger Sub (“Merger Sub”) was formed for the purpose of entering into a business combination agreement. See “Proposed Business Combination” below.

 

Effective as of October 7, 2024, the Company notified the trustee of the Trust Account that it was extending the time to consummate an initial Business Combination from October 14, 2024 to January 14, 2025. Effective as of October 14, 2024, Shenzhen Qianzhi (as defined below) and EBC, two designees of the Sponsors, loaned the Company an aggregate of $690,000, which funds were deposited into the Trust Account for such extension. The loans are evidenced by promissory notes (the “Notes”) issued by the Company to the designees. The Notes bear no interest and are repayable in full upon consummation of a Business Combination. In connection with the loans, one of the Sponsors transferred 30,000 of its Founder Shares to EBC.

 

The Company had called an extraordinary general meeting (the “Extension Meeting”) for January 10, 2025 to approve, by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”), by up to three one-month increments, from January 14, 2025 to as late as April 14, 2025, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. In connection with the meeting, an aggregate of 6,052,095 Public Shares were redeemed at a price of approximately $10.99 per share. Following the redemptions, the Company has 847,905 Public Shares, and approximately $9,319,446 remaining in Trust Account.

 

On January 14, 2025, the Company held another extraordinary general meeting to approve the business combination with Qianzhi (as defined below). At the meeting, all proposals were approved by shareholders. An aggregate of 137,936 Public Shares requested redemption in connection with such vote. However, as the business combination has not been consummated, none of such shares has been redeemed. As of the filing date, since the business combination has not been consummated, none of such shares have been redeemed.

 

On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of 103,432 Public Shares were redeemed at a price of approximately $11.03 per share. Following the redemptions, the Company has 744,473 Public Shares, and approximately $8,211,537 remaining in Trust Account.

 

Proposed Business Combination

 

On January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the “Agreement”) with (i) Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (“Merger Sub”), (ii) Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People’s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (“Shenzhen Qianzhi”or “Qianzhi”), and (iii) Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (“NewCo,” and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the “Parties”, each a “Party”).

 

Pursuant to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the “Merger”), with NewCo being the surviving company of the Merger (“Surviving Company”) and becoming a wholly owned subsidiary of the Company. In the Merger, the holders (the “NewCo Shareholders”) of the ordinary shares of NewCo (“NewCo Ordinary Shares”) will receive ordinary shares of the Company (“Parent Ordinary Shares”).

 

Pursuant to the Agreement, at the effective time of the Merger (the “Effective Time”), all of NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) 7,246,377 Parent Ordinary Shares (the “Merger Shares”), and (b) the right to receive earnout consideration of up to an aggregate of 1,400,000 Parent Ordinary Shares (the “Earnout Shares”).

 

The Company’s Registration Statement on Form S-4 (“S-4”) was declared effective on December 18, 2024. As of the filing date, the business combination remained pending, awaiting required regulatory approvals.

 

 

Going Concern Consideration

 

As of December 31, 2024, the Company had cash and cash equivalent of $103,774 and a working capital deficit of $799,056. The Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. Management expects to obtain additional funds from related parties to provide the additional working capital necessary to carry out its objective to consummate a business combination. The consolidated financial statement does not include any adjustments that might result from the outcome of the uncertainty.

 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

 

Use of Estimates

 

The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $103,774 and $426,913 as of December 31, 2024 and 2023, respectively.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of December 31, 2024 and 2023, the Trust Account had balance of $75,794,241 and $71,419,358, respectively. The interest and dividend income earned from the Trust Account totaled $3,684,883 and $1,729,358 for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) through December 31, 2023, respectively, which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.

 

Offering Costs

 

Offering costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on July 14, 2023.

 

Interest Expenses

 

Interest expense in 2024 is primarily from the amortization of the debt discount in connection with the promissory note issued by the Company to related party. See Note 5 - Related Parties for more information.

 

Amortization of Debt Discount

 

The Company’s promissory note issued with related party is recorded net of debt discount which comprised issuance costs, and the discount initially recognized for the fair value of the shares transferred. The portion of the debt issuance costs allocated to the promissory note, is being amortized over the terms, which is upon consummation of the Business Combination. The amortization of debt issuance costs and discount is included in interest expense within the accompanying consolidated statements of operations.

 

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statements.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

The net income (loss) per share presented in the statements of operations is based on the following:

  

For the Year

Ended
December 31, 2024

  

For the Period

from
February 17, 2023
(Inception)

Through

December 31, 2023

 
Net income  $2,963,852   $1,484,790 
Interest earned on investment held in Trust Account   (3,684,883)   (1,729,358)
Accretion of temporary equity into redemption value   (690,000)   (7,591,500)
Net loss including accretion of equity into redemption value  $(1,411,031)  $(7,836,068)

 

   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
   

For the Year ended

December 31, 2024

  

For the Period from
February 17, 2023
(Inception) Through

December 31, 2023

 
   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
Particulars  Shares   Shares   Shares   Shares 
Basic and diluted net income (loss) per share:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Ownership percentage   75%   25%   65%   35%
Numerators:                    
Allocation of net loss including accretion of temporary equity  $(1,062,141)  $(348,890)  $(5,059,453)  $(2,776,615)
Accretion of temporary equity into redemption value   690,000    -    7,591,500    - 
Interest earned on Trust Account   3,684,883    -    1,729,358    - 
Allocation of net income (loss)  $3,312,742    (348,890)  $4,261,405   $(2,776,615)
                     
Denominators:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Basic and diluted net income/(loss) per share  $0.48   $(0.15)  $1.12   $(1.32)

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

 

 

At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET

Public offering proceeds   $ 60,000,000  
Less:        
Proceeds allocated to Public Rights     (3,272,724 )
Allocation of offering costs related to redeemable shares     (2,925,140 )
Plus:        
Accretion of carrying value to redemption value     6,797,864  
Ordinary shares subject to possible redemption     60,600,000  
         
Over-allotment        
Plus:        
Over-allotment proceeds     9,000,000  
Less:        
Proceeds allocated to Public Rights     (490,909 )
Allocation of offering costs related to redeemable shares     (212,727 )
Plus:        
Accretion of carrying value to redemption value     793,636  
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     1,729,358  
Ordinary shares subject to possible redemption, December 31, 2023   $ 71,419,358  
Plus:        
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     3,684,883  
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)     690,000  
Ordinary shares subject to possible redemption, December 31, 2024   $ 75,794,241  

 

Recent Accounting Standards

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance in ASU 2023-07 on January 1, 2024, and there is no significant impact on the disclosure of the consolidated financial statements. The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.25.1
INITIAL PUBLIC OFFERING
 12 Months Ended
Dec. 31, 2024
Initial Public Offering  
INITIAL PUBLIC OFFERING

NOTE 3 — INITIAL PUBLIC OFFERING

 

On July 14, 2023, the Company sold 6,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights. The Company also granted the underwriters a 45-day option to purchase up to an additional 900,000 units to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.

 

The Company incurred $75,000 Nasdaq delayed entry fee during the IPO in 2023 and this balance was subsequently paid by Qianzhi which is the target company. As of December 31, 2024, this balance is recorded as “Payable to target” on the consolidated balance sheet.

 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.1
PRIVATE PLACEMENTS
 12 Months Ended
Dec. 31, 2024
Private Placements  
PRIVATE PLACEMENTS

NOTE 4 — PRIVATE PLACEMENTS

 

The Sponsors and EBC had agreed to purchase an aggregate of 330,000 Private Placement Units (312,000 Private Placement Units to be purchased by the Sponsors and 18,000 Private Placement Units to be purchased by EBC or its designees), or 361,500 Private Placement Units if the underwriters’ over-allotment is exercised in full, at a price of $10.00 per Private Placement Unit ($3,300,000, or an aggregate of $3,615,000 if the underwriters’ over-allotment is exercised in full) from the Company in a private placement that will occur simultaneously with the closing of the Initial Public Offering.

 

 

Simultaneously with the closing of the IPO on July 14, 2023, the Company consummated the private sale of 330,000 Private Placement Units. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. The proceeds from the sale of the Private Placement Units were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to certain exceptions.

 

On July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.

 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTIES
 12 Months Ended
Dec. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTIES

NOTE 5 — RELATED PARTIES

 

Founder Shares and EBC Founder Shares

 

On February 27, 2023, the Sponsors received 1,725,000 of the Company’s ordinary shares (“Founder Shares”) in exchange for $25,000 paid for offering costs borne by the Sponsors. Up to 225,000 of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full. On July 17, 2023, the underwriters exercised their over-allotment option in full.

 

On March 15, 2023, the Company issued to EBC 180,000 ordinary shares (“EBC founder shares”) for a purchase price of $0.014 per share and an aggregate purchase price of $2,520. The EBC founder shares are deemed to be underwriters’ compensation by FINRA pursuant to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $1,016,000 or $5.65 per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value of the shares as offering cost.

 

The fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:

 

Time to expiration     1.84  
Risk-free rate     4.0 %
Volatility     5.0 %
Dividend yield     0.0 %
Probability of completion of business combination     60.0 %

 

The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an initial business combination.

 

On October 14, 2024, one of the Sponsors transferred 30,000 of its Founder Shares to EBC in connection with $500,000 loan for the extension. See below for more details.

 

Promissory Note — Related Party

 

On February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on July 14, 2023.

 

On October 14, 2024, EBC loaned the Company $500,000 which funds were deposited into the Trust Account for the extension. The loan is evidenced by promissory note issued by the Company (“Extension Note”). The Extension Note bears no interest and is repayable in full upon consummation of a Business Combination. In connection with the loan, one of the Sponsors transferred 30,000 of its Founder Shares to EBC. The value of the shares transferred is reflected as debt discount and fully amortized as interest expense over the life of the loan per ASC 835. As of December 31, 2024, $500,000 was outstanding.

 

 

The Company estimated the fair value of the Founder Shares to be approximately $209,442 or $6.98 per share using the Black-Scholes option pricing model. The fair value of the Founder Shares was estimated at October 14, 2024. The Company used the following assumptions to estimate the fair value of Founder Shares using Level 3 fair value measurements inputs at the measurement date:

 

Time to expiration     1.0  
Risk-free rate     4.2 %
Volatility     5.0 %
Dividend yield     0.0 %
Probability of completion of business combination     65.0 %

 

Based on the fair value of the Founder Shares, the Company recorded a debt discount of $209,442, which is amortized as interest expense over the loan period. The loan period extends until the consummation of the Business Combination, estimated to occur on April 15, 2025. As of December 31, 2024, the Company recorded an interest expense of $87,267.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of IPO to purchase up to 900,000 additional Units to cover over-allotments, at the IPO price less the underwriting discounts and commissions.

 

The underwriters were entitled to a cash underwriting discount of $0.25 per Unit, or $1,500,000 in the aggregate (or $1,725,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable upon the closing of the IPO.

 

On July 17, 2023, the underwriters exercised the over-allotment option in full to purchase 900,000 Units. As a result, on July 18, 2023, the Company sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds to the Company of $9,000,000.

 

Due to Related Party

 

The Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest bearing. Before the IPO, the Sponsors had paid $151,318 on behalf of the Company for expenses related to IPO, which was fully repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.

 

As of December 31, 2024, the total accrued expenses due to related parties was $101,285, which includes $90,000 payable for administration fee and $11,285 payable for accounting related and other service fee. As of December 31, 2023, the total accrued expenses due to related parties was $25,250, which include $20,000 payable for administration fee and $5,250 payable for accounting service fee. See following paragraphs for details.

 

Accounting Service Agreement and Others

 

The Company has engaged TenX Global Capital, a related party of the Company, to assist in initial accounting preparation, preparing quarterly and annual financial statements commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $5,250 each quarter. TenX Global Capital also provides other services following the consummation of the IPO.

 

 

Administration Fee

 

Commencing on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the Company an allocable share of its overhead, up to $10,000 per month, until to the close of the Business Combination, to compensate it for the Company’s use of its office, utilities and personnel.

 

The following table presents details about the expenses incurred and payable for the year ended December 31, 2024 and during the period from February 17, 2023 (inception) through December 31, 2023:

 

                
Nature  Operating Costs   Payable Balance as of December 31, 
   For the year ended December 31, 2024   During the period from February 17, 2023 (inception) through December 31, 2023   2024   2023 
Initial accounting service fee  $-   $20,000   $-   $- 
Accounting service fee and others   21,785    10,500    11,285    5,250 
Administration fee   120,000    56,667    90,000    20,000 
Total  $141,785   $87,167   $101,285   $25,250 

 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6 — COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Business Combination Marketing Agreement

 

The Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation of its initial Business Combination in an amount of $2,415,000, equal to 3.5% of the gross proceeds of the IPO. In addition, the Company will pay EBC a service fee in an amount equal to 1.0% of the total consideration payable in the initial Business Combination if it introduces the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and is due at the closing date of the initial Business Combination. No such service has been provided by EBC.

 

Business Combination Transaction Cost

 

The Company has engaged several service providers including legal and valuation services, specifically for business combination between the Company and Shenzhen Qianzhi BioTechnology Co. Ltd. (“Qianzhi”). Per the agreed terms, Qianzhi agreed to be responsible for all expenses incurred by the Company in connection with business combination. For the year ended December 31, 2024, $527,145 of business combination related cost has been incurred which $389,099 was reimbursed by Qianzhi. During the period from February 17, 2023 (inception) through December 31, 2023, $181,022 of business combination related cost has been incurred and reimbursed by Qianzhi. This activity has been recorded on the net basis and no impact to financial statements.

 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
SHAREHOLDERS’ EQUITY

NOTE 7 — SHAREHOLDERS’ EQUITY

 

Preferred Shares — The Company is authorized to issue 2,000,000 preferred shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2024 and 2023, there were no preferred shares issued or outstanding.

 

 

Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. On February 27, 2023, the Sponsors received 1,725,000 of the Founder Shares in exchange for $25,000 paid for offering costs borne by the Sponsors, of which an aggregate of up to 225,000 of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares will equal 20% of the Company’s issued and outstanding ordinary shares after the IPO (excluding shares underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on July 17, 2023. As of December 31, 2024 and 2023, there were 2,266,500 ordinary shares issued and outstanding (excluding 6,900,000 shares subject to possible redemption).

 

Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.

 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements
 12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements

NOTE 8 — Fair Value Measurements

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2024 and 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

Date   Nature   Level     Fair Value  
December 31, 2024   Marketable securities held in the trust account     1     $ 75,794,241  
                     

December 31, 2024

   Cash equivalents     1     $

103,774

  
                     
December 31, 2023   Marketable securities held in the trust account     1     $ 71,419,358  
                     
December 31, 2023   Cash equivalents     1     $ -  

 

 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required adjustment or disclosure in the financial statements.

 

On January 10, 2025, the Company held an extraordinary general meeting (the “Meeting”) by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date (the “Extension”) by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”), by up to three one-month increments, from January 14, 2025 to as late as April 14, 2025, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. In connection with the meeting, an aggregate of 6,052,095 Public Shares were redeemed at a price of approximately $10.99 per share.

 

On January 13, 2025, the Company entered into Prepaid Forward Purchase Agreement (the “FPA”) by and among the Company, NewCo, and the funds, accounts and/other investment vehicles managed by Harraden Circle Investments, LLC signatory thereto (collectively, the “Purchaser”). In accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser shall purchase from holders of ordinary shares, par value $0.0001 per share, of the Company (“Company Ordinary Share”) that have elected to redeem their Company Ordinary Shares in connection with the contemplated business combination (“Business Combination”) between the Company, NewCo and Qianzhi, up to the lesser of (a) 550,000 Company Ordinary Shares and (b) such number of Company Ordinary Shares as shall, following the Business Combination between the Company, NewCo and Qianzhi, not to exceed 9.9% of the total number of Company Ordinary Shares to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price (the “Redemption Price”) per share to be paid to redeeming public shareholders of the Company. The current Redemption Price payable to redeeming public shareholders is approximately $10.991 per share. Any Company Ordinary Shares purchased pursuant to the FPA will not be voted in favor of approving the Business Combination. Upon the Business Combination closing, 50,000 Purchased Shares shall be deemed to be “Commitment Shares” and the remaining Forward Purchased Shares shall be deemed to be “Prepaid Forward Purchase Shares”. No later than the earlier of (a) one business day after the Business Combination closing and (b) the date any assets from the Company’s trust account are disbursed in connection with the Business Combination, the Company and NewCo shall cause Purchaser to be paid directly, out of the funds held in the Company’s trust account, a cash amount (the “Prepayment Amount”) equal to the number of Forward Purchased Shares multiplied by the Redemption Price. Upon the subsequent sale of the Prepaid Forward Purchase Shares by the Purchaser, the Purchaser will remit the Reference Price (as defined below) per share to the Company. On the date that is twelve months after the closing of the Business Combination (the “Maturity Date”), any Prepaid Forward Purchase Shares not sold by the Purchaser will be returned by the Purchaser to the Company and any remaining amounts in respect of the Prepaid Forward Purchase Shares will be retained by Purchaser. Prior to the Maturity Date, the Purchaser may sell Commitment Shares at any price in Purchaser’s sole discretion. The Purchaser has agreed that until the Maturity Date, the Prepaid Forward Purchase Shares may not be sold for a price less than the Reference Price. The “Reference Price” will initially equal the Redemption Price and may, at the Company’s option, be reduced (but never increased) at any time to the lowest daily volume weighted average price of the Company Ordinary Shares for the preceding 10 trading days.

 

On January 14, 2025, the Company held an extraordinary general meeting (the “Business Combination Meeting”) to approve, among other matters, its proposed business combination (the “Business Combination”) with NewCo and Qianzhi. The Company’s shareholders voted on the proposals at the Business Combination Meeting, all of which were described in the Company’s Registration Statement on Form S-4 (“S-4”) which was filed with the Securities and Exchange Commission (“SEC”) and included a prospectus of the Company as well as the Company’s proxy statement (the “Proxy Statement/Prospectus”). All of the proposals were approved. An aggregate of 137,936 Public Shares requested redemption in connection with such vote. However, as the business combination has not been consummated, none of such shares has been redeemed.

 

On March 19, 2025, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, for the prior 30 consecutive business days (through March 18, 2025), the closing market value of listed securities (MVLS) of the Company’s ordinary shares, $0.00001 par value per share, had been below the minimum of $50 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Rule”). The notice stated that the Company would be afforded 180 calendar days (until September 15, 2025) to regain compliance. In order to regain compliance, the closing MVLS of the Company’s securities must be at least $50 million for a minimum of ten consecutive business days. If the Company does not regain compliance within the 180-day period, the securities will be subject to delisting. On April 10, 2025, the Company received a notice from Nasdaq stating that it has regained compliance with the Rule, and this matter is now closed.

 

On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of 103,432 Public Shares were redeemed at a price of approximately $11.03 per share.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.

 
Emerging Growth Company

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

 
Use of Estimates

Use of Estimates

 

The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 
Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $103,774 and $426,913 as of December 31, 2024 and 2023, respectively.

 
Investments Held in Trust Account

Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of December 31, 2024 and 2023, the Trust Account had balance of $75,794,241 and $71,419,358, respectively. The interest and dividend income earned from the Trust Account totaled $3,684,883 and $1,729,358 for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) through December 31, 2023, respectively, which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.

 
Offering Costs

Offering Costs

 

Offering costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on July 14, 2023.

 
Interest Expenses

Interest Expenses

 

Interest expense in 2024 is primarily from the amortization of the debt discount in connection with the promissory note issued by the Company to related party. See Note 5 - Related Parties for more information.

 
Amortization of Debt Discount

Amortization of Debt Discount

 

The Company’s promissory note issued with related party is recorded net of debt discount which comprised issuance costs, and the discount initially recognized for the fair value of the shares transferred. The portion of the debt issuance costs allocated to the promissory note, is being amortized over the terms, which is upon consummation of the Business Combination. The amortization of debt issuance costs and discount is included in interest expense within the accompanying consolidated statements of operations.

 

 
Income Taxes

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statements.

 
Net Income (Loss) per Ordinary Share

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

The net income (loss) per share presented in the statements of operations is based on the following:

  

For the Year

Ended
December 31, 2024

  

For the Period

from
February 17, 2023
(Inception)

Through

December 31, 2023

 
Net income  $2,963,852   $1,484,790 
Interest earned on investment held in Trust Account   (3,684,883)   (1,729,358)
Accretion of temporary equity into redemption value   (690,000)   (7,591,500)
Net loss including accretion of equity into redemption value  $(1,411,031)  $(7,836,068)

 

   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
   

For the Year ended

December 31, 2024

  

For the Period from
February 17, 2023
(Inception) Through

December 31, 2023

 
   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
Particulars  Shares   Shares   Shares   Shares 
Basic and diluted net income (loss) per share:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Ownership percentage   75%   25%   65%   35%
Numerators:                    
Allocation of net loss including accretion of temporary equity  $(1,062,141)  $(348,890)  $(5,059,453)  $(2,776,615)
Accretion of temporary equity into redemption value   690,000    -    7,591,500    - 
Interest earned on Trust Account   3,684,883    -    1,729,358    - 
Allocation of net income (loss)  $3,312,742    (348,890)  $4,261,405   $(2,776,615)
                     
Denominators:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Basic and diluted net income/(loss) per share  $0.48   $(0.15)  $1.12   $(1.32)

 
Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

 
Ordinary Shares Subject to Possible Redemption

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

 

 

At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET

Public offering proceeds   $ 60,000,000  
Less:        
Proceeds allocated to Public Rights     (3,272,724 )
Allocation of offering costs related to redeemable shares     (2,925,140 )
Plus:        
Accretion of carrying value to redemption value     6,797,864  
Ordinary shares subject to possible redemption     60,600,000  
         
Over-allotment        
Plus:        
Over-allotment proceeds     9,000,000  
Less:        
Proceeds allocated to Public Rights     (490,909 )
Allocation of offering costs related to redeemable shares     (212,727 )
Plus:        
Accretion of carrying value to redemption value     793,636  
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     1,729,358  
Ordinary shares subject to possible redemption, December 31, 2023   $ 71,419,358  
Plus:        
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     3,684,883  
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)     690,000  
Ordinary shares subject to possible redemption, December 31, 2024   $ 75,794,241  

 
Recent Accounting Standards

Recent Accounting Standards

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance in ASU 2023-07 on January 1, 2024, and there is no significant impact on the disclosure of the consolidated financial statements. The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS

  

For the Year

Ended
December 31, 2024

  

For the Period

from
February 17, 2023
(Inception)

Through

December 31, 2023

 
Net income  $2,963,852   $1,484,790 
Interest earned on investment held in Trust Account   (3,684,883)   (1,729,358)
Accretion of temporary equity into redemption value   (690,000)   (7,591,500)
Net loss including accretion of equity into redemption value  $(1,411,031)  $(7,836,068)
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED

   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
   

For the Year ended

December 31, 2024

  

For the Period from
February 17, 2023
(Inception) Through

December 31, 2023

 
   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
Particulars  Shares   Shares   Shares   Shares 
Basic and diluted net income (loss) per share:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Ownership percentage   75%   25%   65%   35%
Numerators:                    
Allocation of net loss including accretion of temporary equity  $(1,062,141)  $(348,890)  $(5,059,453)  $(2,776,615)
Accretion of temporary equity into redemption value   690,000    -    7,591,500    - 
Interest earned on Trust Account   3,684,883    -    1,729,358    - 
Allocation of net income (loss)  $3,312,742    (348,890)  $4,261,405   $(2,776,615)
                     
Denominators:                    
Weighted-average shares outstanding   6,900,000    2,266,500    3,819,156    2,095,943 
Basic and diluted net income/(loss) per share  $0.48   $(0.15)  $1.12   $(1.32)
SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET

At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET

Public offering proceeds   $ 60,000,000  
Less:        
Proceeds allocated to Public Rights     (3,272,724 )
Allocation of offering costs related to redeemable shares     (2,925,140 )
Plus:        
Accretion of carrying value to redemption value     6,797,864  
Ordinary shares subject to possible redemption     60,600,000  
         
Over-allotment        
Plus:        
Over-allotment proceeds     9,000,000  
Less:        
Proceeds allocated to Public Rights     (490,909 )
Allocation of offering costs related to redeemable shares     (212,727 )
Plus:        
Accretion of carrying value to redemption value     793,636  
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     1,729,358  
Ordinary shares subject to possible redemption, December 31, 2023   $ 71,419,358  
Plus:        
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     3,684,883  
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)     690,000  
Ordinary shares subject to possible redemption, December 31, 2024   $ 75,794,241  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTIES (Tables)
 12 Months Ended
Dec. 31, 2024
Related Party Transaction [Line Items]  
SCHEDULE OF EXPENSES INCURRED AND PAYABLES

The following table presents details about the expenses incurred and payable for the year ended December 31, 2024 and during the period from February 17, 2023 (inception) through December 31, 2023:

 

                
Nature  Operating Costs   Payable Balance as of December 31, 
   For the year ended December 31, 2024   During the period from February 17, 2023 (inception) through December 31, 2023   2024   2023 
Initial accounting service fee  $-   $20,000   $-   $- 
Accounting service fee and others   21,785    10,500    11,285    5,250 
Administration fee   120,000    56,667    90,000    20,000 
Total  $141,785   $87,167   $101,285   $25,250 

 
EBC Founder Shares [Member]  
Related Party Transaction [Line Items]  
SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE

The fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:

 

Time to expiration     1.84  
Risk-free rate     4.0 %
Volatility     5.0 %
Dividend yield     0.0 %
Probability of completion of business combination     60.0 %
Founder Shares [Member]  
Related Party Transaction [Line Items]  
SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE

The Company estimated the fair value of the Founder Shares to be approximately $209,442 or $6.98 per share using the Black-Scholes option pricing model. The fair value of the Founder Shares was estimated at October 14, 2024. The Company used the following assumptions to estimate the fair value of Founder Shares using Level 3 fair value measurements inputs at the measurement date:

 

Time to expiration     1.0  
Risk-free rate     4.2 %
Volatility     5.0 %
Dividend yield     0.0 %
Probability of completion of business combination     65.0 %
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS

Date   Nature   Level     Fair Value  
December 31, 2024   Marketable securities held in the trust account     1     $ 75,794,241  
                     

December 31, 2024

   Cash equivalents     1     $

103,774

  
                     
December 31, 2023   Marketable securities held in the trust account     1     $ 71,419,358  
                     
December 31, 2023   Cash equivalents     1     $ -  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Apr. 14, 2025
Jan. 14, 2025
Jan. 10, 2025
Jan. 18, 2024
Jul. 18, 2023
Jul. 17, 2023
Jul. 14, 2023
Dec. 31, 2023
Dec. 31, 2024
Mar. 19, 2025
Oct. 07, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Ordinary shares, par value               $ 0.0001 $ 0.0001    
Gross proceeds               $ 3,615,000    
Deposit into trust account                     $ 690,000
Cash and cash equivalent               $ 426,913 103,774    
Working capital                 799,056    
Merger Shares [Member] | Agreement [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of stock issued       7,246,377              
Earnout Shares [Member] | Agreement [Member] | Maximum [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of stock issued       1,400,000              
Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Ordinary shares, par value                   $ 0.00001  
Number of stock issued 103,432 137,936 6,052,095                
Share price $ 11.03   $ 10.99                
Number of stock issued, shares 744,473   847,905                
Number of stock issued, value $ 8,211,537   $ 9,319                
EarlyBirdCapital [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of shares transferred                     30,000
IPO [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of stock issued             6,000,000        
Ordinary shares, par value             $ 0.0001        
Price per share             $ 10.00        
Proceeds from issuance of IPO             $ 60,000,000   60,000,000    
Number of stock issued             6,000,000        
Transaction cost         $ 3,318,898            
Cash underwriting fees         1,725,000            
Other offering costs         $ 1,593,898            
Private Placement [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Price per share             $ 10.00        
Number of stock issued         31,500   330,000        
Gross proceeds             $ 3,300,000        
Over-Allotment Option [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of stock issued         900,000 900,000 900,000        
Price per share         $ 10.00            
Number of stock issued           900,000          
Gross proceeds         $ 9,000,000            
Cash underwriting fees                 $ 1,725,000    
Over-Allotment Option [Member] | Maximum [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of stock issued                 900,000    
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Accounting Policies [Abstract]    
Net income $ 1,484,790 $ 2,963,852
Interest earned on investment held in Trust Account (1,729,358) (3,684,883)
Accretion of temporary equity into redemption value (7,591,500) (690,000)
Net loss including accretion of equity into redemption value $ (7,836,068) $ (1,411,031)
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Accretion of temporary equity into redemption value $ 7,591,500 $ 690,000
Interest earned on Trust Account 1,729,358 3,684,883
Allocation of net income (loss) $ 1,484,790 $ 2,963,852
Redeemable Shares [Member]    
Weighted average shares outstanding - basic 3,819,156 6,900,000
Weighted average shares outstanding - diluted 3,819,156 6,900,000
Ownership percentage 65.00% 75.00%
Allocation of net loss including accretion of temporary equity $ (5,059,453) $ (1,062,141)
Accretion of temporary equity into redemption value 7,591,500 690,000
Interest earned on Trust Account 1,729,358 3,684,883
Allocation of net income (loss) $ 4,261,405 $ 3,312,742
Basic net income/(loss) per share $ 1.12 $ 0.48
Diluted net income/(loss) per share $ 1.12 $ 0.48
Non Redeemable Shares [Member]    
Weighted average shares outstanding - basic 2,095,943 2,266,500
Weighted average shares outstanding - diluted 2,095,943 2,266,500
Ownership percentage 35.00% 25.00%
Allocation of net loss including accretion of temporary equity $ (2,776,615) $ (348,890)
Accretion of temporary equity into redemption value
Interest earned on Trust Account
Allocation of net income (loss) $ (2,776,615) $ (348,890)
Basic net income/(loss) per share $ (1.32) $ (0.15)
Diluted net income/(loss) per share $ (1.32) $ (0.15)
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) - USD ($)
 10 Months Ended 12 Months Ended
Jul. 14, 2023
Dec. 31, 2023
Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]      
Proceeds allocated to Public Rights   $ 1,016,000  
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account   1,729,358 $ 3,684,883
Ordinary shares subject to possible redemption   690,000
Ordinary shares subject to possible redemption     75,794,241
IPO [Member]      
Subsidiary, Sale of Stock [Line Items]      
Public offering proceeds $ 60,000,000   60,000,000
Proceeds allocated to public rights     (3,272,724)
Allocation of offering costs related to redeemable shares     (2,925,140)
Accretion of carrying value to redemption value     6,797,864
Ordinary shares subject to possible redemption     60,600,000
Ordinary shares subject to possible redemption   60,600,000  
Over-Allotment Option [Member]      
Subsidiary, Sale of Stock [Line Items]      
Allocation of offering costs related to redeemable shares     (212,727)
Accretion of carrying value to redemption value     793,636
Ordinary shares subject to possible redemption     71,419,358
Over-allotment proceeds     9,000,000
Proceeds allocated to Public Rights     (490,909)
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account     1,729,358
Ordinary shares subject to possible redemption     $ 690,000
Ordinary shares subject to possible redemption   $ 71,419,358  
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Accounting Policies [Abstract]    
Cash and cash equivalents $ 426,913 $ 103,774
Trust account balance 71,419,358 75,794,241
Interest and dividend income earned from trust account 1,729,358 3,684,883
Unrecognized tax benefits 0 0
Interest and penalties accrued $ 0 0
Cash, FDIC insured amount   $ 250,000
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
INITIAL PUBLIC OFFERING (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Jul. 18, 2023
Jul. 17, 2023
Jul. 14, 2023
Dec. 31, 2023
Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]          
Nasdaq entry fee       $ 87,167 $ 141,785
Qianzhi [Member]          
Subsidiary, Sale of Stock [Line Items]          
Nasdaq entry fee         $ 75,000
IPO [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock issued during period shares     6,000,000    
Sale of stock, par share     $ 10.00    
Stock holders equity related to initial public offering description     Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights.    
Stock issued during the period, shares     6,000,000    
Over-Allotment Option [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock issued during period shares   900,000      
Sale of stock, par share $ 10.00        
Stock issued during the period, shares 900,000 900,000 900,000    
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.1
PRIVATE PLACEMENTS (Details Narrative) - USD ($)
 10 Months Ended
Jul. 18, 2023
Jul. 14, 2023
Mar. 15, 2023
Feb. 27, 2023
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]          
Value of stock issued         $ 1,016,000
Sponsors [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares to Underwriter, shares       1,725,000  
Value of stock issued       $ 25,000  
EBC [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares to Underwriter, shares     180,000    
Unit exercise price per share     $ 0.014    
Value of stock issued     $ 2,520    
Private Placement [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares to Underwriter, shares 31,500 330,000      
Unit exercise price per share   $ 10.00      
Value of stock issued   $ 3,300,000      
Units related to private placement description   Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination.      
Private Placement [Member] | Sponsors [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares to Underwriter, shares   312,000      
Private Placement [Member] | EBC [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares to Underwriter, shares   18,000      
Private Placement [Member] | Underwriters [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares to Underwriter, shares   361,500      
Value of stock issued   $ 3,615,000      
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)
 10 Months Ended 12 Months Ended
Oct. 14, 2024
$ / shares
Mar. 15, 2023
Dec. 31, 2023
USD ($)
Dec. 31, 2024
USD ($)
Related Party Transaction [Line Items]        
Time to expiration 1 year 1 year 10 months 2 days    
Debt discount     $ (1,729,358) $ 209,442
Founder Shares [Member]        
Related Party Transaction [Line Items]        
Debt discount       $ 209,442
Share price | $ / shares $ 6.98      
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Risk Free Interest Rate [Member]        
Related Party Transaction [Line Items]        
Founder shares measurement input 0.042 0.040    
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Price Volatility [Member]        
Related Party Transaction [Line Items]        
Founder shares measurement input 0.050 0.050    
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Expected Dividend Rate [Member]        
Related Party Transaction [Line Items]        
Founder shares measurement input 0.000 0.000    
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Probability of Completion of Business Combination [Member]        
Related Party Transaction [Line Items]        
Founder shares measurement input 0.650 0.600    
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF EXPENSES INCURRED AND PAYABLES (Details) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Related Party Transaction [Line Items]    
Initial accounting service fee $ 20,000
Accounting service fee and others 10,500 21,785
Administration fee 56,667 120,000
Total 87,167 141,785
Related Party [Member]    
Related Party Transaction [Line Items]    
Accrued expenses 25,250 101,285
Related Party [Member] | Initial Accounting Service Fee [Member]    
Related Party Transaction [Line Items]    
Accrued expenses
Related Party [Member] | Accounting Service Fee and Others [Member]    
Related Party Transaction [Line Items]    
Accrued expenses 5,250 11,285
Related Party [Member] | Administration Fee [Member]    
Related Party Transaction [Line Items]    
Accrued expenses $ 20,000 $ 90,000
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTIES (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Oct. 14, 2024
Jul. 18, 2023
Jul. 17, 2023
Jul. 14, 2023
Jul. 11, 2023
Mar. 15, 2023
Feb. 27, 2023
Dec. 31, 2023
Dec. 31, 2024
Related Party Transaction [Line Items]                  
Value of stock issued               $ 1,016,000  
Debt discount               (1,729,358) $ 209,442
Interest expense               87,267
Related party debt               151,318
Accounting Service Agreement And Other [Member]                  
Related Party Transaction [Line Items]                  
Related Party Transaction, Amounts of Transaction               5,250  
Sponsors [Member]                  
Related Party Transaction [Line Items]                  
Issuance of ordinary shares to Underwriter, shares 30,000                
Sponsors [Member] | Promissory Note [Member]                  
Related Party Transaction [Line Items]                  
Debt Instrument, Face Amount             $ 300,000    
Debt Instrument, Maturity Date             Jul. 14, 2023    
EBC Founder Shares [Member]                  
Related Party Transaction [Line Items]                  
Loans payable $ 500,000                
Debt short term amount                 500,000
Related Party [Member]                  
Related Party Transaction [Line Items]                  
Accrued expenses               25,250 101,285
Related Party [Member] | General and Administrative Expense [Member]                  
Related Party Transaction [Line Items]                  
Accrued expenses               20,000 90,000
Related Party [Member] | Accounting Services Expense [Member]                  
Related Party Transaction [Line Items]                  
Accrued expenses               $ 5,250 11,285
Over-Allotment Option [Member]                  
Related Party Transaction [Line Items]                  
Issuance of ordinary shares to Underwriter, shares     900,000            
Value of stock issued                 $ (490,909)
Stock issued during the period, shares   900,000 900,000 900,000          
Cash underwriting discount per unit                 $ 0.25
Aggregate cash underwriting discount                 $ 1,500,000
Payments for underwriting expense                 $ 1,725,000
Price per share   $ 10.00              
Gross proceeds   $ 9,000,000              
Over-Allotment Option [Member] | Maximum [Member]                  
Related Party Transaction [Line Items]                  
Stock issued during the period, shares                 900,000
Sponsors [Member]                  
Related Party Transaction [Line Items]                  
Issuance of ordinary shares to Underwriter, shares             1,725,000    
Value of stock issued             $ 25,000    
Sponsors [Member] | Maximum [Member]                  
Related Party Transaction [Line Items]                  
Affiliate Costs         $ 10,000        
Sponsors [Member] | Over-Allotment Option [Member]                  
Related Party Transaction [Line Items]                  
Number of shares subject to forfeiture             225,000    
EBC [Member]                  
Related Party Transaction [Line Items]                  
Issuance of ordinary shares to Underwriter, shares           180,000      
Value of stock issued           $ 2,520      
Ordinary share price           $ 0.014      
Fair value of shares issued           $ 1,016,000      
Fair value of ordinary per share price           $ 5.65      
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Business combination related cost $ 181,022 $ 527,145
Qianzhi [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Business combination related cost   389,099
Business Combination Marketing Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Business combination related cost   $ 2,415,000
Percentage of gross proceeds of initial public offering   3.50%
Percentage of service fee of total consideration payable   1.00%
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Jul. 17, 2023
Feb. 27, 2023
Dec. 31, 2023
Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]        
Preferred stock, shares authorized     2,000,000 2,000,000
Preferred stock, par value     $ 0.0001 $ 0.0001
Preferred stock voting rights       voting and other rights and preferences as may be determined from time to time by the Company’s board of directors.
Preferred stock, shares issued     0 0
Preferred stock, shares outstanding     0 0
Common stock, shares authorized     200,000,000 200,000,000
Common stock, par value     $ 0.0001 $ 0.0001
Common stock voting rights       Holders of ordinary shares are entitled to one vote for each share.
Issuance of ordinary shares to Underwriter     $ 1,016,000  
Ordinary shares issued     2,266,500 2,266,500
Ordinary shares outstanding     2,266,500 2,266,500
Ordinary shares subject to redemption     6,900,000 6,900,000
Common Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Common stock voting rights       each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.
Issuance of ordinary shares to Underwriter, shares     180,000  
Issuance of ordinary shares to Underwriter     $ 18  
Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issuance of ordinary shares to Underwriter, shares 900,000      
Issuance of ordinary shares to Underwriter       $ (490,909)
Sponsors [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issuance of ordinary shares to Underwriter, shares   1,725,000    
Issuance of ordinary shares to Underwriter   $ 25,000    
Sponsors [Member] | Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of shares subject to forfeiture   225,000    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities held in the trust account $ 75,794,241 $ 71,419,358
Cash equivalents 103,774 426,913
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities held in the trust account 75,794,241 71,419,358
Cash equivalents $ 103,774
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS (Details Narrative) - $ / shares
Apr. 14, 2025
Jan. 14, 2025
Jan. 13, 2025
Jan. 10, 2025
Mar. 19, 2025
Dec. 31, 2024
Dec. 31, 2023
Subsequent Event [Line Items]              
Ordinary stock, par value           $ 0.0001 $ 0.0001
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Number of stock issued 103,432 137,936   6,052,095      
Share price $ 11.03     $ 10.99      
Subsequent descripition     In accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser shall purchase from holders of ordinary shares, par value $0.0001 per share, of the Company (“Company Ordinary Share”) that have elected to redeem their Company Ordinary Shares in connection with the contemplated business combination (“Business Combination”) between the Company, NewCo and Qianzhi, up to the lesser of (a) 550,000 Company Ordinary Shares and (b) such number of Company Ordinary Shares as shall, following the Business Combination between the Company, NewCo and Qianzhi, not to exceed 9.9% of the total number of Company Ordinary Shares to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price (the “Redemption Price”) per share to be paid to redeeming public shareholders of the Company. The current Redemption Price payable to redeeming public shareholders is approximately $10.991 per share. Any Company Ordinary Shares purchased pursuant to the FPA will not be voted in favor of approving the Business Combination. Upon the Business Combination closing, 50,000 Purchased Shares shall be deemed to be “Commitment Shares” and the remaining Forward Purchased Shares shall be deemed to be “Prepaid Forward Purchase Shares”.        
Ordinary stock, par value         $ 0.00001    
EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 49 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 114 220 1 false 43 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://bowenspac.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://bowenspac.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://bowenspac.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://bowenspac.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Statements of Changes in Shareholders' (Deficit) Equity Sheet http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity Statements of Changes in Shareholders' (Deficit) Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://bowenspac.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 9 false false R10.htm 999014 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS Sheet http://bowenspac.com/role/OrganizationAndBusinessOperations ORGANIZATION AND BUSINESS OPERATIONS Notes 10 false false R11.htm 999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 11 false false R12.htm 999016 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://bowenspac.com/role/InitialPublicOffering INITIAL PUBLIC OFFERING Notes 12 false false R13.htm 999017 - Disclosure - PRIVATE PLACEMENTS Sheet http://bowenspac.com/role/PrivatePlacements PRIVATE PLACEMENTS Notes 13 false false R14.htm 999018 - Disclosure - RELATED PARTIES Sheet http://bowenspac.com/role/RelatedParties RELATED PARTIES Notes 14 false false R15.htm 999019 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://bowenspac.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 15 false false R16.htm 999020 - Disclosure - SHAREHOLDERS??? EQUITY Sheet http://bowenspac.com/role/ShareholdersEquity SHAREHOLDERS??? EQUITY Notes 16 false false R17.htm 999021 - Disclosure - Fair Value Measurements Sheet http://bowenspac.com/role/FairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 999022 - Disclosure - SUBSEQUENT EVENTS Sheet http://bowenspac.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 18 false false R19.htm 999023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 999024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 999025 - Disclosure - RELATED PARTIES (Tables) Sheet http://bowenspac.com/role/RelatedPartiesTables RELATED PARTIES (Tables) Tables http://bowenspac.com/role/RelatedParties 21 false false R22.htm 999026 - Disclosure - Fair Value Measurements (Tables) Sheet http://bowenspac.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://bowenspac.com/role/FairValueMeasurements 22 false false R23.htm 999027 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) Sheet http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) Details http://bowenspac.com/role/OrganizationAndBusinessOperations 23 false false R24.htm 999028 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) Sheet http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) Details 24 false false R25.htm 999029 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) Sheet http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) Details 25 false false R26.htm 999030 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) Sheet http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) Details 26 false false R27.htm 999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables 27 false false R28.htm 999032 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative) Sheet http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative INITIAL PUBLIC OFFERING (Details Narrative) Details http://bowenspac.com/role/InitialPublicOffering 28 false false R29.htm 999033 - Disclosure - PRIVATE PLACEMENTS (Details Narrative) Sheet http://bowenspac.com/role/PrivatePlacementsDetailsNarrative PRIVATE PLACEMENTS (Details Narrative) Details http://bowenspac.com/role/PrivatePlacements 29 false false R30.htm 999034 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details) Sheet http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details) Details 30 false false R31.htm 999035 - Disclosure - SCHEDULE OF EXPENSES INCURRED AND PAYABLES (Details) Sheet http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails SCHEDULE OF EXPENSES INCURRED AND PAYABLES (Details) Details 31 false false R32.htm 999036 - Disclosure - RELATED PARTIES (Details Narrative) Sheet http://bowenspac.com/role/RelatedPartiesDetailsNarrative RELATED PARTIES (Details Narrative) Details http://bowenspac.com/role/RelatedPartiesTables 32 false false R33.htm 999037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://bowenspac.com/role/CommitmentsAndContingencies 33 false false R34.htm 999038 - Disclosure - SHAREHOLDERS??? EQUITY (Details Narrative) Sheet http://bowenspac.com/role/ShareholdersEquityDetailsNarrative SHAREHOLDERS??? EQUITY (Details Narrative) Details http://bowenspac.com/role/ShareholdersEquity 34 false false R35.htm 999039 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) Sheet http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) Details 35 false false R36.htm 999040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://bowenspac.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://bowenspac.com/role/SubsequentEvents 36 false false All Reports Book All Reports bown-20241231.xsd bown-20241231_cal.xml bown-20241231_def.xml bown-20241231_lab.xml bown-20241231_pre.xml form10-k.htm http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/cyd/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 54 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "BOWN", "nsuri": "http://bowenspac.com/20241231", "dts": { "schema": { "local": [ "bown-20241231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "bown-20241231_cal.xml" ] }, "definitionLink": { "local": [ "bown-20241231_def.xml" ] }, "labelLink": { "local": [ "bown-20241231_lab.xml" ] }, "presentationLink": { "local": [ "bown-20241231_pre.xml" ] }, "inline": { "local": [ "form10-k.htm" ] } }, "keyStandard": 167, "keyCustom": 53, "axisStandard": 13, "axisCustom": 0, "memberStandard": 16, "memberCustom": 25, "hidden": { "total": 86, "http://bowenspac.com/20241231": 35, "http://fasb.org/us-gaap/2024": 47, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 114, "entityCount": 1, "segmentCount": 43, "elementCount": 448, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 386, "http://xbrl.sec.gov/dei/2024": 48, "http://xbrl.sec.gov/cyd/2024": 5, "http://xbrl.sec.gov/ecd/2024": 4, "http://fasb.org/srt/2024": 1 }, "report": { "R1": { "role": "http://bowenspac.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://bowenspac.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:OtherReceivablesNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R3": { "role": "http://bowenspac.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "BOWN:OrdinarySharesSubjectToRedemption", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R4": { "role": "http://bowenspac.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R5": { "role": "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity", "longName": "00000005 - Statement - Statements of Changes in Shareholders' (Deficit) Equity", "shortName": "Statements of Changes in Shareholders' (Deficit) Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalOther", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalOther", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://bowenspac.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-10-012024-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-10-012024-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://bowenspac.com/role/OrganizationAndBusinessOperations", "longName": "999014 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS", "shortName": "ORGANIZATION AND BUSINESS OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies", "longName": "999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://bowenspac.com/role/InitialPublicOffering", "longName": "999016 - Disclosure - INITIAL PUBLIC OFFERING", "shortName": "INITIAL PUBLIC OFFERING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "BOWN:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "BOWN:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://bowenspac.com/role/PrivatePlacements", "longName": "999017 - Disclosure - PRIVATE PLACEMENTS", "shortName": "PRIVATE PLACEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "BOWN:PrivatePlacementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "BOWN:PrivatePlacementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://bowenspac.com/role/RelatedParties", "longName": "999018 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://bowenspac.com/role/CommitmentsAndContingencies", "longName": "999019 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://bowenspac.com/role/ShareholdersEquity", "longName": "999020 - Disclosure - SHAREHOLDERS\u2019 EQUITY", "shortName": "SHAREHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://bowenspac.com/role/FairValueMeasurements", "longName": "999021 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://bowenspac.com/role/SubsequentEvents", "longName": "999022 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "999023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "999024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://bowenspac.com/role/RelatedPartiesTables", "longName": "999025 - Disclosure - RELATED PARTIES (Tables)", "shortName": "RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "BOWN:ScheduleOfExpensesIncurredAndPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "BOWN:ScheduleOfExpensesIncurredAndPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://bowenspac.com/role/FairValueMeasurementsTables", "longName": "999026 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "longName": "999027 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)", "shortName": "ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-07", "name": "us-gaap:Deposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R24": { "role": "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails", "longName": "999028 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)", "shortName": "SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "BOWN:InterestEarnedOnInvestmentHeldInTrustAccount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R25": { "role": "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "longName": "999029 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)", "shortName": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "BOWN:AccretionOfTemporaryEquityIntoRedemptionValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31_custom_RedeemableSharesMember", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R26": { "role": "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "longName": "999030 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)", "shortName": "SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock", "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R27": { "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "span", "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R28": { "role": "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "longName": "999032 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)", "shortName": "INITIAL PUBLIC OFFERING (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:PaymentsForFees", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "BOWN:ScheduleOfExpensesIncurredAndPayableTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_custom_QianzhiMember", "name": "us-gaap:PaymentsForFees", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "BOWN:InitialPublicOfferingTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R29": { "role": "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "longName": "999033 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)", "shortName": "PRIVATE PLACEMENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-07-14_us-gaap_PrivatePlacementMember", "name": "us-gaap:SharesIssuedPricePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "BOWN:PrivatePlacementsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R30": { "role": "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "longName": "999034 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)", "shortName": "SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2024-10-142024-10-14", "name": "BOWN:EquitySecuritiesFvNiTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-10-142024-10-14", "name": "BOWN:EquitySecuritiesFvNiTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails", "longName": "999035 - Disclosure - SCHEDULE OF EXPENSES INCURRED AND PAYABLES (Details)", "shortName": "SCHEDULE OF EXPENSES INCURRED AND PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "BOWN:InitialAccountingServiceFee", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "BOWN:ScheduleOfExpensesIncurredAndPayableTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "BOWN:InitialAccountingServiceFee", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "BOWN:ScheduleOfExpensesIncurredAndPayableTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "longName": "999036 - Disclosure - RELATED PARTIES (Details Narrative)", "shortName": "RELATED PARTIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31_custom_AccountingServiceAgreementAndOtherMember", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R33": { "role": "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "999037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-172023-12-31", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "longName": "999038 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:PreferredStockVotingRights", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R35": { "role": "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails", "longName": "999039 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)", "shortName": "SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R36": { "role": "http://bowenspac.com/role/SubsequentEventsDetailsNarrative", "longName": "999040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-132025-01-13_us-gaap_SubsequentEventMember", "name": "us-gaap:SubsequentEventDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "BOWN_AccountingServiceAgreementAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AccountingServiceAgreementAndOtherMember", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounting Service Agreement And Other [Member]", "documentation": "Accounting Service Agreement And Other [Member]" } } }, "auth_ref": [] }, "BOWN_AccountingServiceFeeAndOthers": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AccountingServiceFeeAndOthers", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting service fee and others", "documentation": "Accounting service fee and others" } } }, "auth_ref": [] }, "BOWN_AccountingServiceFeeAndOthersMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AccountingServiceFeeAndOthersMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting Service Fee and Others [Member]", "documentation": "Accounting Service Fee and Others [Member]" } } }, "auth_ref": [] }, "BOWN_AccountingServicesExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AccountingServicesExpenseMember", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounting Services Expense [Member]", "documentation": "Accounting Services Expense [Member]" } } }, "auth_ref": [] }, "BOWN_AccretionOfCarryingValueToRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AccretionOfCarryingValueToRedemptionValue", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Accretion of carrying value to redemption value", "documentation": "Accretion of carrying value to redemption value." } } }, "auth_ref": [] }, "BOWN_AccretionOfTemporaryEquityIntoRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AccretionOfTemporaryEquityIntoRedemptionValue", "crdr": "debit", "calculation": { "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": { "parentTag": "BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accretion of temporary equity into redemption value", "label": "Accretion of temporary equity into redemption value", "documentation": "Accretion of temporary equity into redemption value." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r41" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r549" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r49", "r475", "r664" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r359", "r613", "r614", "r615", "r616", "r637", "r665" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r555" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r555" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r555" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r555" ] }, "BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Allocation of offering costs to ordinary shares subject to redemption", "documentation": "Adjustments to additional paid in capital allocation of offering costs to ordinary shares subject to redemption." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Deduction for increase of carrying value of redeemable shares", "documentation": "Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock." } } }, "auth_ref": [ "r8", "r66", "r70" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)", "label": "Debt discount", "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)." } } }, "auth_ref": [] }, "BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Other offering costs", "documentation": "Adjustments to additional paid in capital underwriter\u2019s commission on sale of Public Units." } } }, "auth_ref": [] }, "BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Underwriter\u2019s commission on Over-allotment", "documentation": "Adjustments to additional paid in capital underwriters commission on overallotment." } } }, "auth_ref": [] }, "BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Underwriter\u2019s commission on sale of Public Units", "documentation": "Adjustments to additional paid in capital underwriters commission on sale of public units." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "auth_ref": [] }, "BOWN_AdministrationFeeMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AdministrationFeeMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Administration Fee [Member]" } } }, "auth_ref": [] }, "us-gaap_AffiliateCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AffiliateCosts", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Affiliate Costs", "documentation": "Costs associated with revenues arising from an entity that is an affiliate of the reporting entity by means of direct or indirect ownership." } } }, "auth_ref": [ "r54" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r516", "r527", "r541", "r567" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r519", "r530", "r544", "r570" ] }, "BOWN_AgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AgreementMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Agreement [Member]", "documentation": "Agreement [Member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r555" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r562" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r520", "r531", "r545", "r562", "r571", "r575", "r583" ] }, "BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AllocationOfNetLossIncludingAccretionOfTemporaryEquity", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Allocation of net loss including accretion of temporary equity", "documentation": "Allocation of net loss including accretion of temporary equity." } } }, "auth_ref": [] }, "BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Allocation of offering costs to ordinary shares subject to redemption", "documentation": "Allocation of offering costs to ordinary shares subject to redemption.", "label": "AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortized interest expense from debt discount", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r187", "r459", "r460", "r606", "r646" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r523" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r259" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r75", "r82", "r101", "r121", "r148", "r152", "r154", "r155", "r157", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r260", "r262", "r290", "r323", "r393", "r453", "r454", "r475", "r487", "r633", "r634", "r651" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r98", "r107", "r121", "r157", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r260", "r262", "r290", "r475", "r633", "r634", "r651" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrustNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsHeldInTrustNoncurrent", "crdr": "debit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails", "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment held in Trust Account", "verboseLabel": "Trust account balance", "terseLabel": "Marketable securities held in the trust account", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r607" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r523" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r499", "r501", "r523" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r499", "r501", "r523" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r499", "r501", "r523" ] }, "dei_AuditorOpinionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorOpinionTextBlock", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Opinion [Text Block]" } } }, "auth_ref": [ "r598" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r578" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r579" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r574" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r574" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r574" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r574" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r574" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r574" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r577" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r576" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r575" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r575" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of Financial Position Location, Balance [Axis]", "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r168", "r660", "r661" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r32", "r33", "r168", "r660", "r661" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Principles of Consolidation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r162", "r163", "r164", "r165", "r166", "r256", "r465", "r466" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r29", "r30", "r162", "r163", "r164", "r165", "r166", "r256", "r465", "r466" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business combination related cost", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r28" ] }, "BOWN_BusinessCombinationMarketingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "BusinessCombinationMarketingAgreementMember", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Combination Marketing Agreement [Member]", "documentation": "Business Combination Marketing Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails", "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalent", "terseLabel": "Cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r13", "r100", "r448" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r14" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash at beginning of period", "periodEndLabel": "Cash at the end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r13", "r60", "r117" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r60" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of noncash financing activities" } } }, "auth_ref": [] }, "BOWN_CashUnderwritingDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "CashUnderwritingDiscount", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate cash underwriting discount", "documentation": "Cash underwriting discount." } } }, "auth_ref": [] }, "BOWN_CashUnderwritingDiscountPerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "CashUnderwritingDiscountPerUnit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash underwriting discount per unit", "documentation": "Cash underwriting discount per unit." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r553" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://bowenspac.com/role/Cover", "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r88", "r103", "r104", "r105", "r121", "r140", "r141", "r143", "r145", "r150", "r151", "r157", "r175", "r177", "r178", "r179", "r182", "r183", "r190", "r191", "r193", "r196", "r202", "r290", "r351", "r352", "r353", "r354", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r381", "r402", "r424", "r439", "r440", "r441", "r442", "r443", "r602", "r608", "r617" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r554" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r554" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r259" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 6)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r45", "r78", "r325", "r380" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r65", "r169", "r170", "r445", "r627", "r632" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r477", "r478", "r479", "r481", "r482", "r483", "r484", "r613", "r614", "r616", "r637", "r663", "r665" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary stock, par value", "verboseLabel": "Ordinary shares, par value", "terseLabel": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r48" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary stock, shares authorized", "verboseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r48", "r381" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary stock, shares issued", "verboseLabel": "Ordinary shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r48" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary stock, shares outstanding", "verboseLabel": "Ordinary shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r48", "r381", "r399", "r665", "r666" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding (excluding 6,900,000 shares subject to redemption on December 31, 2024 and 2023, respectively)", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r48", "r327", "r475" ] }, "us-gaap_CommonStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockVotingRights", "presentation": [ "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock voting rights", "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r23" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r559" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r558" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r560" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r557" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r37", "r85" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r509", "r593" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r509", "r593" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r511", "r595" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r511", "r595" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r504", "r588" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r505", "r589" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r505", "r589" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r503", "r587" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r506", "r590" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r508", "r592" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r508", "r592" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r509", "r593" ] }, "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r512", "r596" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r510", "r594" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r507", "r591" ] }, "us-gaap_DebtDefaultShorttermDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDefaultShorttermDebtAmount", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt short term amount", "documentation": "Amount of outstanding short-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured." } } }, "auth_ref": [ "r119" ] }, "BOWN_DebtDiscountInConnectionWithPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "DebtDiscountInConnectionWithPromissoryNote", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Debt discount in connection with promissory note", "documentation": "Debt discount in connection with promissory note." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r184", "r298", "r299", "r457", "r458", "r474" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r102", "r456", "r641", "r642" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscountCurrent", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Unamortized debt discount", "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer." } } }, "auth_ref": [ "r644", "r645", "r647" ] }, "us-gaap_DebtPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Discount", "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt." } } }, "auth_ref": [ "r4" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of shares issued", "documentation": "The total fair value of shares issued during the period under a deferred compensation arrangement." } } }, "auth_ref": [ "r72" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_Deposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Deposits", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deposit into trust account", "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others." } } }, "auth_ref": [ "r76" ] }, "BOWN_DisclosureInitialPublicOfferingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "DisclosureInitialPublicOfferingAbstract", "lang": { "en-us": { "role": { "label": "Initial Public Offering" } } }, "auth_ref": [] }, "BOWN_DisclosurePrivatePlacementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "DisclosurePrivatePlacementsAbstract", "lang": { "en-us": { "role": { "label": "Private Placements" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r501" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r499", "r501", "r523" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r499", "r501", "r523", "r563" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r500" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r488" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r501" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r501" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r548" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r491" ] }, "BOWN_EBCFounderSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "EBCFounderSharesMember", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "EBC Founder Shares [Member]", "documentation": "EBC Founder Shares [Member]" } } }, "auth_ref": [] }, "BOWN_EBCMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "EBCMember", "presentation": [ "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "EBC [Member]", "documentation": "EBC [Member]" } } }, "auth_ref": [] }, "BOWN_EarlyBirdCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "EarlyBirdCapitalMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "EarlyBirdCapital [Member]", "documentation": "EarlyBirdCapital [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic net income (loss) per share", "verboseLabel": "Basic net income/(loss) per share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r114", "r129", "r130", "r131", "r132", "r133", "r134", "r138", "r140", "r143", "r144", "r145", "r147", "r254", "r258", "r272", "r273", "r322", "r334", "r450" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted net income (loss) per share", "verboseLabel": "Diluted net income/(loss) per share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r114", "r129", "r130", "r131", "r132", "r133", "r134", "r140", "r143", "r144", "r145", "r147", "r254", "r258", "r272", "r273", "r322", "r334", "r450" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) per Ordinary Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r15", "r16", "r146" ] }, "BOWN_EarnoutSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "EarnoutSharesMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Earnout Shares [Member]", "documentation": "Earnout Shares [Member]" } } }, "auth_ref": [] }, "BOWN_EmergingGrowthCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "EmergingGrowthCompanyPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Company", "documentation": "Emerging Growth Company Policy [Text Block]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r494" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r490" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r490" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r601" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r490" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r597" ] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingParValuePerShare", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r523" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r490" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r490" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r490" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r490" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r599" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r96", "r111", "r112", "r113", "r124", "r125", "r126", "r128", "r133", "r135", "r137", "r149", "r158", "r159", "r167", "r203", "r249", "r250", "r251", "r252", "r253", "r255", "r257", "r258", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r291", "r292", "r293", "r294", "r295", "r296", "r300", "r301", "r302", "r333", "r338", "r339", "r340", "r359", "r424" ] }, "us-gaap_EquitySecuritiesFvNiMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesFvNiMeasurementInput", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Founder shares measurement input", "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r277", "r278", "r279" ] }, "BOWN_EquitySecuritiesFvNiTerm": { "xbrltype": "durationItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "EquitySecuritiesFvNiTerm", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Time to expiration", "documentation": "Equity securities fvni term." } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r556" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r516", "r527", "r541", "r567" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r513", "r524", "r538", "r564" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r562" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "BOWN_ExtensionDepositToTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "ExtensionDepositToTrustAccount", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Extension deposit to Trust Account", "documentation": "Extension deposit to trust account", "label": "ExtensionDepositToTrustAccount" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r275", "r276", "r284", "r469" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r275", "r276", "r284", "r469" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://bowenspac.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r277", "r278", "r470" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://bowenspac.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r638", "r639" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r186", "r205", "r206", "r207", "r208", "r209", "r210", "r274", "r276", "r277", "r278", "r279", "r283", "r284", "r285", "r314", "r315", "r316", "r457", "r458", "r462", "r463", "r464", "r469", "r470" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://bowenspac.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r285", "r286", "r287", "r288", "r289", "r321", "r469", "r471" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r186", "r205", "r210", "r276", "r284", "r314", "r462", "r463", "r464", "r469" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r186", "r205", "r206", "r207", "r208", "r209", "r210", "r276", "r277", "r278", "r279", "r284", "r316", "r457", "r458", "r462", "r463", "r464", "r469", "r470" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r186", "r205", "r206", "r207", "r208", "r209", "r210", "r274", "r276", "r277", "r278", "r279", "r283", "r284", "r285", "r314", "r315", "r316", "r457", "r458", "r462", "r463", "r464", "r469", "r470" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r5" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r520", "r531", "r545", "r571" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r520", "r531", "r545", "r571" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r520", "r531", "r545", "r571" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r520", "r531", "r545", "r571" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r520", "r531", "r545", "r571" ] }, "BOWN_FounderSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "FounderSharesMember", "presentation": [ "http://bowenspac.com/role/RelatedPartiesTables", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Founder Shares [Member]", "documentation": "Founder Shares [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r56" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IPOMember", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r499", "r501", "r523" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "auth_ref": [] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest and penalties accrued", "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations." } } }, "auth_ref": [ "r636" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r110", "r242", "r243", "r245", "r246", "r247", "r248", "r350" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in current assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r3" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r520", "r531", "r545", "r562", "r571", "r575", "r583" ] }, "BOWN_InitialAccountingServiceFee": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "InitialAccountingServiceFee", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Initial accounting service fee", "documentation": "Initial accounting service fee" } } }, "auth_ref": [] }, "BOWN_InitialAccountingServiceFeeMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "InitialAccountingServiceFeeMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Initial Accounting Service Fee [Member]", "documentation": "Initial Accounting Service Fee [Member]" } } }, "auth_ref": [] }, "BOWN_InitialPublicOfferingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "InitialPublicOfferingTextBlock", "presentation": [ "http://bowenspac.com/role/InitialPublicOffering" ], "lang": { "en-us": { "role": { "label": "INITIAL PUBLIC OFFERING", "documentation": "Initial Public Offering [Text Block]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r581" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r502", "r586" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r502", "r586" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r502", "r586" ] }, "BOWN_InterestEarnedOnInvestmentHeldInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "InterestEarnedOnInvestmentHeldInTrustAccount", "crdr": "debit", "calculation": { "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": { "parentTag": "BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest earned on investment held in Trust Account", "documentation": "Interest earned on investment held in trust account.", "label": "InterestEarnedOnInvestmentHeldInTrustAccount" } } }, "auth_ref": [] }, "BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "InterestEarnedOnInvestmentsHeldInTrustAccount", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingIncome", "weight": 1.0, "order": 1.0 }, "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfCashFlows", "http://bowenspac.com/role/StatementsOfOperations", "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest earned on investments held in trust account", "negatedLabel": "Income earned on investment held in Trust Account", "verboseLabel": "Interest earned on Trust Account", "terseLabel": "Interest and dividend income earned from trust account", "documentation": "Interest earned on investments held in trust account." } } }, "auth_ref": [] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest expense", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r153", "r604" ] }, "BOWN_InterestExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "InterestExpensesPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Interest Expenses", "documentation": "Interest Expenses Policy [Text Block]" } } }, "auth_ref": [] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investments Held in Trust Account", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r335", "r346", "r347", "r348", "r349", "r433", "r434" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r9", "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r121", "r157", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r261", "r262", "r263", "r290", "r379", "r451", "r487", "r633", "r651", "r652" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Shareholders\u2019 Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r53", "r79", "r330", "r475", "r609", "r625", "r643" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r42", "r99", "r121", "r157", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r261", "r262", "r263", "r290", "r475", "r633", "r651", "r652" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansPayable", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loans payable", "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r9", "r77", "r659" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Promissory Note", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r9", "r77", "r185", "r188", "r457", "r458", "r474", "r659" ] }, "cyd_MaterialCybersecurityIncidentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAbstract", "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Abstract]" } } }, "auth_ref": [ "r534", "r535" ] }, "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]" } } }, "auth_ref": [ "r534", "r536" ] }, "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]" } } }, "auth_ref": [ "r534", "r537" ] }, "cyd_MaterialCybersecurityIncidentNatureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentNatureTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Nature [Text Block]" } } }, "auth_ref": [ "r534", "r537" ] }, "cyd_MaterialCybersecurityIncidentScopeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentScopeTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Scope [Text Block]" } } }, "auth_ref": [ "r534", "r537" ] }, "cyd_MaterialCybersecurityIncidentTimingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTimingTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Timing [Text Block]" } } }, "auth_ref": [ "r534", "r537" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r171", "r172", "r173", "r174", "r212", "r240", "r279", "r319", "r336", "r337", "r343", "r371", "r372", "r432", "r435", "r436", "r437", "r438", "r446", "r447", "r455", "r461", "r467", "r470", "r471", "r472", "r473", "r476", "r635", "r653", "r654", "r655", "r656", "r657", "r658" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r554" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r554" ] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r640", "r641", "r642" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r470", "r640", "r641", "r642" ] }, "BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Probability of Completion of Business Combination [Member]", "documentation": "Measurement Input, Probability of Completion of Business Combination [Member]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r640", "r641", "r642" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r277", "r278", "r279", "r470" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r277", "r278", "r279", "r470" ] }, "BOWN_MergerSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "MergerSharesMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Merger Shares [Member]", "documentation": "Merger Shares [Member]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r574" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r582" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r555" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r116" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r116" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r60", "r61", "r62" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": { "parentTag": "BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue", "weight": 1.0, "order": 1.0 }, "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails", "http://bowenspac.com/role/StatementsOfCashFlows", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://bowenspac.com/role/StatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "label": "Net income", "verboseLabel": "Net Income (Loss)", "terseLabel": "Allocation of net income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r55", "r62", "r80", "r97", "r108", "r109", "r113", "r121", "r127", "r129", "r130", "r131", "r132", "r133", "r136", "r137", "r142", "r157", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r254", "r258", "r273", "r290", "r332", "r401", "r422", "r423", "r485", "r633" ] }, "BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "NetLossIncludingAccretionOfEquityIntoRedemptionValue", "crdr": "credit", "calculation": { "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss including accretion of equity into redemption value", "documentation": "Net loss including accretion of equity into redemption value.", "label": "NetLossIncludingAccretionOfEquityIntoRedemptionValue" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "NonCashOfferingCostsChargedToAdditionalPaidinCapital", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Offering costs charged to APIC", "documentation": "Offering costs charged to Additional Paid-in Capital." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r554" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r552" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r551" ] }, "BOWN_NonRedeemableOrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "NonRedeemableOrdinarySharesMember", "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Non Redeemable Ordinary Shares [Member]", "documentation": "Non Redeemable Ordinary Shares [Member]" } } }, "auth_ref": [] }, "BOWN_NonRedeemableSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "NonRedeemableSharesMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Non Redeemable Shares [Member]", "documentation": "Non Redeemable Shares [Member]" } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r582" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r582" ] }, "BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "NoncashOfferingCostsAdjustedFromPrepaidExpenses", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Offering costs adjusted from prepaid expenses", "documentation": "Offering costs adjusted from prepaid expenses." } } }, "auth_ref": [] }, "BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Offering costs paid by Sponsor in exchange for issuance of ordinary shares", "documentation": "Offering costs paid by Sponsor in exchange for issuance of ordinary shares." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income:" } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonrelatedPartyMember", "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r610", "r611" ] }, "BOWN_OfferingCostsPaidByRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "OfferingCostsPaidByRelatedParty", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Offering costs paid by related party", "documentation": "Offering costs paid by related party." } } }, "auth_ref": [] }, "us-gaap_OfferingCostsPartnershipInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OfferingCostsPartnershipInterests", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allocation of offering costs related to redeemable shares", "label": "Offering Costs, Partnership Interests", "documentation": "Costs incurred in connection with the offering and selling of additional partner interest." } } }, "auth_ref": [ "r626", "r662" ] }, "BOWN_OfferingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "OfferingCostsPolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Offering Costs", "documentation": "Offering Costs Policy [Text Block]" } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Formation and operating costs", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r81", "r452", "r619", "r620", "r621", "r622", "r623" ] }, "BOWN_OrdinarySharesParValue0.0001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "OrdinarySharesParValue0.0001PerShareMember", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares, par value $0.0001 per share" } } }, "auth_ref": [] }, "BOWN_OrdinarySharesSubjectToRedemption": { "xbrltype": "sharesItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "OrdinarySharesSubjectToRedemption", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares subject to redemption", "documentation": "Ordinary shares subject to redemption." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperations" ], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND BUSINESS OPERATIONS", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r38", "r73", "r344", "r345" ] }, "us-gaap_OtherNonoperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingExpense", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total other expense", "label": "Other Nonoperating Expense", "documentation": "Amount of expense related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r57" ] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income", "label": "Other Nonoperating Income", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r115" ] }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpenseAbstract", "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other expense:" } } }, "auth_ref": [] }, "us-gaap_OtherOwnershipInterestsOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOwnershipInterestsOfferingCosts", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Other offering costs", "label": "Other Ownership Interests, Offering Costs", "documentation": "The cumulative amount of offering costs allocated to the other unit holders." } } }, "auth_ref": [ "r71" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r554" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other receivable", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r501" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r518", "r529", "r543", "r569" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r521", "r532", "r546", "r572" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r521", "r532", "r546", "r572" ] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OverAllotmentOptionMember", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Over-Allotment Option [Member]", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "BOWN_OwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "OwnershipPercentage", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Ownership percentage", "documentation": "Ownership percentage." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r550" ] }, "BOWN_PayableToTargetCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PayableToTargetCompany", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Payable to target company", "documentation": "Payable to target company" } } }, "auth_ref": [] }, "us-gaap_PaymentForAdministrativeFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentForAdministrativeFees", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Administration fee", "documentation": "Amount paid to managing member or general partner, affiliate of managing member or general partner, or affiliate of limited liability company (LLC) or limited partnership (LP) for administrative services provided to the LLC or LP, for example, but not limited to, salaries, rent, or overhead costs." } } }, "auth_ref": [ "r605", "r648" ] }, "BOWN_PaymentOfOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PaymentOfOfferingCosts", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of offering costs", "documentation": "Payment of offering costs.", "label": "PaymentOfOfferingCosts" } } }, "auth_ref": [] }, "us-gaap_PaymentsForFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForFees", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Nasdaq entry fee", "verboseLabel": "Total", "documentation": "Amount of cash outflow for fees classified as other." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsForUnderwritingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForUnderwritingExpense", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash underwriting fees", "verboseLabel": "Payments for underwriting expense", "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction cost", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r12" ] }, "BOWN_PaymentsOfUnderwritersDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PaymentsOfUnderwritersDiscount", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of underwriter\u2019s discount", "documentation": "Payments of underwriter\u2019s discount.", "label": "PaymentsOfUnderwritersDiscount" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireOtherInvestments", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Investments of cash into Trust Account", "label": "Payments to Acquire Other Investments", "documentation": "Amount of cash outflow to acquire investments classified as other." } } }, "auth_ref": [ "r58" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r553" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r553" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r552" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r555" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r551" ] }, "BOWN_PercentageOfGrossProceedsOfInitialPublicOffering": { "xbrltype": "percentItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PercentageOfGrossProceedsOfInitialPublicOffering", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of gross proceeds of initial public offering", "documentation": "Percentage of gross proceeds of initial public offering." } } }, "auth_ref": [] }, "BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable": { "xbrltype": "percentItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PercentageOfServiceFeeOfTotalConsiderationPayable", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of service fee of total consideration payable", "documentation": "Percentage of service fee of total consideration payable." } } }, "auth_ref": [] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r552" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r495" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r497" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r47", "r190" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r47", "r381" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r47", "r190" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r47", "r381", "r399", "r665", "r666" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r47", "r326", "r475" ] }, "us-gaap_PreferredStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockVotingRights", "presentation": [ "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock voting rights", "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r23", "r47" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r106", "r160", "r161", "r449" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrivatePlacementMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "BOWN_PrivatePlacementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PrivatePlacementsTextBlock", "presentation": [ "http://bowenspac.com/role/PrivatePlacements" ], "lang": { "en-us": { "role": { "label": "PRIVATE PLACEMENTS", "documentation": "Private Placements [Text Block]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of IPO", "verboseLabel": "Public offering proceeds", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of ordinary shares", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r1" ] }, "BOWN_ProceedsFromIssuanceOfFounderShares": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "ProceedsFromIssuanceOfFounderShares", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of founder shares", "documentation": "Proceeds from issuance of founder shares." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from promissory note", "documentation": "Amount of cash inflow from issuance of long-term debt classified as other." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Private Placement", "verboseLabel": "Gross proceeds", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds allocated to public rights", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r1", "r351" ] }, "us-gaap_ProceedsFromOtherEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromOtherEquity", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Over-allotment proceeds", "documentation": "Amount of cash inflow from the issuance of equity classified as other." } } }, "auth_ref": [ "r1" ] }, "BOWN_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "PromissoryNoteMember", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]", "documentation": "Promissory Note [Member]" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r550" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r550" ] }, "BOWN_QianzhiMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "QianzhiMember", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Qianzhi [Member]", "documentation": "Qianzhi [Member]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r171", "r172", "r173", "r174", "r204", "r212", "r235", "r236", "r237", "r240", "r279", "r317", "r318", "r319", "r336", "r337", "r343", "r371", "r372", "r432", "r435", "r436", "r437", "r438", "r446", "r447", "r455", "r461", "r467", "r470", "r471", "r472", "r473", "r476", "r479", "r631", "r635", "r641", "r654", "r655", "r656", "r657", "r658" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r171", "r172", "r173", "r174", "r204", "r212", "r235", "r236", "r237", "r240", "r279", "r317", "r318", "r319", "r336", "r337", "r343", "r371", "r372", "r432", "r435", "r436", "r437", "r438", "r446", "r447", "r455", "r461", "r467", "r470", "r471", "r472", "r473", "r476", "r479", "r631", "r635", "r641", "r654", "r655", "r656", "r657", "r658" ] }, "BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "ReclassificationOfOrdinarySharesSubjectToRedemption", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Reclassification of ordinary shares subject to redemption", "documentation": "Reclassification of ordinary shares subject to redemption." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r513", "r524", "r538", "r564" ] }, "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Ordinary shares subject to possible redemption", "periodEndLabel": "Ordinary shares subject to possible redemption", "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount", "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form." } } }, "auth_ref": [ "r21", "r22", "r67", "r68" ] }, "BOWN_RedeemableOrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "RedeemableOrdinarySharesMember", "presentation": [ "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Redeemable Ordinary Shares [Member]", "documentation": "Redeemable Ordinary Shares [Member]" } } }, "auth_ref": [] }, "BOWN_RedeemableSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "RedeemableSharesMember", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Redeemable Shares [Member]", "documentation": "Redeemable Shares [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesTables", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r156", "r211", "r306", "r307", "r324", "r331", "r374", "r375", "r376", "r377", "r378", "r398", "r400", "r431" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r122", "r123", "r306", "r307", "r308", "r309", "r324", "r331", "r374", "r375", "r376", "r377", "r378", "r398", "r400", "r431" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r35", "r306" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesTables", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r156", "r405", "r406", "r409" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesTables", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r156", "r211", "r306", "r307", "r324", "r331", "r374", "r375", "r376", "r377", "r378", "r398", "r400", "r431", "r650" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://bowenspac.com/role/RelatedParties" ], "lang": { "en-us": { "role": { "label": "RELATED PARTIES", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r303", "r304", "r305", "r307", "r310", "r356", "r357", "r358", "r407", "r408", "r409", "r428", "r430" ] }, "BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Remeasurement adjustment on ordinary shares subject to possible redemption", "documentation": "Remeasurement adjustment on ordinary shares subject to possible redemption." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://bowenspac.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments to related party", "label": "Related party debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r59" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r514", "r525", "r539", "r565" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r515", "r526", "r540", "r566" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r522", "r533", "r547", "r573" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained earnings (Accumulated deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r50", "r70", "r329", "r341", "r342", "r355", "r382", "r475" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r96", "r124", "r125", "r126", "r128", "r133", "r135", "r137", "r158", "r159", "r167", "r249", "r250", "r251", "r252", "r253", "r255", "r257", "r258", "r264", "r266", "r267", "r269", "r271", "r300", "r301", "r338", "r340", "r359", "r665" ] }, "BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company\u0092s initial business combination" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r582" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r582" ] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockDescriptionOfTransaction", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock holders equity related to initial public offering description", "verboseLabel": "Units related to private placement description", "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination." } } }, "auth_ref": [ "r7", "r31", "r74" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock issued", "verboseLabel": "Stock issued during the period, shares", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Price per share", "verboseLabel": "Sale of stock, par share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r259" ] }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS", "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r603", "r612" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/BalanceSheetsParenthetical", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r6", "r24", "r25", "r26", "r27" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r618" ] }, "BOWN_ScheduleOfExpensesIncurredAndPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "ScheduleOfExpensesIncurredAndPayableTableTextBlock", "presentation": [ "http://bowenspac.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EXPENSES INCURRED AND PAYABLES", "documentation": "Schedule of Expenses Incurred and Payable [Table Text Block]" } } }, "auth_ref": [] }, "BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET", "documentation": "Schedule Of Ordinary Shares Subject To Possible Redemption Reflected In The Balance Sheet [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesTables", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r34", "r35", "r405", "r406", "r409" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r489" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r493" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r492" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r498" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails", "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "verboseLabel": "Fair value of ordinary per share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssued", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares transferred", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r8" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unit exercise price per share", "verboseLabel": "Ordinary share price", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares Subject to Possible Redemption", "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r40", "r628", "r629", "r630" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r39", "r628", "r629", "r630" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r63", "r118" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r496" ] }, "BOWN_SponsorsMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "SponsorsMember", "presentation": [ "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sponsors [Member]", "documentation": "Sponsors [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://bowenspac.com/role/Cover", "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r88", "r103", "r104", "r105", "r121", "r140", "r141", "r143", "r145", "r150", "r151", "r157", "r175", "r177", "r178", "r179", "r182", "r183", "r190", "r191", "r193", "r196", "r202", "r290", "r351", "r352", "r353", "r354", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r381", "r402", "r424", "r439", "r440", "r441", "r442", "r443", "r602", "r608", "r617" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfExpensesIncurredAndPayablesDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r48", "r51", "r52", "r96", "r111", "r112", "r113", "r124", "r125", "r126", "r128", "r133", "r135", "r137", "r149", "r158", "r159", "r167", "r203", "r249", "r250", "r251", "r252", "r253", "r255", "r257", "r258", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r291", "r292", "r293", "r294", "r295", "r296", "r300", "r301", "r302", "r333", "r338", "r339", "r340", "r359", "r424" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://bowenspac.com/role/Cover", "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r124", "r125", "r126", "r149", "r301", "r320", "r346", "r370", "r373", "r374", "r375", "r376", "r377", "r378", "r381", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r400", "r403", "r404", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r480" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://bowenspac.com/role/Cover", "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r124", "r125", "r126", "r149", "r156", "r301", "r320", "r346", "r370", "r373", "r374", "r375", "r376", "r377", "r378", "r381", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r400", "r403", "r404", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r480" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r517", "r528", "r542", "r568" ] }, "BOWN_StockIssuedDuringPeriodSharesInitialMeasurementOfOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodSharesInitialMeasurementOfOrdinaryShares", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares", "documentation": "Stock issued during period shares initial measurement of ordinary shares." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of ordinary shares to Underwriter, shares", "verboseLabel": "Number of stock issued", "terseLabel": "Stock issued during period shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r47", "r48", "r70", "r351", "r424", "r440" ] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of ordinary shares to Sponsor, shares", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits": { "xbrltype": "sharesItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Over-allotment of Private Units, shares", "documentation": "Stock issued during period shares overallotment of private units." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment": { "xbrltype": "sharesItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodSharesProceedsFromOverallotment", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Proceeds from over-allotment, shares", "documentation": "Stock issued during period shares proceeds from overallotment." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits": { "xbrltype": "sharesItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of public units, shares", "documentation": "Stock issued during period shares proceeds from sale of public units." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits": { "xbrltype": "sharesItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodSharesSaleOfPrivateUnits", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Sale of Private Units, shares", "documentation": "Stock issued during period shares sale of private units." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "presentation": [ "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares subject to forfeiture", "documentation": "Number of shares (or other type of equity) forfeited during the period." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodValueInitialMeasurementOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodValueInitialMeasurementOfOrdinaryShares", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital", "documentation": "Stock issued during period value initial measurement of ordinary shares." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of ordinary shares to Underwriter", "verboseLabel": "Proceeds allocated to Public Rights", "terseLabel": "Value of stock issued", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r47", "r48", "r70", "r359", "r424", "r440", "r486" ] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of ordinary shares to Sponsors", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Over-allotment of Private Units", "documentation": "Stock issued during period value over-allotment of Private Units." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodValueProceedsFromOverallotment", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Proceeds from over-allotment", "documentation": "Stock issued during period value proceeds from over-allotment." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of public units", "documentation": "Stock issued during period value proceeds from sale of public units." } } }, "auth_ref": [] }, "BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "StockIssuedDuringPeriodValueSaleOfPrivateUnits", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Sale of Private Units", "documentation": "Stock issued during period value sale of private units." } } }, "auth_ref": [] }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRedeemedOrCalledDuringPeriodShares", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock issued, shares", "documentation": "Number of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRedeemedOrCalledDuringPeriodValue", "crdr": "debit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock issued, value", "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders\u2019 Equity (Deficit)", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r48", "r51", "r52", "r64", "r383", "r399", "r425", "r426", "r475", "r487", "r609", "r625", "r643", "r665" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://bowenspac.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r69", "r120", "r189", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r203", "r270", "r427", "r429", "r444" ] }, "us-gaap_SubsequentEventDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventDescription", "presentation": [ "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent descripition", "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued." } } }, "auth_ref": [ "r36" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r297", "r312" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r297", "r312" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r297", "r312" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r297", "r312" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r297", "r312" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://bowenspac.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r311", "r313" ] }, "BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionExtensionDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionExtensionDeposit", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/StatementsOfCashFlows", "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Subsequent measurement of Common stock subject to possible redemption (extension deposit)", "label": "Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)", "verboseLabel": "Ordinary shares subject to possible redemption", "documentation": "Subsequent measurement of common stock subject to possible redemption extension deposit." } } }, "auth_ref": [] }, "BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)", "documentation": "Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)." } } }, "auth_ref": [] }, "BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)", "verboseLabel": "Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account", "documentation": "Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account)." } } }, "auth_ref": [] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]", "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r561" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://bowenspac.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://bowenspac.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Ordinary shares subject to possible redemption, 6,900,000 shares at redemption value of $10.98 and $10.35 per share as of December 31, 2024 and 2023, respectively", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r175", "r177", "r178", "r179", "r182", "r183", "r239", "r328" ] }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TemporaryEquityParOrStatedValuePerShare", "presentation": [ "http://bowenspac.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Ordinary shares redemption value per share", "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable." } } }, "auth_ref": [ "r10", "r20" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]", "documentation": "Information by title and position of individual or group within organization." } } }, "auth_ref": [ "r624", "r649" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative", "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative", "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Title and position of individual or group within organization." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r553" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r560" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r584" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r585" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r585" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r583" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r583" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r584" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://bowenspac.com/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r259" ] }, "BOWN_UnderwritersMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "UnderwritersMember", "presentation": [ "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriters [Member]", "documentation": "Underwriters [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r580" ] }, "BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember": { "xbrltype": "domainItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Units, each consisting of one ordinary share and one right" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized tax benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r241", "r244", "r468" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r17", "r18", "r19", "r83", "r84", "r86", "r87" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted weighted average ordinary shares outstanding", "verboseLabel": "Weighted average shares outstanding - diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r139", "r145" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://bowenspac.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic weighted average ordinary shares outstanding", "verboseLabel": "Weighted average shares outstanding - basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r138", "r145" ] }, "BOWN_WorkingCapitalDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://bowenspac.com/20241231", "localname": "WorkingCapitalDeficit", "crdr": "credit", "presentation": [ "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital", "documentation": "Working capital deficit." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://bowenspac.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r600" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "855", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 3.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(14)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(15)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r451": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r452": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r453": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r454": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r455": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r456": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r457": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r458": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r459": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r460": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r461": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r462": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r465": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r466": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r467": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r468": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217" }, "r469": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r470": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r471": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r472": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r473": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r474": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r475": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r476": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r477": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r479": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r486": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r487": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r489": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r490": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r492": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r494": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r500": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r501": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r502": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r503": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r504": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r505": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r506": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r507": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r508": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r509": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r510": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r511": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r512": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "ii" }, "r513": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r514": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r515": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r516": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r517": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r518": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r519": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r520": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r521": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r522": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r523": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r524": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r525": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r526": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r527": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r528": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r529": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r530": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r531": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r532": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r533": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r534": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 6-K", "Section": "General Instruction", "Subsection": "B" }, "r535": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05" }, "r536": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "Instruction", "Paragraph": "2" }, "r537": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "a" }, "r538": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r545": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r546": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r547": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r548": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r559": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r560": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r561": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r562": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r563": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r564": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r565": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r566": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r567": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r590": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r591": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r592": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r593": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "ii" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-X", "Number": "210", "Section": "2", "Subsection": "2" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r602": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 5.D.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-4" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 55 0001641172-25-004916-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001641172-25-004916-xbrl.zip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ə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form10-k_htm.xml IDEA: XBRL DOCUMENT 0001973056 2024-01-01 2024-12-31 0001973056 BOWN:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2024-01-01 2024-12-31 0001973056 BOWN:OrdinarySharesParValue0.0001PerShareMember 2024-01-01 2024-12-31 0001973056 BOWN:RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember 2024-01-01 2024-12-31 0001973056 2024-06-28 0001973056 2025-04-15 0001973056 2024-10-01 2024-12-31 0001973056 2024-12-31 0001973056 2023-12-31 0001973056 us-gaap:NonrelatedPartyMember 2024-12-31 0001973056 us-gaap:NonrelatedPartyMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember 2023-12-31 0001973056 2023-02-17 2023-12-31 0001973056 BOWN:RedeemableOrdinarySharesMember 2024-01-01 2024-12-31 0001973056 BOWN:RedeemableOrdinarySharesMember 2023-02-17 2023-12-31 0001973056 BOWN:NonRedeemableOrdinarySharesMember 2024-01-01 2024-12-31 0001973056 BOWN:NonRedeemableOrdinarySharesMember 2023-02-17 2023-12-31 0001973056 us-gaap:CommonStockMember 2023-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001973056 us-gaap:RetainedEarningsMember 2023-12-31 0001973056 us-gaap:CommonStockMember 2023-02-16 0001973056 us-gaap:AdditionalPaidInCapitalMember 2023-02-16 0001973056 us-gaap:RetainedEarningsMember 2023-02-16 0001973056 2023-02-16 0001973056 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001973056 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001973056 us-gaap:CommonStockMember 2023-02-17 2023-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2023-02-17 2023-12-31 0001973056 us-gaap:RetainedEarningsMember 2023-02-17 2023-12-31 0001973056 us-gaap:CommonStockMember 2024-12-31 0001973056 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001973056 us-gaap:RetainedEarningsMember 2024-12-31 0001973056 us-gaap:NonrelatedPartyMember 2024-01-01 2024-12-31 0001973056 us-gaap:NonrelatedPartyMember 2023-02-17 2023-12-31 0001973056 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0001973056 us-gaap:RelatedPartyMember 2023-02-17 2023-12-31 0001973056 us-gaap:IPOMember 2023-07-14 2023-07-14 0001973056 us-gaap:IPOMember 2023-07-14 0001973056 us-gaap:PrivatePlacementMember 2023-07-14 2023-07-14 0001973056 us-gaap:PrivatePlacementMember 2023-07-14 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-17 2023-07-17 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-18 2023-07-18 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-18 0001973056 us-gaap:PrivatePlacementMember 2023-07-18 2023-07-18 0001973056 us-gaap:IPOMember 2023-07-18 2023-07-18 0001973056 us-gaap:IPOMember 2023-07-18 0001973056 2024-10-07 0001973056 BOWN:EarlyBirdCapitalMember 2024-10-07 0001973056 us-gaap:SubsequentEventMember 2025-01-10 2025-01-10 0001973056 us-gaap:SubsequentEventMember 2025-01-10 0001973056 us-gaap:SubsequentEventMember 2025-01-14 2025-01-14 0001973056 us-gaap:SubsequentEventMember 2025-04-14 2025-04-14 0001973056 us-gaap:SubsequentEventMember 2025-04-14 0001973056 BOWN:MergerSharesMember BOWN:AgreementMember 2024-01-18 2024-01-18 0001973056 srt:MaximumMember BOWN:EarnoutSharesMember BOWN:AgreementMember 2024-01-18 2024-01-18 0001973056 BOWN:RedeemableSharesMember 2024-01-01 2024-12-31 0001973056 BOWN:NonRedeemableSharesMember 2024-01-01 2024-12-31 0001973056 BOWN:RedeemableSharesMember 2023-02-17 2023-12-31 0001973056 BOWN:NonRedeemableSharesMember 2023-02-17 2023-12-31 0001973056 us-gaap:IPOMember 2024-01-01 2024-12-31 0001973056 us-gaap:IPOMember 2024-12-31 0001973056 us-gaap:IPOMember 2023-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2024-01-01 2024-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2024-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2023-12-31 0001973056 us-gaap:OverAllotmentOptionMember 2023-07-14 2023-07-14 0001973056 BOWN:QianzhiMember 2024-01-01 2024-12-31 0001973056 BOWN:SponsorsMember us-gaap:PrivatePlacementMember 2023-07-14 2023-07-14 0001973056 BOWN:EBCMember us-gaap:PrivatePlacementMember 2023-07-14 2023-07-14 0001973056 BOWN:UnderwritersMember us-gaap:PrivatePlacementMember 2023-07-14 2023-07-14 0001973056 BOWN:SponsorsMember 2023-02-27 2023-02-27 0001973056 BOWN:SponsorsMember us-gaap:OverAllotmentOptionMember 2023-02-27 2023-02-27 0001973056 BOWN:EBCMember 2023-03-15 2023-03-15 0001973056 BOWN:EBCMember 2023-03-15 0001973056 BOWN:SponsorsMember 2024-10-14 2024-10-14 0001973056 BOWN:EBCFounderSharesMember 2024-10-14 0001973056 BOWN:SponsorsMember BOWN:PromissoryNoteMember 2023-02-27 0001973056 BOWN:SponsorsMember BOWN:PromissoryNoteMember 2023-02-27 2023-02-27 0001973056 BOWN:EBCFounderSharesMember 2024-12-31 0001973056 srt:MaximumMember us-gaap:OverAllotmentOptionMember 2024-01-01 2024-12-31 0001973056 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RelatedPartyMember 2024-12-31 0001973056 BOWN:AccountingServicesExpenseMember us-gaap:RelatedPartyMember 2024-12-31 0001973056 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RelatedPartyMember 2023-12-31 0001973056 BOWN:AccountingServicesExpenseMember us-gaap:RelatedPartyMember 2023-12-31 0001973056 BOWN:AccountingServiceAgreementAndOtherMember 2023-02-17 2023-12-31 0001973056 srt:MaximumMember BOWN:SponsorsMember 2023-07-11 2023-07-11 0001973056 BOWN:EBCFounderSharesMember 2024-01-01 2024-12-31 0001973056 BOWN:FounderSharesMember 2024-01-01 2024-12-31 0001973056 2023-03-15 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-15 0001973056 us-gaap:FairValueInputsLevel3Member BOWN:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember 2023-03-15 0001973056 BOWN:FounderSharesMember 2024-10-14 0001973056 2024-10-14 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2024-10-14 0001973056 us-gaap:FairValueInputsLevel3Member BOWN:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember 2024-10-14 0001973056 us-gaap:RelatedPartyMember BOWN:InitialAccountingServiceFeeMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:InitialAccountingServiceFeeMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AccountingServiceFeeAndOthersMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AccountingServiceFeeAndOthersMember 2023-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AdministrationFeeMember 2024-12-31 0001973056 us-gaap:RelatedPartyMember BOWN:AdministrationFeeMember 2023-12-31 0001973056 BOWN:BusinessCombinationMarketingAgreementMember 2024-01-01 2024-12-31 0001973056 BOWN:BusinessCombinationMarketingAgreementMember 2024-12-31 0001973056 BOWN:QianzhiMember 2024-01-01 2024-12-31 0001973056 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001973056 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001973056 us-gaap:SubsequentEventMember 2025-01-13 2025-01-13 0001973056 us-gaap:SubsequentEventMember 2025-03-19 iso4217:USD shares iso4217:USD shares pure false FY 0001973056 00-0000000 10-K true 2024-12-31 --12-31 2024 false 001-41741 BOWEN ACQUISITION CORP E9 420 Lexington Ave Suite 2446 New York NY 10170 (203) 998-5540 Units, each consisting of one ordinary share and one right BOWNU NASDAQ Ordinary Shares, par value $0.0001 per share BOWN NASDAQ Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination BOWNR NASDAQ No No Yes Yes Non-accelerated Filer true true false false false true 74900000 3010973 0.0001 The information contained in the registrant’s definitive proxy statement/prospectus dated December 18, 2024, as filed with the Securities and Exchange Commission on such date, pursuant to Rule 424(b)(3) (SEC File No. 333-282021) is incorporated into certain portions of Parts I, II, and III, as disclosed herein. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>We are a blank check company with no business operations. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zNd7DfIGHX6e">Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable target businesses for a business combination. Therefore, we do not consider that we face significant cybersecurity risk. Nevertheless, we employ various procedures designed to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zrBNPm6KPWXi">identify, protect, detect and respond</span> to and manage reasonably foreseeable cybersecurity risks and threats given our limited operations.</span> These include, but are not limited to, internal reporting, monitoring and detection tools and anti-virus software. We also periodically assess risks from cybersecurity and technology threats and monitor our information systems for potential vulnerabilities, including those that could arise from internal sources and external sources such as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zf5O27idch0c">third-party service providers</span> we do business with.</span></span><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To date, we have not experienced any cybersecurity attacks. However, any such attack could adversely affect our business. Further, a penetration of our systems or a third-party’s systems or other misappropriation or misuse of personal information could subject us to business, regulatory, litigation and reputation risk, which could have a negative effect on our business, financial condition and results of operations.</span></p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span> </span></span><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20240101__20241231_zux014dXJpF4">The Audit Committee of the Board oversees our cybersecurity risk and receives regular reports from our management team on various potential cybersecurity matters, including areas of emerging risks, incidents and industry trends, and other areas of importance.</span> We may in the future engage an assessor(s), consultant(s), auditor(s) or other third party(s) to supplement our existing cybersecurity processes.</span></p>   Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable target businesses for a business combination. Therefore, we do not consider that we face significant cybersecurity risk. Nevertheless, we employ various procedures designed to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zrBNPm6KPWXi">identify, protect, detect and respond</span> to and manage reasonably foreseeable cybersecurity risks and threats given our limited operations. true true The Audit Committee of the Board oversees our cybersecurity risk and receives regular reports from our management team on various potential cybersecurity matters, including areas of emerging risks, incidents and industry trends, and other areas of importance. false false false false 1195 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have audited the accompanying consolidated balance sheets of Bowen Acquisition Corp and its wholly owned subsidiary (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of operations, changes in shareholders’ equity (deficit), and cash flows for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) to December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements presents fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) to December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span> UHY LLP New York, New York 103774 426913 138046 12239 79481 254059 506394 75794241 71419358 76048300 71925752 309004 78610 101285 25250 101285 25250 122174 0 377826 190000 75000 1053115 103860 1053115 103860 6900000 6900000 10.98 10.35 75794241 71419358 0.0001 0.0001 2000000 2000000 0 0 0 0 0.0001 0.0001 200000000 200000000 2266500 2266500 2266500 2266500 6900000 6900000 227 227 -799283 402307 -799056 402534 76048300 71925752 633764 244568 -633764 -244568 3684883 1729358 3684883 1729358 87267 87267 2963852 1484790 6900000 6900000 3819156 3819156 0.48 0.48 1.12 1.12 2266500 2266500 2095943 2095943 -0.15 -0.15 -1.32 -1.32 2266500 227 402307 402534 -209442 -3475442 -3684884 690000 690000 209442 209442 2963852 2963852 2266500 227 -799283 -799056 1725000 173 24827 25000 180000 18 1015982 1016000 6000000 600 59999400 60000000 900000 90 8999910 9000000 330000 33 3299967 3300000 31500 3 314997 315000 -1500000 -1500000 -225000 -225000 -1593898 -1593898 -6900000 -690 -65235677 -65236367 3137867 3137867 -7591500 -7591500 -646875 -1082483 -1729358 1484790 1484790 2266500 227 402307 402534 2266500 227 402307 402534 2963852 1484790 3684883 1729358 87267 161565 6714 75780 25250 75780 25250 -73280 79481 -323139 -292085 69690000 690000 -690000 -69690000 500000 190000 2520 69000000 3615000 1725000 151318 332204 690000 70408998 -323139 426913 426913 103774 426913 3684883 1729358 690000 75000 894 209442 25000 1593898 65236367 3137868 7591500 <p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z4K0XaVtqVAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>NOTE 1 - <span id="xdx_823_zqMvuibklXa6">ORGANIZATION AND BUSINESS OPERATIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i>Organizational and General</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Bowen Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”).The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company’s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership (the “Sponsors”). As of December 31, 2024, the Company had not commenced any operations. All activities for the period from February 17, 2023 (inception) through December 31, 2024 relate to the Company’s formation, the initial public offering (“IPO”) and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company is generating non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on July 11, 2023. On July 14, 2023, the Company consummated the IPO of <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFV7cL0pNVue" title="Number of shares sold">6,000,000</span> of its units (“Public Units”). Each Public Unit consists of one ordinary share, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ztlngWYHWHz7" title="Ordinary shares, par value">0.0001</span> par value (“Ordinary Shares”), of the Company and one right (“Rights”), each Right entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company’s initial business combination. The Public Units were sold at an offering price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zULnXhk7wvka" title="Sale of stock, par share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1PnViHWraC7" title="Proceeds from issuance of IPO">60,000,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Simultaneously with the consummation of the IPO, the Company consummated the private placement (“Private Placement”) of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zysN3FVs6Pfb" title="Stock issued during period shares">330,000</span> units (“Private Placement Units”) at a price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvVDgES4PZje" title="Price per share">10.00</span> per Private Placement Unit, generating total proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVJ3RmiiZ2T8" title="Proceeds from issuance of private placement">3,300,000</span>. The Private Placement Units were purchased by Createcharm Holdings Ltd, one of the Company’s sponsors, and EarlyBirdCapital, Inc. (“EBC”), the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion of the Company’s initial Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXdrG8rt7qyi" title="Stock issued during period shares">900,000</span> Units. As a result, on July 18, 2023, the Company sold an additional <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zUFQOKFHoJ69" title="Number of stock issued">900,000</span> Units at $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zk28h2m5IcP7" title="Price per share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zf4Lnb8jve05" title="Gross proceeds">9,000,000</span>. In connection with this sale, Createcharm Holdings Ltd. and EBC also purchased an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zyHEi85ykHEk" title="Ordinary shares issued to underwriter, shares">31,500</span> Private Placement Units from the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of July 18, 2023, transaction costs amounted to $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxSMGRGQZSkj" title="Transaction cost">3,318,898</span> consisting of $<span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMcXrfmVMfwa" title="Cash underwriting fees">1,725,000</span> of cash underwriting fees and $<span id="xdx_908_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z97VYYfHB7if" title="Other offering costs">1,593,898</span> of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon completion of the IPO.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company will have until 18 months from the closing of the IPO to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period and shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay the Company’s taxes, if any (less certain amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 20, 2023, a wholly-owned subsidiary of the Company, Bowen Merger Sub (“Merger Sub”) was formed for the purpose of entering into a business combination agreement. See “Proposed Business Combination” below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Effective as of October 7, 2024, the Company notified the trustee of the Trust Account that it was extending the time to consummate an initial Business Combination from October 14, 2024 to January 14, 2025. Effective as of October 14, 2024, Shenzhen Qianzhi (as defined below) and EBC, two designees of the Sponsors, loaned the Company an aggregate of $<span id="xdx_901_eus-gaap--Deposits_iI_c20241007_zEh2J0bJzPzb" title="Deposit into trust account">690,000</span>, which funds were deposited into the Trust Account for such extension. The loans are evidenced by promissory notes (the “Notes”) issued by the Company to the designees. The Notes bear no interest and are repayable in full upon consummation of a Business Combination. In connection with the loans, one of the Sponsors transferred <span id="xdx_90E_eus-gaap--SharesIssued_iI_c20241007__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EarlyBirdCapitalMember_zd8a0FVRTvk4" title="Number of shares transferred">30,000</span> of its Founder Shares to EBC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="background-color: white">The Company had called an extraordinary general meeting (the “Extension Meeting”) for January 10, 2025 to approve, by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”), by up to three one-month increments, from January 14, 2025 to as late as April 14, 2025, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. In connection with the meeting, an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250110__20250110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZVoOnRd02E7" title="Stock issued during period, shares">6,052,095</span> Public Shares were redeemed at a price of approximately $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20250110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z53EHnIpVnUh" title="Share price">10.99</span> per share. Following the redemptions, the Company has <span id="xdx_907_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250110__20250110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVLKAvgkHso2" title="Number of stock issued, shares">847,905</span> Public Shares, and approximately $<span id="xdx_904_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20250110__20250110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7RKsn2O3a58" title="Number of stock issued, value">9,319,<span style="background-color: white">446</span></span> remaining in Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="background-color: white">On January 14, 2025, the Company held another extraordinary general meeting to approve the business combination with Qianzhi (as defined below). At the meeting, all proposals were approved by shareholders. An aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250114__20250114__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zthGglCKqaeg" title="Number of stock issued">137,936</span> Public Shares requested redemption in connection with such vote. However, as the business combination has not been consummated, none of such shares has been redeemed. <span style="background-color: white">As of the filing date, since the business combination has not been consummated, none of such shares have been redeemed</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250414__20250414__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWednCsC7cN6" title="Number of stock issued">103,432</span> Public Shares were redeemed at a price of approximately $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20250414__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2fC9ZCDjLFl" title="Share price">11.03</span> per share. Following the redemptions, the Company has <span id="xdx_901_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250414__20250414__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOnwtvcg5YA2" title="Number of stock issued, shares">744,473</span> Public Shares, and approximately $<span id="xdx_905_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20250414__20250414__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcwBuw3pOQm7" title="Number of stock issued, value">8,211,537</span> remaining in Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b><i>Proposed Business Combination</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the “Agreement”) with (i) Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (“Merger Sub”), (ii) Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People’s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (“Shenzhen Qianzhi”or “Qianzhi”), and (iii) Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (“<span style="text-decoration: underline">NewCo</span>,” and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the “<span style="text-decoration: underline">Parties</span>”, each a “<span style="text-decoration: underline">Party</span>”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pursuant to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the “<span style="text-decoration: underline">Merger</span>”), with NewCo being the surviving company of the Merger (“<span style="text-decoration: underline">Surviving Company</span>”) and becoming a wholly owned subsidiary of the Company. In the Merger, the holders (the “NewCo Shareholders”) of the ordinary shares of NewCo (“NewCo Ordinary Shares”) will receive ordinary shares of the Company (“Parent Ordinary Shares”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pursuant to the Agreement, at the effective time of the Merger (the “Effective Time”), all of NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_znD5pkkU5Slj" title="Number of stock issued">7,246,377 </span>Parent Ordinary Shares (the “Merger Shares”), and (b) the right to receive earnout consideration of up to an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zvPUPdKtkoS5" title="Number of stock issued">1,400,000</span> Parent Ordinary Shares (the “Earnout Shares”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company’s Registration Statement on Form S-4 (“S-4”) was declared effective on December 18, 2024. As of the filing date, the business combination remained pending, awaiting required regulatory approvals.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i>Going Concern Consideration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of December 31, 2024, the Company had cash and cash equivalent of $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20241231_zeaSdCcSSvA5" title="Cash and cash equivalent">103,774</span> and a working capital deficit of $<span id="xdx_90D_ecustom--WorkingCapitalDeficit_iI_c20241231_zuLKrNsDq7Y7" title="Working capital">799,056</span>. The Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. Management expects to obtain additional funds from related parties to provide the additional working capital necessary to carry out its objective to consummate a business combination. The consolidated financial statement does not include any adjustments that might result from the outcome of the uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> 6000000 0.0001 10.00 60000000 330000 10.00 3300000 900000 900000 10.00 9000000 31500 3318898 1725000 1593898 690000 30000 6052095 10.99 847905 9319 137936 103432 11.03 744473 8211537 7246377 1400000 103774 799056 <p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zhA3lqIBM57g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b>NOTE 2 - <span id="xdx_825_zEvWxxSNOt5f">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzDWTneI3EXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_86A_znICnkpTptbl">Basis of Presentation and Principles of Consolidation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zbRXbwwcwm43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_869_zOuDDGdMcmEl">Emerging Growth Company</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--UseOfEstimates_zdrBNlKaFxnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_868_zDuJeSqOWjj">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zoMFPI2yN3wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_862_zanvcibydo1a">Cash and cash equivalents</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20241231_zPntbMIucFk5" title="Cash and cash equivalents">103,774</span> and $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zxryDYlBgj13" title="Cash and cash equivalents">426,913 </span>as of December 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_zwQKrcN6JPw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_861_zvjcaho8pkqd">Investments Held in Trust Account</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of December 31, 2024 and 2023, the Trust Account had balance of $<span id="xdx_90A_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20241231_zGXS6Ou3iL5a" title="Trust account balance">75,794,241</span> and $<span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zJPinm4d53Ni" title="Trust account balance">71,419,358</span>, respectively. The interest and dividend income earned from the Trust Account totaled $<span id="xdx_903_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20241231_zNyEdcprCWWf" title="Interests earned from trust account">3,684,883</span> and $<span id="xdx_90D_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20230217__20231231_z515QFDpjICl" title="Interest and dividend income earned from trust account">1,729,358</span> for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) through December 31, 2023, respectively, which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_84B_ecustom--OfferingCostsPolicyTextBlock_zkb0jpuYqSr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_863_zhxqih77B8Q1">Offering Costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Offering costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on July 14, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_84B_ecustom--InterestExpensesPolicyTextBlock_z2zFBsMTnm0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_86B_zVIH0586smYe">Interest Expenses</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Interest expense in 2024 is primarily from the amortization of the debt discount in connection with the promissory note issued by the Company to related party. See Note 5</span> - Related Parties for more information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zrcnbRbPgMOa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_866_ziSxscaeahYc">Amortization of Debt Discount</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company’s promissory note issued with related party is recorded net of debt discount which comprised issuance costs, and the discount initially recognized for the fair value of the shares transferred. The portion of the debt issuance costs allocated to the promissory note, is being amortized over the terms, which is upon consummation of the Business Combination. The amortization of debt issuance costs and discount is included in interest expense within the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"></p> <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zQ8sW8GQlC7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_867_zuiivAcBISI">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “<i>Income Taxes</i>.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zse9gv9D1F9l" title="Unrecognized tax benefits"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zagxnlRzv8Wl" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_90D_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20241231_ztbyjfgDUA3l" title="Interest and penalties accrued"><span id="xdx_908_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zZG6lUpTO9e" title="Interest and penalties accrued">no</span></span> amounts accrued for interest and penalties as of December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_z8Vww5P0FOai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_863_z8mlvJHKS51e">Net Income (Loss) per Ordinary Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The net income (loss) per share presented in the statements of operations is based on the following:</span></p> <p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zLHmK4HS4vDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_z0q1PfPZ1E2b" style="display: none">SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20240101__20241231_zHkZuLJTDCAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year</p> <p style="margin-top: 0; margin-bottom: 0">Ended<br/> December 31, 2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20230217__20231231_zcUDw52Bm8P3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Period</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>from<br/> February 17, 2023<br/> (Inception)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>Through</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--NetIncomeLoss_maNLIAOz8yg_zVObB206Kckl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,963,852</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,484,790</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz8yg_z2TibQ3IMON7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on investment held in Trust Account</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,684,883</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,729,358</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz8yg_zIJHV4UuEK48" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(690,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,591,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz8yg_zKUW9BSJ7lDd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,411,031</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,836,068</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zy6jQjmMwjMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zJsEhEY2b1sf" style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B0_z4ANMBSvVJK3" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z0GiEu7Y9L8i" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zEOwnnZTc702" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zD8p9HqcpzNd" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMDvO7uG3o73" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> <span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2024</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Period from<br/> February 17, 2023<br/> (Inception) Through</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted net income (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Weighted-average shares outstanding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zsxWIHMwiuzb" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVHni2KahKRl" title="Weighted average shares outstanding - diluted">6,900,000</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNEw6vE2bhEl" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCflkv6WhEyl" title="Weighted average shares outstanding - diluted">2,266,500</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdtPfAzhs4U1" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zWMkjcQhRMdg" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zblVC9k1Gbs7" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZg1dqXstfQ5" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ownership percentage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTJHz5kEuo1c" title="Ownership percentage">75</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zTQKBGHr4XN4" title="Ownership percentage">25</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzypNCzMb90d" title="Ownership percentage">65</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zR2RigqiKNMh" title="Ownership percentage">35</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Numerators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zTPo6SMloJ8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,062,141</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(348,890</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(5,059,453</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(2,776,615</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_z8SosdwYN8a1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion of temporary equity into redemption value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">690,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,591,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0673">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_zAtrCzi90M49" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Interest earned on Trust Account</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,684,883</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,729,358</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0678">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_zwGqGJa9IJqb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Allocation of net income (loss)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,312,742</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(348,890</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,261,405</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,776,615</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zf3aMhLR1lmh" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSvXVO6mcl1d" title="Weighted average shares outstanding - diluted">6,900,000</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMxjCR5kqalk" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ztyFahSCOeO" title="Weighted average shares outstanding - diluted">2,266,500</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOZlG1hvI6Le" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zEjkBA7uZnV4" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrnMCHOtq2m3" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOdYcOIFoA7" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQyfV4MR305l" title="Basic net income/(loss) per share"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zmHBPrrc5vXg" title="Diluted net income/(loss) per share">0.48</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zn8myMps81Vl" title="Basic net income/(loss) per share"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zE0RQHjQsQJ6" title="Diluted net income/(loss) per share">(0.15</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zUPgykvewTH8" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z4CiicYwzcz7" title="Diluted net income/(loss) per share">1.12</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYYhXJvMghBi" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zvZUNgj5D8M7" title="Diluted net income/(loss) per share">(1.32</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AB_zA3MeltYTkCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zRgdpkmJYvji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_86C_z9boLubmHE39">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20241231_ziqJYSvEQ40k" title="Cash, FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zte1dxL6vmf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_869_z2YL44pwuX07">Fair Value of Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “<i>Fair Value Measurement</i>,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_84F_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zgvTqC16o1bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_861_zMaqi9OWUGD9">Ordinary Shares Subject to Possible Redemption</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #212529"> </p> <p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zw2k7D0lC0Xh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="display: none"><span id="xdx_8B8_z9sDeMme6D9d">SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-size: 10pt">Public offering proceeds</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaAWhDeObJmk" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Public offering proceeds"><span style="font-size: 10pt">60,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Less:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Proceeds allocated to Public Rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zsAg58WAJsJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds allocated to public rights"><span style="font-size: 10pt">(3,272,724</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allocation of offering costs related to redeemable shares</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znVWt5L8FUbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Allocation of offering costs related to redeemable shares"><span style="font-size: 10pt">(2,925,140</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt">Accretion of carrying value to redemption value</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--AccretionOfCarryingValueToRedemptionValue_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziCJB7nafd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion of carrying value to redemption value"><span style="font-size: 10pt">6,797,864</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Ordinary shares subject to possible redemption</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvAcQ5kOw9ph" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt">60,600,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><i>Over-allotment</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Over-allotment proceeds</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ProceedsFromOtherEquity_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zIJqc2fOlLR5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Over-allotment proceeds"><span style="font-size: 10pt">9,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Less:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Proceeds allocated to Public Rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoMoeEPwD4wf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds allocated to Public Rights"><span style="font-size: 10pt">(490,909</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allocation of offering costs related to redeemable shares</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zuZSmNLjou4h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Allocation of offering costs related to redeemable shares"><span style="font-size: 10pt">(212,727</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Accretion of carrying value to redemption value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--AccretionOfCarryingValueToRedemptionValue_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoI80HtTHlXb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion of carrying value to redemption value"><span style="font-size: 10pt">793,636</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFczx95O9su7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"><span style="font-size: 10pt">1,729,358</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Ordinary shares subject to possible redemption, December 31, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>$</b></span></td> <td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zbamD9mXpmbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt"><b>71,419,358</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20241231_zXqFRookmhej" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account"><span style="font-size: 10pt">3,684,883</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_ecustom--SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionExtensionDeposit_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3lb7GbHuOfk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt">690,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Ordinary shares subject to possible redemption, December 31, 2024</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20241231_zvylAHtiledd" style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt"><b>75,794,241</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> </table> <p id="xdx_8AA_zIOqqb7zpxV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zif1TLbnWyce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_86C_zEatBHyEdu2j">Recent Accounting Standards</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance in ASU 2023-07 on January 1, 2024, and there is no significant impact on the disclosure of the consolidated financial statements. The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.</span></p> <p id="xdx_855_zuUz4TeEX1Za" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzDWTneI3EXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_86A_znICnkpTptbl">Basis of Presentation and Principles of Consolidation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zbRXbwwcwm43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_869_zOuDDGdMcmEl">Emerging Growth Company</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--UseOfEstimates_zdrBNlKaFxnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_868_zDuJeSqOWjj">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zoMFPI2yN3wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_862_zanvcibydo1a">Cash and cash equivalents</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20241231_zPntbMIucFk5" title="Cash and cash equivalents">103,774</span> and $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zxryDYlBgj13" title="Cash and cash equivalents">426,913 </span>as of December 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> 103774 426913 <p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_zwQKrcN6JPw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i><span id="xdx_861_zvjcaho8pkqd">Investments Held in Trust Account</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of December 31, 2024 and 2023, the Trust Account had balance of $<span id="xdx_90A_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20241231_zGXS6Ou3iL5a" title="Trust account balance">75,794,241</span> and $<span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zJPinm4d53Ni" title="Trust account balance">71,419,358</span>, respectively. The interest and dividend income earned from the Trust Account totaled $<span id="xdx_903_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20241231_zNyEdcprCWWf" title="Interests earned from trust account">3,684,883</span> and $<span id="xdx_90D_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20230217__20231231_z515QFDpjICl" title="Interest and dividend income earned from trust account">1,729,358</span> for the year ended December 31, 2024 and for the period from February 17, 2023 (inception) through December 31, 2023, respectively, which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> 75794241 71419358 3684883 1729358 <p id="xdx_84B_ecustom--OfferingCostsPolicyTextBlock_zkb0jpuYqSr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_863_zhxqih77B8Q1">Offering Costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Offering costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on July 14, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_84B_ecustom--InterestExpensesPolicyTextBlock_z2zFBsMTnm0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_86B_zVIH0586smYe">Interest Expenses</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Interest expense in 2024 is primarily from the amortization of the debt discount in connection with the promissory note issued by the Company to related party. See Note 5</span> - Related Parties for more information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zrcnbRbPgMOa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_866_ziSxscaeahYc">Amortization of Debt Discount</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company’s promissory note issued with related party is recorded net of debt discount which comprised issuance costs, and the discount initially recognized for the fair value of the shares transferred. The portion of the debt issuance costs allocated to the promissory note, is being amortized over the terms, which is upon consummation of the Business Combination. The amortization of debt issuance costs and discount is included in interest expense within the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"></p> <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zQ8sW8GQlC7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_867_zuiivAcBISI">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “<i>Income Taxes</i>.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20241231_zse9gv9D1F9l" title="Unrecognized tax benefits"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zagxnlRzv8Wl" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_90D_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20241231_ztbyjfgDUA3l" title="Interest and penalties accrued"><span id="xdx_908_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zZG6lUpTO9e" title="Interest and penalties accrued">no</span></span> amounts accrued for interest and penalties as of December 31, 2024 and 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> 0 0 0 0 <p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_z8Vww5P0FOai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_863_z8mlvJHKS51e">Net Income (Loss) per Ordinary Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The net income (loss) per share presented in the statements of operations is based on the following:</span></p> <p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zLHmK4HS4vDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_z0q1PfPZ1E2b" style="display: none">SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20240101__20241231_zHkZuLJTDCAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year</p> <p style="margin-top: 0; margin-bottom: 0">Ended<br/> December 31, 2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20230217__20231231_zcUDw52Bm8P3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Period</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>from<br/> February 17, 2023<br/> (Inception)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>Through</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--NetIncomeLoss_maNLIAOz8yg_zVObB206Kckl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,963,852</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,484,790</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz8yg_z2TibQ3IMON7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on investment held in Trust Account</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,684,883</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,729,358</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz8yg_zIJHV4UuEK48" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(690,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,591,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz8yg_zKUW9BSJ7lDd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,411,031</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,836,068</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zy6jQjmMwjMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zJsEhEY2b1sf" style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B0_z4ANMBSvVJK3" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z0GiEu7Y9L8i" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zEOwnnZTc702" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zD8p9HqcpzNd" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMDvO7uG3o73" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> <span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2024</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Period from<br/> February 17, 2023<br/> (Inception) Through</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted net income (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Weighted-average shares outstanding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zsxWIHMwiuzb" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVHni2KahKRl" title="Weighted average shares outstanding - diluted">6,900,000</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNEw6vE2bhEl" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCflkv6WhEyl" title="Weighted average shares outstanding - diluted">2,266,500</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdtPfAzhs4U1" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zWMkjcQhRMdg" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zblVC9k1Gbs7" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZg1dqXstfQ5" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ownership percentage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTJHz5kEuo1c" title="Ownership percentage">75</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zTQKBGHr4XN4" title="Ownership percentage">25</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzypNCzMb90d" title="Ownership percentage">65</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zR2RigqiKNMh" title="Ownership percentage">35</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Numerators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zTPo6SMloJ8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,062,141</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(348,890</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(5,059,453</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(2,776,615</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_z8SosdwYN8a1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion of temporary equity into redemption value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">690,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,591,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0673">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_zAtrCzi90M49" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Interest earned on Trust Account</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,684,883</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,729,358</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0678">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_zwGqGJa9IJqb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Allocation of net income (loss)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,312,742</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(348,890</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,261,405</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,776,615</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zf3aMhLR1lmh" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSvXVO6mcl1d" title="Weighted average shares outstanding - diluted">6,900,000</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMxjCR5kqalk" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ztyFahSCOeO" title="Weighted average shares outstanding - diluted">2,266,500</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOZlG1hvI6Le" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zEjkBA7uZnV4" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrnMCHOtq2m3" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOdYcOIFoA7" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQyfV4MR305l" title="Basic net income/(loss) per share"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zmHBPrrc5vXg" title="Diluted net income/(loss) per share">0.48</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zn8myMps81Vl" title="Basic net income/(loss) per share"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zE0RQHjQsQJ6" title="Diluted net income/(loss) per share">(0.15</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zUPgykvewTH8" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z4CiicYwzcz7" title="Diluted net income/(loss) per share">1.12</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYYhXJvMghBi" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zvZUNgj5D8M7" title="Diluted net income/(loss) per share">(1.32</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AB_zA3MeltYTkCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zLHmK4HS4vDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_z0q1PfPZ1E2b" style="display: none">SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20240101__20241231_zHkZuLJTDCAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year</p> <p style="margin-top: 0; margin-bottom: 0">Ended<br/> December 31, 2024</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20230217__20231231_zcUDw52Bm8P3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Period</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>from<br/> February 17, 2023<br/> (Inception)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>Through</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--NetIncomeLoss_maNLIAOz8yg_zVObB206Kckl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,963,852</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,484,790</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz8yg_z2TibQ3IMON7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on investment held in Trust Account</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,684,883</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,729,358</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz8yg_zIJHV4UuEK48" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(690,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,591,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz8yg_zKUW9BSJ7lDd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,411,031</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,836,068</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> 2963852 1484790 3684883 1729358 690000 7591500 -1411031 -7836068 <p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zJsEhEY2b1sf" style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B0_z4ANMBSvVJK3" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z0GiEu7Y9L8i" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zEOwnnZTc702" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zD8p9HqcpzNd" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMDvO7uG3o73" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> <span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2024</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>For the Period from<br/> February 17, 2023<br/> (Inception) Through</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>December 31, 2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Non-</p> <p style="margin-top: 0; margin-bottom: 0">Redeemable</p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted net income (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Weighted-average shares outstanding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zsxWIHMwiuzb" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVHni2KahKRl" title="Weighted average shares outstanding - diluted">6,900,000</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNEw6vE2bhEl" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCflkv6WhEyl" title="Weighted average shares outstanding - diluted">2,266,500</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdtPfAzhs4U1" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zWMkjcQhRMdg" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zblVC9k1Gbs7" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZg1dqXstfQ5" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ownership percentage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTJHz5kEuo1c" title="Ownership percentage">75</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zTQKBGHr4XN4" title="Ownership percentage">25</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzypNCzMb90d" title="Ownership percentage">65</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zR2RigqiKNMh" title="Ownership percentage">35</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Numerators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zTPo6SMloJ8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,062,141</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(348,890</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(5,059,453</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(2,776,615</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_z8SosdwYN8a1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion of temporary equity into redemption value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">690,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,591,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0673">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_zAtrCzi90M49" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Interest earned on Trust Account</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,684,883</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,729,358</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0678">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_zwGqGJa9IJqb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Allocation of net income (loss)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,312,742</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(348,890</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,261,405</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,776,615</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zf3aMhLR1lmh" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSvXVO6mcl1d" title="Weighted average shares outstanding - diluted">6,900,000</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMxjCR5kqalk" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ztyFahSCOeO" title="Weighted average shares outstanding - diluted">2,266,500</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOZlG1hvI6Le" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zEjkBA7uZnV4" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrnMCHOtq2m3" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOdYcOIFoA7" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQyfV4MR305l" title="Basic net income/(loss) per share"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zmHBPrrc5vXg" title="Diluted net income/(loss) per share">0.48</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zn8myMps81Vl" title="Basic net income/(loss) per share"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zE0RQHjQsQJ6" title="Diluted net income/(loss) per share">(0.15</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zUPgykvewTH8" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z4CiicYwzcz7" title="Diluted net income/(loss) per share">1.12</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYYhXJvMghBi" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zvZUNgj5D8M7" title="Diluted net income/(loss) per share">(1.32</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 6900000 6900000 2266500 2266500 3819156 3819156 2095943 2095943 0.75 0.25 0.65 0.35 -1062141 -348890 -5059453 -2776615 690000 7591500 3684883 1729358 3312742 -348890 4261405 -2776615 6900000 6900000 2266500 2266500 3819156 3819156 2095943 2095943 0.48 0.48 -0.15 -0.15 1.12 1.12 -1.32 -1.32 <p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zRgdpkmJYvji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_86C_z9boLubmHE39">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20241231_ziqJYSvEQ40k" title="Cash, FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> 250000 <p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zte1dxL6vmf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_869_z2YL44pwuX07">Fair Value of Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “<i>Fair Value Measurement</i>,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p id="xdx_84F_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zgvTqC16o1bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_861_zMaqi9OWUGD9">Ordinary Shares Subject to Possible Redemption</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #212529"> </p> <p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zw2k7D0lC0Xh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="display: none"><span id="xdx_8B8_z9sDeMme6D9d">SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-size: 10pt">Public offering proceeds</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaAWhDeObJmk" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Public offering proceeds"><span style="font-size: 10pt">60,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Less:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Proceeds allocated to Public Rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zsAg58WAJsJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds allocated to public rights"><span style="font-size: 10pt">(3,272,724</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allocation of offering costs related to redeemable shares</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znVWt5L8FUbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Allocation of offering costs related to redeemable shares"><span style="font-size: 10pt">(2,925,140</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt">Accretion of carrying value to redemption value</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--AccretionOfCarryingValueToRedemptionValue_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziCJB7nafd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion of carrying value to redemption value"><span style="font-size: 10pt">6,797,864</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Ordinary shares subject to possible redemption</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvAcQ5kOw9ph" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt">60,600,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><i>Over-allotment</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Over-allotment proceeds</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ProceedsFromOtherEquity_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zIJqc2fOlLR5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Over-allotment proceeds"><span style="font-size: 10pt">9,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Less:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Proceeds allocated to Public Rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoMoeEPwD4wf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds allocated to Public Rights"><span style="font-size: 10pt">(490,909</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allocation of offering costs related to redeemable shares</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zuZSmNLjou4h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Allocation of offering costs related to redeemable shares"><span style="font-size: 10pt">(212,727</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Accretion of carrying value to redemption value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--AccretionOfCarryingValueToRedemptionValue_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoI80HtTHlXb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion of carrying value to redemption value"><span style="font-size: 10pt">793,636</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFczx95O9su7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"><span style="font-size: 10pt">1,729,358</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Ordinary shares subject to possible redemption, December 31, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>$</b></span></td> <td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zbamD9mXpmbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt"><b>71,419,358</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20241231_zXqFRookmhej" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account"><span style="font-size: 10pt">3,684,883</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_ecustom--SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionExtensionDeposit_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3lb7GbHuOfk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt">690,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Ordinary shares subject to possible redemption, December 31, 2024</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20241231_zvylAHtiledd" style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt"><b>75,794,241</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> </table> <p id="xdx_8AA_zIOqqb7zpxV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zw2k7D0lC0Xh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">At December 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="display: none"><span id="xdx_8B8_z9sDeMme6D9d">SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-size: 10pt">Public offering proceeds</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaAWhDeObJmk" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Public offering proceeds"><span style="font-size: 10pt">60,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Less:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Proceeds allocated to Public Rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zsAg58WAJsJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds allocated to public rights"><span style="font-size: 10pt">(3,272,724</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allocation of offering costs related to redeemable shares</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znVWt5L8FUbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Allocation of offering costs related to redeemable shares"><span style="font-size: 10pt">(2,925,140</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt">Accretion of carrying value to redemption value</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--AccretionOfCarryingValueToRedemptionValue_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziCJB7nafd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion of carrying value to redemption value"><span style="font-size: 10pt">6,797,864</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Ordinary shares subject to possible redemption</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvAcQ5kOw9ph" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt">60,600,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><i>Over-allotment</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Over-allotment proceeds</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ProceedsFromOtherEquity_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zIJqc2fOlLR5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Over-allotment proceeds"><span style="font-size: 10pt">9,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Less:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Proceeds allocated to Public Rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoMoeEPwD4wf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds allocated to Public Rights"><span style="font-size: 10pt">(490,909</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allocation of offering costs related to redeemable shares</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zuZSmNLjou4h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Allocation of offering costs related to redeemable shares"><span style="font-size: 10pt">(212,727</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Accretion of carrying value to redemption value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--AccretionOfCarryingValueToRedemptionValue_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoI80HtTHlXb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion of carrying value to redemption value"><span style="font-size: 10pt">793,636</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFczx95O9su7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"><span style="font-size: 10pt">1,729,358</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Ordinary shares subject to possible redemption, December 31, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>$</b></span></td> <td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zbamD9mXpmbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt"><b>71,419,358</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Plus:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20241231_zXqFRookmhej" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account"><span style="font-size: 10pt">3,684,883</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_ecustom--SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionExtensionDeposit_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3lb7GbHuOfk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt">690,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Ordinary shares subject to possible redemption, December 31, 2024</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20241231_zvylAHtiledd" style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font-size: 10pt"><b>75,794,241</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> </table> 60000000 -3272724 2925140 6797864 60600000 9000000 -490909 212727 793636 1729358 71419358 3684883 690000 75794241 <p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zif1TLbnWyce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i><span id="xdx_86C_zEatBHyEdu2j">Recent Accounting Standards</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance in ASU 2023-07 on January 1, 2024, and there is no significant impact on the disclosure of the consolidated financial statements. The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.</span></p> <p id="xdx_80A_ecustom--InitialPublicOfferingTextBlock_zbh2tCdKAq6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b>NOTE 3 — <span id="xdx_825_zmE9IEIeYFzl">INITIAL PUBLIC OFFERING</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">On July 14, 2023, the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMXEJuDqRi48" title="Stock issued during period shares">6,000,000</span> Units at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDG6XpuciUu4" title="Sale of stock, par share">10.00</span> per Unit. <span id="xdx_905_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zcsaTw2E9Xu8" title="Stock holders equity related to initial public offering description">Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights.</span> The Company also granted the underwriters a 45-day option to purchase up to an additional <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zKbvDBFWwuki" title="Stock issued during the period, shares">900,000</span> units to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company incurred $<span id="xdx_909_eus-gaap--PaymentsForFees_c20240101__20241231__srt--TitleOfIndividualAxis__custom--QianzhiMember_zHVRuLOqvbp" title="Nasdaq entry fee">75,000</span> Nasdaq delayed entry fee during the IPO in 2023 and this balance was subsequently paid by Qianzhi which is the target company. As of December 31, 2024, this balance is recorded as “Payable to target” on the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> 6000000 10.00 Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights. 900000 75000 <p id="xdx_803_ecustom--PrivatePlacementsTextBlock_zvheYXyQRnph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b>NOTE 4 — <span id="xdx_822_zqA675Ye9dj2">PRIVATE PLACEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Sponsors and EBC had agreed to purchase an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbAIeRH1el9i" title="Number of shares issued">330,000</span> Private Placement Units (<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_znhbHozScHBc" title="Number of shares issued">312,000 </span>Private Placement Units to be purchased by the Sponsors and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_zWj0t4iEK561" title="Number of shares issued">18,000</span> Private Placement Units to be purchased by EBC or its designees), or <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zHTXtJNVYOg3" title="Number of shares issued">361,500</span> Private Placement Units if the underwriters’ over-allotment is exercised in full, at a price of $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhEQ5vVNi8bk" title="Unit exercise price per share">10.00</span> per Private Placement Unit ($<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zldR7vc2vxIi" title="Value of stock issued">3,300,000</span>, or an aggregate of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zdIjZIXUnPfk" title="Value of stock issued">3,615,000</span> if the underwriters’ over-allotment is exercised in full) from the Company in a private placement that will occur simultaneously with the closing of the Initial Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Simultaneously with the closing of the IPO on July 14, 2023, the Company consummated the private sale of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zxpZSfLmCRoa" title="Number of shares issued">330,000</span> Private Placement Units. <span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zqzF3PVbY3B" title="Units related to private placement description">Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination.</span> The proceeds from the sale of the Private Placement Units were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to certain exceptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">On July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> 330000 312000 18000 361500 10.00 3300000 3615000 330000 Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. <p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z9XKUYvvbQD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"><b>NOTE 5 — <span id="xdx_82D_zilsGAZGcYu8">RELATED PARTIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"><b><i>Founder Shares and EBC Founder Shares</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">On February 27, 2023, the Sponsors received <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zWUAiaQgLuz7" title="Number of shares issued">1,725,000</span> of the Company’s ordinary shares (“Founder Shares”) in exchange for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zEd9Vi1C7Zxb" title="Sponsors received ordinary shares, value">25,000</span> paid for offering costs borne by the Sponsors. Up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrBEiutXkoyc" title="Number of shares subject to forfeiture">225,000</span> of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full. On July 17, 2023, the underwriters exercised their over-allotment option in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">On March 15, 2023, the Company issued to EBC <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zRJmpTVDBHb9" title="Number of shares issued">180,000</span> ordinary shares (“EBC founder shares”) for a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zEMDzkcjOVd7" title="Ordinary share price">0.014</span> per share and an aggregate purchase price of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zd4nFSxTOn8b" title="Value of stock issued">2,520</span>. The EBC founder shares are deemed to be underwriters’ compensation by FINRA pursuant to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $<span id="xdx_908_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zb5UXJafd4lf" title="Fair value of shares issued">1,016,000</span> or $<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_z9fvMpQQJgsi" title="Fair value of ordinary per share price">5.65</span> per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value of the shares as offering cost.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EBCFounderSharesMember_z1Z8TnLsKYg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span id="xdx_8B8_zBAOYTqL9D1e" style="display: none">SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-size: 10pt; color: black">Time to expiration</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_90A_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zu8VYVffYW2e" title="Time to expiration">1.84</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt; color: black"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Risk-free rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_909_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zDh9yHQLl7Si" title="Risk-free rate">4.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zfWfucEQUYvb" title="Risk-free rate">5.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Dividend yield</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zeo5eGucRsed" title="Risk-free rate">0.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Probability of completion of business combination</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_90B_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zjLF4dEvei3h" title="Founder shares measurement input">60.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> </table> <p id="xdx_8A6_zfgE0swXD946" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an initial business combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On October 14, 2024, one of the Sponsors transferred <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241014__20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_zdWDXbjkMqd6" title="Founder shartes issued">30,000</span> of its Founder Shares to EBC in connection with $<span id="xdx_90A_eus-gaap--LoansPayable_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EBCFounderSharesMember_z6di5WOD2jCg" title="Loans payable">500,000</span> loan for the extension. See below for more details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"><b><i>Promissory Note — Related Party</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">On February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_z9LB4iIshhGk">300,000</span>. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230227__20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_zCrXXVXkNbG9">July 14, 2023</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">On October 14, 2024, EBC loaned the Company $<span id="xdx_90A_eus-gaap--LoansPayable_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EBCFounderSharesMember_zaSWVd9mold" title="Loans payable">500,000</span> which funds were deposited into the Trust Account for the extension. The loan is evidenced by promissory note issued by the Company (“Extension Note”). The Extension Note bears no interest and is repayable in full upon consummation of a Business Combination. In connection with the loan, one of the Sponsors transferred <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241014__20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_zZlU4ieNSKqe" title="Founder shartes issued">30,000</span> of its Founder Shares to EBC. The value of the shares transferred is reflected as debt discount and fully amortized as interest expense over the life of the loan per ASC 835. As of December 31, 2024, $<span id="xdx_907_eus-gaap--DebtDefaultShorttermDebtAmount_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EBCFounderSharesMember_z4XfvWB81n8d" title="Debt short term amount">500,000</span> was outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #212529"> </p> <p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zT5lNF9eurr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529">The Company estimated the fair value of the Founder Shares to be approximately $<span id="xdx_900_eus-gaap--AdjustmentsToAdditionalPaidInCapitalOther_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zr2yeRl1tiO5" title="Debt discount">209,442</span> or $<span id="xdx_904_eus-gaap--SharePrice_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zb79tN4tYjN1" title="Share price">6.98</span> per share using the Black-Scholes option pricing model. The fair value of the Founder Shares was estimated at October 14, 2024. <span style="background-color: white">The Company used the following assumptions to estimate the fair value of Founder Shares using Level 3 fair value measurements inputs at the measurement date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B7_z0VdNF7i0oB7" style="display: none">SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 81%"><span style="font-size: 10pt">Time to expiration</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-size: 10pt"><span id="xdx_900_ecustom--EquitySecuritiesFvNiTerm_dtY_c20241014__20241014_z0QeBwLliMH9" title="Time to expiration">1.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Risk-free rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUt6udbDXs6c" title="Risk-free rate">4.2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_902_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_ziiUfvaL23Kc" title="Risk-free rate">5.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Dividend yield</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zKVGZVf1MFg2" title="Risk-free rate">0.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Probability of completion of business combination</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zVA1KzrOG6df" title="Founder shares measurement input">65.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A9_zgJWMsN1MXI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">Based on the fair value of the Founder Shares, the Company recorded a debt discount of $<span id="xdx_90C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalOther_c20240101__20241231_zvfKYE5TtrXj" title="Debt discount">209,442</span>, which is amortized as interest expense over the loan period. The loan period extends until the consummation of the Business Combination, estimated to occur on April 15, 2025. As of December 31, 2024, the Company recorded an interest expense of $<span id="xdx_900_eus-gaap--InterestExpenseNonoperating_c20240101__20241231_zCfenpu4TJUk" title="Interest expense">87,267</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"><b><i>Underwriting Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">The Company granted the underwriters a 45-day option from the date of IPO to purchase up to <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zrQDTzLuTgR8" title="Stock issued during the period, shares">900,000</span> additional Units to cover over-allotments, at the IPO price less the underwriting discounts and commissions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">The underwriters were entitled to a cash underwriting discount of $<span id="xdx_90E_ecustom--CashUnderwritingDiscountPerUnit_pid_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zqoraVv6ROX8" title="Cash underwriting discount per unit">0.25</span> per Unit, or $<span id="xdx_903_ecustom--CashUnderwritingDiscount_pid_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zWKFQgH4QQB4" title="Aggregate cash underwriting discount">1,500,000</span> in the aggregate (or $<span id="xdx_901_eus-gaap--PaymentsForUnderwritingExpense_pid_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zu1YpzexJoQa" title="Payments for underwriting expense">1,725,000</span> in the aggregate if the underwriters’ over-allotment option is exercised in full), payable upon the closing of the IPO.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">On July 17, 2023, the underwriters exercised the over-allotment option in full to purchase <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjOw3aC6umHl" title="Stock issued during the period, shares">900,000</span> Units. As a result, on July 18, 2023, the Company sold an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4u0wCJfFgRl" title="Stock issued during the period, shares">900,000</span> Units at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zlfDZVuZv50k" title="Price per share">10.00</span> per Unit, generating gross proceeds to the Company of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zizwr0t2hVRk" title="Gross proceeds">9,000,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"><b><i>Due to Related Party</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">The Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest bearing. Before the IPO, the Sponsors had paid $<span id="xdx_902_eus-gaap--RepaymentsOfRelatedPartyDebt_c20230217__20231231_zX0nCWXTb0r9" title="Related party debt">151,318</span> on behalf of the Company for expenses related to IPO, which was fully repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">As of December 31, 2024, the total accrued expenses due to related parties was $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zL35pASqUpZb" title="Accrued expenses">101,285</span>, which includes $<span id="xdx_901_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--BalanceSheetLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z17bqVaCp9Cf" title="Accrued expenses">90,000</span> payable for administration fee and $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--BalanceSheetLocationAxis__custom--AccountingServicesExpenseMember_zEBPkyantdo4" title="Accrued expenses">11,285</span> payable for accounting related and other service fee. As of December 31, 2023, the total accrued expenses due to related parties was $<span id="xdx_901_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z6gu263EZT55" title="Accrued expenses">25,250</span>, which include $<span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--BalanceSheetLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z2JRv0zhOYJf" title="Accrued expenses">20,000</span> payable for administration fee and $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--BalanceSheetLocationAxis__custom--AccountingServicesExpenseMember_zEqvBL1bXX24" title="Accrued expenses">5,250</span> payable for accounting service fee. See following paragraphs for details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529"><b><i>Accounting Service Agreement and Others</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: #212529">The Company has engaged TenX Global Capital, a related party of the Company, to assist in initial accounting preparation, preparing quarterly and annual financial statements commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $<span id="xdx_90F_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230217__20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementAndOtherMember_zSymNrkzuKpc">5,250 </span>each quarter. TenX Global Capital also provides other services following the consummation of the IPO.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Administration Fee</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">Commencing on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the Company an allocable share of its overhead, up to $<span id="xdx_90A_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_zruCZLLBzF63">10,000 </span></span><span style="background-color: white">per month, until to the close of the Business Combination, to compensate it for the Company’s use of its office, utilities and personnel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_891_ecustom--ScheduleOfExpensesIncurredAndPayableTableTextBlock_zkT84OVJ4IGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The following table presents details about the expenses incurred and payable for the year ended December 31, 2024 and during the period </span>from February 17, 2023 (inception) through December 31, 2023:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span id="xdx_8BB_ztCRV5C1hAS9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF EXPENSES INCURRED AND PAYABLES</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" id="xdx_492_20240101__20241231_zxe91j4Xa08" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230217__20231231_zT0FNUdehfB5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nature</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Operating Costs</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Payable Balance as of December 31,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center">For the year ended December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: black"><b>During the period from February 17, 2023 (</b></span><b><span style="font-size: 10pt; color: #212529">inception) through December 31, 2023</span></b></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td></tr> <tr id="xdx_403_ecustom--InitialAccountingServiceFee_zFPSairc6Gja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; color: black; text-align: left">Initial accounting service fee</td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td style="width: 11%; font-size: 10pt; color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0885">-</span></td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td style="width: 11%; font-size: 10pt; color: black; text-align: right">20,000</td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td id="xdx_988_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--InitialAccountingServiceFeeMember_zZwOY6uhQGuj" style="width: 11%; font-size: 10pt; color: black; text-align: right" title="Accrued expenses"><span style="-sec-ix-hidden: xdx2ixbrl0888">-</span></td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td id="xdx_982_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--InitialAccountingServiceFeeMember_zFtuKKQeOMde" style="width: 11%; font-size: 10pt; color: black; text-align: right" title="Accrued expenses"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--AccountingServiceFeeAndOthers_zHQJeOXPyRGf" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; color: black; text-align: left">Accounting service fee and others</td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; text-align: right">21,785</td><td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; text-align: right">10,500</td><td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_989_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AccountingServiceFeeAndOthersMember_zdm6Z5Hwuhkl" style="font-size: 10pt; color: black; text-align: right" title="Accrued expenses">11,285</td><td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AccountingServiceFeeAndOthersMember_zK44WLrZtMf1" style="font-size: 10pt; color: black; text-align: right" title="Accrued expenses">5,250</td><td style="font-size: 10pt; color: black; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PaymentForAdministrativeFees_zbMUmlhdaAPk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; color: black; text-align: left; padding-bottom: 1pt">Administration fee</td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">120,000</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">56,667</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_983_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AdministrationFeeMember_z9nqN4UNCQGf" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right" title="Accrued expenses">90,000</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_987_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AdministrationFeeMember_zxs6jdj9xvfi" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right" title="Accrued expenses">20,000</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PaymentsForFees_zJGQT3BSqNk2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right">141,785</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right">87,167</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zFjB8lYRptQ7" style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right" title="Accrued expenses">101,285</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zAABJTpc7wzc" style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right" title="Accrued expenses">25,250</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> 1725000 25000 225000 180000 0.014 2520 1016000 5.65 <p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EBCFounderSharesMember_z1Z8TnLsKYg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span id="xdx_8B8_zBAOYTqL9D1e" style="display: none">SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-size: 10pt; color: black">Time to expiration</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_90A_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zu8VYVffYW2e" title="Time to expiration">1.84</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt; color: black"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Risk-free rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_909_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zDh9yHQLl7Si" title="Risk-free rate">4.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zfWfucEQUYvb" title="Risk-free rate">5.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Dividend yield</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zeo5eGucRsed" title="Risk-free rate">0.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">Probability of completion of business combination</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt; color: black"><span id="xdx_90B_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zjLF4dEvei3h" title="Founder shares measurement input">60.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: black">%</span></td></tr> </table> P1Y10M2D 0.040 0.050 0.000 0.600 30000 500000 300000 2023-07-14 500000 30000 500000 <p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zT5lNF9eurr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529">The Company estimated the fair value of the Founder Shares to be approximately $<span id="xdx_900_eus-gaap--AdjustmentsToAdditionalPaidInCapitalOther_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zr2yeRl1tiO5" title="Debt discount">209,442</span> or $<span id="xdx_904_eus-gaap--SharePrice_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zb79tN4tYjN1" title="Share price">6.98</span> per share using the Black-Scholes option pricing model. The fair value of the Founder Shares was estimated at October 14, 2024. <span style="background-color: white">The Company used the following assumptions to estimate the fair value of Founder Shares using Level 3 fair value measurements inputs at the measurement date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B7_z0VdNF7i0oB7" style="display: none">SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 81%"><span style="font-size: 10pt">Time to expiration</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-size: 10pt"><span id="xdx_900_ecustom--EquitySecuritiesFvNiTerm_dtY_c20241014__20241014_z0QeBwLliMH9" title="Time to expiration">1.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Risk-free rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUt6udbDXs6c" title="Risk-free rate">4.2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_902_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_ziiUfvaL23Kc" title="Risk-free rate">5.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Dividend yield</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zKVGZVf1MFg2" title="Risk-free rate">0.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Probability of completion of business combination</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_dp_uPure_c20241014__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zVA1KzrOG6df" title="Founder shares measurement input">65.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">%</span></td></tr> </table> 209442 6.98 P1Y 0.042 0.050 0.000 0.650 209442 87267 900000 0.25 1500000 1725000 900000 900000 10.00 9000000 151318 101285 90000 11285 25250 20000 5250 5250 10000 <p id="xdx_891_ecustom--ScheduleOfExpensesIncurredAndPayableTableTextBlock_zkT84OVJ4IGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The following table presents details about the expenses incurred and payable for the year ended December 31, 2024 and during the period </span>from February 17, 2023 (inception) through December 31, 2023:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span id="xdx_8BB_ztCRV5C1hAS9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF EXPENSES INCURRED AND PAYABLES</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" id="xdx_492_20240101__20241231_zxe91j4Xa08" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230217__20231231_zT0FNUdehfB5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nature</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Operating Costs</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Payable Balance as of December 31,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center">For the year ended December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: black"><b>During the period from February 17, 2023 (</b></span><b><span style="font-size: 10pt; color: #212529">inception) through December 31, 2023</span></b></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold"> </td></tr> <tr id="xdx_403_ecustom--InitialAccountingServiceFee_zFPSairc6Gja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; color: black; text-align: left">Initial accounting service fee</td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td style="width: 11%; font-size: 10pt; color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0885">-</span></td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td style="width: 11%; font-size: 10pt; color: black; text-align: right">20,000</td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td id="xdx_988_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--InitialAccountingServiceFeeMember_zZwOY6uhQGuj" style="width: 11%; font-size: 10pt; color: black; text-align: right" title="Accrued expenses"><span style="-sec-ix-hidden: xdx2ixbrl0888">-</span></td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td><td style="width: 2%; font-size: 10pt; color: black"> </td> <td style="width: 1%; font-size: 10pt; color: black; text-align: left">$</td><td id="xdx_982_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--InitialAccountingServiceFeeMember_zFtuKKQeOMde" style="width: 11%; font-size: 10pt; color: black; text-align: right" title="Accrued expenses"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="width: 1%; font-size: 10pt; color: black; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--AccountingServiceFeeAndOthers_zHQJeOXPyRGf" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; color: black; text-align: left">Accounting service fee and others</td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; text-align: right">21,785</td><td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; text-align: right">10,500</td><td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_989_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AccountingServiceFeeAndOthersMember_zdm6Z5Hwuhkl" style="font-size: 10pt; color: black; text-align: right" title="Accrued expenses">11,285</td><td style="font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black"> </td> <td style="font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AccountingServiceFeeAndOthersMember_zK44WLrZtMf1" style="font-size: 10pt; color: black; text-align: right" title="Accrued expenses">5,250</td><td style="font-size: 10pt; color: black; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PaymentForAdministrativeFees_zbMUmlhdaAPk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; color: black; text-align: left; padding-bottom: 1pt">Administration fee</td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">120,000</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">56,667</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_983_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AdministrationFeeMember_z9nqN4UNCQGf" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right" title="Accrued expenses">90,000</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td><td style="font-size: 10pt; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left"> </td><td id="xdx_987_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--AdministrationFeeMember_zxs6jdj9xvfi" style="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right" title="Accrued expenses">20,000</td><td style="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PaymentsForFees_zJGQT3BSqNk2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right">141,785</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right">87,167</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--AccruedLiabilitiesCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zFjB8lYRptQ7" style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right" title="Accrued expenses">101,285</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zAABJTpc7wzc" style="border-bottom: Black 2.5pt double; font-size: 10pt; color: black; font-weight: bold; text-align: right" title="Accrued expenses">25,250</td><td style="padding-bottom: 2.5pt; font-size: 10pt; color: black; font-weight: bold; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> 20000 21785 10500 11285 5250 120000 56667 90000 20000 141785 87167 101285 25250 <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zi77zUb8wDEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b>NOTE 6 — <span id="xdx_82E_zCC7OXdzO8w2">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Registration Rights</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Business Combination Marketing Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation of its initial Business Combination in an amount of $<span id="xdx_90D_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zI5DXNX5q444" title="Service fee">2,415,000</span>, equal to <span id="xdx_90F_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20241231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zSTporyQbQYg" title="Percentage of gross proceeds of initial public offering">3.5%</span> of the gross proceeds of the IPO. In addition, the Company will pay EBC a service fee in an amount equal to <span id="xdx_901_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20241231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zrqnipYpYJUh" title="Percentage of service fee of total consideration payable">1.0%</span> of the total consideration payable in the initial Business Combination if it introduces the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and is due at the closing date of the initial Business Combination. No such service has been provided by EBC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Business Combination Transaction Cost</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company has engaged several service providers including legal and valuation services, specifically for business combination between the Company and Shenzhen Qianzhi BioTechnology Co. Ltd. (“Qianzhi”). Per the agreed terms, Qianzhi agreed to be responsible for all expenses incurred by the Company in connection with business combination. For the year ended December 31, 2024, $<span id="xdx_90B_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20241231_zDUxP2pEPMjg" title="Business combination related cost incurred"><span style="background-color: white">527,145</span></span> of business combination related cost has been incurred which $<span style="background-color: white"><span id="xdx_909_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_z9QZyRG5AMX2" title="Business combination related cost incurred">389,099</span></span> was reimbursed by Qianzhi. During the period from February 17, 2023 (inception) through December 31, 2023, $<span id="xdx_90B_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230217__20231231_za9kpasFy0Xd" title="Business combination related cost">181,022</span> of business combination related cost has been incurred and reimbursed by Qianzhi. This activity has been recorded on the net basis and no impact to financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> 2415000 0.035 0.010 527145 389099 181022 <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zUKOLXSz2W61" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b>NOTE 7 — <span id="xdx_828_zVH1KoE4StAb">SHAREHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Preferred Shares</i></b> — The Company is authorized to issue <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20241231_zJ51oamnglC8" title="Preferred stock, shares authorized">2,000,000</span> preferred shares with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20241231_z2MOflEZklea" title="Preferred stock, par value">0.0001</span> per share with such designations, <span id="xdx_902_eus-gaap--PreferredStockVotingRights_c20240101__20241231_z0RqdNwHJlXe" title="Preferred stock voting rights">voting and other rights and preferences as may be determined from time to time by the Company’s board of directors.</span> As of December 31, 2024 and 2023, there were <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_do_c20241231_zm5NunrsJGa6" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z5FLJKpDRL75" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20241231_zyJqNWMr6iNd" title="Preferred stock, shares outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z64QuVQkMmRc" title="Preferred stock, shares outstanding">no</span></span></span></span> preferred shares issued or outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Ordinary Shares</i></b> — The Company is authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20241231_z3ePra8b2FQi" title="Common stock, shares authorized">200,000,000</span> ordinary shares with a par value of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20241231_zThHEDbwmVA5" title="Common stock, par value">0.0001</span> per share. <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20240101__20241231_z5p3wUouzQol" title="Common stock voting rights">Holders of ordinary shares are entitled to one vote for each share.</span> On February 27, 2023, the Sponsors received <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zpJUIhTk0l0d" title="Issuance of ordinary shares to Sponsor, shares">1,725,000</span> of the Founder Shares in exchange for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zuODYTNvCr4g" title="Issuance of ordinary shares to Sponsor, value">25,000</span> paid for offering costs borne by the Sponsors, of which an aggregate of up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcJz0bzKpQn3" title="Number of shares subject to forfeiture">225,000</span> of such Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares will equal 20% of the Company’s issued and outstanding ordinary shares after the IPO (excluding shares underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on July 17, 2023. As of December 31, 2024 and 2023, there were <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20241231_z0U2gOruwAMe" title="Ordinary shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20241231_zqUTbDYc9057" title="Ordinary shares outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zyiIoFQ3xlXc" title="Ordinary shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zC91XQwNUeUi" title="Ordinary shares outstanding">2,266,500</span></span></span></span> ordinary shares issued and outstanding (excluding <span id="xdx_904_ecustom--OrdinarySharesSubjectToRedemption_iI_c20241231_zY8PSj6fFHJc" title="Ordinary shares subject to redemption"><span id="xdx_90F_ecustom--OrdinarySharesSubjectToRedemption_iI_c20231231_zd5ens2XdWWi" title="Ordinary shares subject to redemption">6,900,000</span></span> shares subject to possible redemption).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b><i>Rights </i></b>— Except in cases where the Company is not the surviving company in a business combination, <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNMBlK6OPUS3" title="Common stock voting rights">each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.</span> The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> 2000000 0.0001 voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. 0 0 0 0 200000000 0.0001 Holders of ordinary shares are entitled to one vote for each share. 1725000 25000 225000 2266500 2266500 2266500 2266500 6900000 6900000 each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. <p id="xdx_808_eus-gaap--FairValueDisclosuresTextBlock_zkigjL8WAJci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"><b>NOTE 8 — <span id="xdx_822_zZQ9Abvk4Vwd">Fair Value Measurements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: #212529; background-color: white">Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: #212529"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: #212529">Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: #212529"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt; color: #212529">Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2024 and 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p id="xdx_898_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zB0Wnzr0D6cl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BC_zFluzydXxNoe" style="display: none">SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Nature</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Level</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Fair Value</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><span style="font-size: 10pt">December 31, 2024</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-size: 10pt">Marketable securities held in the trust account</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zFUMw5OROIc5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Marketable securities held in the trust account"><span style="font-size: 10pt">75,794,241</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0; text-align: justify">December 31, 2024</p></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p id="xdx_983_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyhCyzt7iQJ6" style="margin: 0" title="Cash equivalents">103,774</p></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">December 31, 2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Marketable securities held in the trust account</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfDWgJr4z7V5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Marketable securities held in the trust account"><span style="font-size: 10pt">71,419,358</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Marketable securities held in the trust account"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">December 31, 2023</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_989_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsZzj9xYenR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <p id="xdx_8A6_zLXQbOXnO1Ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_898_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zB0Wnzr0D6cl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BC_zFluzydXxNoe" style="display: none">SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Nature</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Level</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Fair Value</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><span style="font-size: 10pt">December 31, 2024</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-size: 10pt">Marketable securities held in the trust account</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zFUMw5OROIc5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Marketable securities held in the trust account"><span style="font-size: 10pt">75,794,241</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0; text-align: justify">December 31, 2024</p></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p id="xdx_983_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyhCyzt7iQJ6" style="margin: 0" title="Cash equivalents">103,774</p></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">December 31, 2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Marketable securities held in the trust account</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfDWgJr4z7V5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Marketable securities held in the trust account"><span style="font-size: 10pt">71,419,358</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Marketable securities held in the trust account"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">December 31, 2023</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_989_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsZzj9xYenR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> 75794241 103774 71419358 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z9GSWsqwWool" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>NOTE 9 — <span id="xdx_82B_zewx2ZSkKqk1">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required adjustment or disclosure in the financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On January 10, 2025, the Company held an extraordinary general meeting (the “Meeting”) by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date (the “Extension”) by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”), by up to three one-month increments, from January 14, 2025 to as late as April 14, 2025, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. <span style="background-color: white">In connection with the meeting, an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250110__20250110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1ko1PiF5LJ5" title="Stock issued during period, shares">6,052,095</span> Public Shares were redeemed at a price of approximately $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20250110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zK4Vrvj8x9Eg" title="Share price">10.99</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On January 13, 2025, the Company entered into Prepaid Forward Purchase Agreement (the “FPA”) by and among the Company, NewCo, and the funds, accounts and/other investment vehicles managed by Harraden Circle Investments, LLC signatory thereto (collectively, the “Purchaser”). <span id="xdx_902_eus-gaap--SubsequentEventDescription_c20250113__20250113__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLg2pZq9ugv4" title="Subsequent descripition">In accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser shall purchase from holders of ordinary shares, par value $0.0001 per share, of the Company (“Company Ordinary Share”) that have elected to redeem their Company Ordinary Shares in connection with the contemplated business combination (“Business Combination”) between the Company, NewCo and Qianzhi, up to the lesser of (a) 550,000 Company Ordinary Shares and (b) such number of Company Ordinary Shares as shall, following the Business Combination between the Company, NewCo and Qianzhi, not to exceed 9.9% of the total number of Company Ordinary Shares to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price (the “Redemption Price”) per share to be paid to redeeming public shareholders of the Company. The current Redemption Price payable to redeeming public shareholders is approximately $10.991 per share. Any Company Ordinary Shares purchased pursuant to the FPA will not be voted in favor of approving the Business Combination. Upon the Business Combination closing, 50,000 Purchased Shares shall be deemed to be “Commitment Shares” and the remaining Forward Purchased Shares shall be deemed to be “Prepaid Forward Purchase Shares”. </span>No later than the earlier of (a) one business day after the Business Combination closing and (b) the date any assets from the Company’s trust account are disbursed in connection with the Business Combination, the Company and NewCo shall cause Purchaser to be paid directly, out of the funds held in the Company’s trust account, a cash amount (the “Prepayment Amount”) equal to the number of Forward Purchased Shares multiplied by the Redemption Price. Upon the subsequent sale of the Prepaid Forward Purchase Shares by the Purchaser, the Purchaser will remit the Reference Price (as defined below) per share to the Company. On the date that is twelve months after the closing of the Business Combination (the “Maturity Date”), any Prepaid Forward Purchase Shares not sold by the Purchaser will be returned by the Purchaser to the Company and any remaining amounts in respect of the Prepaid Forward Purchase Shares will be retained by Purchaser. Prior to the Maturity Date, the Purchaser may sell Commitment Shares at any price in Purchaser’s sole discretion. The Purchaser has agreed that until the Maturity Date, the Prepaid Forward Purchase Shares may not be sold for a price less than the Reference Price. The “Reference Price” will initially equal the Redemption Price and may, at the Company’s option, be reduced (but never increased) at any time to the lowest daily volume weighted average price of the Company Ordinary Shares for the preceding 10 trading days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On January 14, 2025, the Company held an extraordinary general meeting (the “Business Combination Meeting”) to approve, among other matters, its proposed business combination (the “Business Combination”) with NewCo and Qianzhi. The Company’s shareholders voted on the proposals at the Business Combination Meeting, all of which were described in the Company’s Registration Statement on Form S-4 (“S-4”) which was filed with the Securities and Exchange Commission (“SEC”) and included a prospectus of the Company as well as the Company’s proxy statement (the “Proxy Statement/Prospectus”). All of the proposals were approved. <span style="background-color: white">An aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250114__20250114__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSxsS1rFpMZa" title="Stock issued during period, shares">137,936</span> Public Shares requested redemption in connection with such vote. However, as the business combination has not been consummated, none of such shares has been redeemed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On March 19, 2025, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, for the prior 30 consecutive business days (through March 18, 2025), the closing market value of listed securities (MVLS) of the Company’s ordinary shares, $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250319__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsFsIOdWuKbd" title="Common stock par value">0.00001</span> par value per share, had been below the minimum of $50 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Rule”). The notice stated that the Company would be afforded 180 calendar days (until September 15, 2025) to regain compliance. In order to regain compliance, the closing MVLS of the Company’s securities must be at least $50 million for a minimum of ten consecutive business days. If the Company does not regain compliance within the 180-day period, the securities will be subject to delisting. On April 10, 2025, the Company received a notice from Nasdaq stating that it has regained compliance with the Rule, and this matter is now closed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On April 14, 2025, the Company held an extraordinary general meeting to approve a proposal to extend the time the Company had to consummate its initial Business Combination to up to July 14, 2025. In connection with the meeting, an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250414__20250414__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFl5Z3wjzvXg" title="Number of stock issued">103,432</span> Public Shares were redeemed at a price of approximately $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20250414__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYO8HP4NIqrb" title="Share price">11.03</span> per share.</p> 6052095 10.99 In accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser shall purchase from holders of ordinary shares, par value $0.0001 per share, of the Company (“Company Ordinary Share”) that have elected to redeem their Company Ordinary Shares in connection with the contemplated business combination (“Business Combination”) between the Company, NewCo and Qianzhi, up to the lesser of (a) 550,000 Company Ordinary Shares and (b) such number of Company Ordinary Shares as shall, following the Business Combination between the Company, NewCo and Qianzhi, not to exceed 9.9% of the total number of Company Ordinary Shares to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price (the “Redemption Price”) per share to be paid to redeeming public shareholders of the Company. The current Redemption Price payable to redeeming public shareholders is approximately $10.991 per share. Any Company Ordinary Shares purchased pursuant to the FPA will not be voted in favor of approving the Business Combination. Upon the Business Combination closing, 50,000 Purchased Shares shall be deemed to be “Commitment Shares” and the remaining Forward Purchased Shares shall be deemed to be “Prepaid Forward Purchase Shares”. 137936 0.00001 103432 11.03